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Abstract
Glutamate is one of the primary neurotransmitters in the human brain, and many unanswered questions in
neuroscience, psychiatry and medicine revolve around this molecule: its production, transport, conversion
or degradation, regulation and effects. Yet, to date, methods for actually measuring glutamate within the
human body are extremely limited. Amongst the few options in the medical imaging toolbox are magnetic
resonance spectroscopy (MRS) and a recently introduced specialized form of magnetic resonance
imaging (MRI) known as glutamate-weighted chemical exchange saturation transfer imaging, or gluCEST.
MRS, while providing good specificity at high field strengths, lacks spatial or temporal resolution. GluCEST
has the potential to provide excellent spatial resolution, but has generally been limited to single-slice
acquisitions with sub-optimal B1 correction, precluding its wider application to volumetric measurements
of brain structures. In this thesis, we present a novel way to correct gluCEST for B1 inhomogeneity,
yielding higher quality images. We then demonstrate expansion of single-slice gluCEST imaging to
volumetric ‘slab’ imaging, greatly expanding our ability to capture specific structures within the brain. We
apply gluCEST in both two and three dimensions to investigate healthy brain physiology as well as the
response of healthy subjects to transcranial magnetic stimulation (TMS). We were able to detect elevated
gluCEST in the dentate gyrus in the brains of healthy subjects, the first non invasive measurement of its
kind pertaining to this small but vital structure. We also detected, for the first time, a change in glutamate
concentration in the brains of subjects who have received TMS. Finally, we present work in the area of
spectroscopy, presenting a technique in which –in sharp contrast to existing methodologies requiring
non-standard hardware-- metabolic dynamics of glutamate can be detected using only proton-based
chemical shift imaging (CSI) in conjunction with oral ingestion of deuterium labeled glucose. While itself
limited in spatial resolution, this ability to detect and visualize the dynamic neural metabolism of glucose
to glutamate provides a deeply complimentary source of information to gluCEST. In the future, qCSI and
gluCEST could be used in tandem to provide next-generation precision diagnostics for patients suffering
from neurological maladies of metabolic origin.
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ABSTRACT
IMAGING GLUTAMATE IN THE HUMAN BRAIN AT ULTRA-HIGH MAGNETIC FIELD: ADVANCES
AND APPLICATIONS
Abigail Talya Jordan Cember
Ravinder Reddy
Glutamate is one of the primary neurotransmitters in the human brain, and many unanswered
questions in neuroscience, psychiatry and medicine revolve around this molecule: its
production, transport, conversion or degradation, regulation and effects. Yet, to date, methods
for actually measuring glutamate within the human body are extremely limited. Amongst the
few options in the medical imaging toolbox are magnetic resonance spectroscopy (MRS) and a
recently introduced specialized form of magnetic resonance imaging (MRI) known as glutamateweighted chemical exchange saturation transfer imaging, or gluCEST. MRS, while providing good
specificity at high field strengths, lacks spatial or temporal resolution. GluCEST has the potential
to provide excellent spatial resolution, but has generally been limited to single-slice acquisitions
with sub-optimal B1 correction, precluding its wider application to volumetric measurements of
brain structures. In this thesis, we present a novel way to correct gluCEST for B1 inhomogeneity,
yielding higher quality images. We then demonstrate expansion of single-slice gluCEST imaging
to volumetric ‘slab’ imaging, greatly expanding our ability to capture specific structures within
the brain. We apply gluCEST in both two and three dimensions to investigate healthy brain
physiology as well as the response of healthy subjects to transcranial magnetic stimulation
(TMS). We were able to detect elevated gluCEST in the dentate gyrus in the brains of healthy
subjects, the first non invasive measurement of its kind pertaining to this small but vital
structure. We also detected, for the first time, a change in glutamate concentration in the brains
of subjects who have received TMS. Finally, we present work in the area of spectroscopy,
presenting a technique in which –in sharp contrast to existing methodologies requiring nonstandard hardware-- metabolic dynamics of glutamate can be detected using only proton-based
chemical shift imaging (CSI) in conjunction with oral ingestion of deuterium labeled glucose.
While itself limited in spatial resolution, this ability to detect and visualize the dynamic neural
metabolism of glucose to glutamate provides a deeply complimentary source of information to
gluCEST. In the future, qCSI and gluCEST could be used in tandem to provide next-generation
precision diagnostics for patients suffering from neurological maladies of metabolic origin.
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Preface
The centrality of glutamate cannot be overstated. It is the molecule which, perhaps more than
any other, forms the link between our core metabolism inherited from the Paleozoic and the
complex thoughts, feelings, and ideas which make us human beings. Stupendous achievements
of the 20th century gave rise to the observation of nuclear magnetic resonance and its
application to medical imaging. The work in this thesis builds directly on that of my predecessors
and mentors at the Center for Magnetic Resonance and Optical Imaging at the University of
Pennsylvania, as we attempt to further the capabilities of magnetic resonance based technology
to detect and visualize the presence of glutamate in the human brain. This endeavor, like any
other which seeks to wrench territory from the impossible and annex it to the possible, is
dynamic, tenuous, and replete with opportunity for error in procedure or interpretation.
However, it is my understanding that there are only three kinds of contributions that a scientist
can make at any given time in history: 1) measure what you can with the tools of the day; 2) do
what you can to improve the tools themselves; 3) think very hard about the problem. To this
end:
Chapter 1 provides a tri-partite introduction to the field of research: 1a focuses on the history
and physics of the magnetic resonance phenomenon and its application to medical imaging; 1b,
on the Chemical Exchange Saturation Transfer (or CEST) experiment specifically; 1c, on the
molecule glutamate itself and existing applications of the corresponding, specialized imaging
technique known as gluCEST.
Chapter 2 presents a recently proposed and applied method for correcting gluCEST images for
inhomogeneity of the B1 field, a set-back which has plagued this type of measurement and
inhibited its expansion.
Chapter 3 explores the specific challenges of imaging glutamate in the brains of aging adults,
and presents preliminary results of some of the observed trends in such experiments.
Chapter 4 applies gluCEST in an experiment which images the brains of volunteers before and
after they undergo a type of non-invasive brain stimulation called TMS, which is an active area
of research at Penn and around the world.
Chapter 5 communicates the first results of using a volumetric (3D) gluCEST sequence to make
previously impossible measurements of very small structures of the medial temporal lobe, the
locus of learning, navigation, pattern recognition and memory formation in the human brain.
Chapter 6, lastly, describes the first human application of a newly developed technique for
measuring metabolic dynamics – that is, the actual conversion of one chemical to another –
using only the magnetic resonance of the proton, while existing technologies required the more
involved detection of other isotopes.
Thus what follows is an attempt to, to some degree, translate (3) into successful instances of (2)
and then (1), the success of which may be judged by the reader-- and of course, in the end, will
be fatefully judged only by the infamous and protean pantheon: Reviewers 1, 2 and 3.
A.T.J.C.
Philadelphia, 2021
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Chapter 1: Introduction
1a) Magnetic Resonance Imaging and Spectroscopy: Overview of Physical
Underpinnings

1a.1 Magnetic resonance and the intrinsic property ‘spin’
The history – and indeed, “prehistory”—of nuclear magnetic resonance is nothing short of an
epic tale of investigative valiance. After years of adversity-laden attempts by Evgeny Zavoisky in
Kazan, USSR and even published negative results by Dutch physicist Cornelius J.Gorter1,2, a
nuclear magnetic moment of condensed-phase matter was finally detected for the first time by
Bloch, Hansen and Packard in liquid water and Purcell, Torrey and Pound in a sample of paraffin
– which, due to misestimation of relaxation times by the venerable I.I. Rabi, had already spent
the night in the magnet3–5.These scientists, understanding that nuclei possessed an intrinsic
angular momentum which should interact with a magnetic field, foresaw that in principle,
oscillating external fields could be used to manipulate the motion of this ‘magnetization’ and
that this experiment, in analogy to existing forms of spectroscopy, could be used to access
information about a physical system. Pursuing this hypothesis, Isidor Isaac Rabi had won the
1944 Nobel Prize in Physics for his work on “determination of the nuclear magnetic moment
through resonance with radio waves”1, which he accomplished using a sophisticated set-up in
which the molecules of interest comprised a so-called ‘molecular beam’. Eight years later, in
1952, the experiments of Bloch and Purcell also earned them the Nobel Prize. The achievement

1

This description of Rabi’s work is also from Prof. Hulthen’s presentation speech of the award to Bloch
and Purcell.

1

for which they were recognized-- the extension of this type of measurement to condensed
phase matter –came to include today’s widespread and indispensable application of NMR to
analytical chemistry, biomedical imaging and other fields.
The intrinsic angular momentum of all particles, affectionately named for its familiar
macroscopic counterpart, is called ‘spin’. It is a fundamental property of all matter, but
manifests itself differently in the two major ‘categories’ of physical entities, fermions (protons,
neutrons and electrons)2 and bosons (e.g., photons). Because of their respective composition on
the even smaller scale of quarks, fermions have so-called ‘spin = ½’, while bosons have ‘spin = 1’.
Fascinatingly, modern theoretical physics has yet to account completely for these values; the socalled ‘spin crisis’ remains amongst the nebula of unreconciled problems which next generation
particle accelerators are built to solve6.
Spin is a ‘quantum number’: an expression of a discrete properties of quantized systems (i.e.,
those on the time, space and energy scale such as to be described by the laws of quantum
mechanics). A nucleus is composed of two types of particles: protons and neutrons. Since the
nucleus is a composite particle having a certain number of protons and neutrons, its total spin is
determined by the sum of these quantum numbers. This means that, depending on how many
nucleons are in a particular nucleus, it may have different total spin than its neighbor on the
periodic table. The existence of a non-zero total spin of the nucleus itself is the first physical
requirement for observing nuclear magnetic resonance. Consider as examples a few important

2

I think it’s actually more correct to say that the particles which compose protons and neutrons
themselves are the fermions.

2

nuclei in organic matter: 1H and 12C, and their isotopes 2H and 13C. The composition of these
nuclei is as follows:
Nucleus
1

No. of protons

H (hydrogen)
1
H (deuterium)
1
12
C (carbon)
6
13
C
6
Table 1a.1 Properties of selected nuclei
2

No. of neutrons

Total spin

0
1
6
7

1/2
1
0
1/2

Gyrom. Ratio
(γ), rad.MHzT-1
267.5
41.1
N/A
67.3

Note that 12C has zero spin not because of the even number of total nucleons, but because of
the even number of each type. Similar to electrons, nucleons of each type must fill their “energy
shell” as pairs where each “partner” in the pair has opposite angular momentum: thus, every
pair of protons or pair of neutrons contributes zero spin to the total, and only an unpaired
nucleon of either type gives rise to total spin. In the case where there is one of each, the ground
state interaction of the single proton and single neutron is for their spin components to be
‘parallel’, hence giving a nucleus like deuterium spin of 1, rather than 0.
Out of the nuclei enumerated above, 1H, 2H and 13C – but not 12C – are observable by magnetic
resonance. This is a key consideration in the design of experiments using NMR in biological
contexts, as direct detection of carbon metabolism requires introduction of the heavy isotope.

1a.2 The external field B0 breaks the degeneracy of spin eigenstates and induces
precession
Quantum mechanics describes that a particle with spin quantum number I (e.g. ½) has
associated substates mI described by the set {-I – I+1, … I}. Hence for I = ½, this set is mI = {- ½, ½
}. This means that, if one solves the Schrodinger equation for a Hamiltonian which describes this
physical situation, there are two possible solutions, or eigenstates.
3

In the absence of an external field, these eigenstates are isoenergetic – or ‘degenerate’.
According to the laws of thermodynamics, degenerate states will, on average at any given
‘instant’, be populated equally. They also have no inherent orientation with respect to physical
3-space: despite the non-zero magnetic moment of a nucleus like hydrogen, a bulk body with
very many hydrogens (e.g. a person, or a bottle of water) will itself have no net magnetic
moment, because these spins from the nuclei are randomly oriented, and taking their vector
sum will result in a quantity which is rapidly time-averaged to zero. The absence of any
difference in population or orientation means that, at zero field, these states are
indistinguishable and inaccesible to experiment.
The presence of an external field does two important and related things: it breaks the
degeneracy of the spin eigenstates, and couples their orientation to an external reference. It
also induces a motion known as ‘precession’.
Mathematically, we can write some of these relationships as:
𝐸 = −𝜇 ∙ 𝑩

[1.1]

𝑤ℎ𝑒𝑟𝑒 𝑩 = 𝐵0 ∗ 𝒛,
𝜇 = 𝛾 ∗ 𝐼Z

[1.2]

[1.3]

where ‘E’ is the energy imparted to the system by the presence of the field, 𝜇 is the magnetic
moment of the particle, and by convention, 𝒛 is the direction of the magnetic field, B, which has
magnitude B03. Note that 𝜇, which relates the strength of the field to the energy of each state, is
a function of the scalar quantity γ. Known as the gyromagnetic ratio, it relates the spin quantum

3

For references sourcing the material in this introductory section, please see the ‘General Bibliography’ at
the end of this chapter.
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number of the nucleus to the magnitude of the magnetic moment that it will generate. It is
related to the mass, charge, and nuclear shell geometric properties of the nucleus and can vary
widely even amongst nuclei with identical total spin I. This also has important practical
consequences for NMR and MRI experiment design.

𝐼𝑋 =

1 0
(
2 1

1
)
0

𝐼𝑌 =

1
0
(
2𝑖 −1

1
)
0

𝐼𝑍 =

1 1
(
2 0

0
) [1.4]
−1

are the angular momentum operators7 for spin ½ nucleus in the Zeeman (i.e. taking the effect
of B0 into account) eigenbasis. These operators have a very important property, which is cyclic
commutation:
[𝐼𝑖 , 𝐼𝑗 ] = 𝑖 𝜀𝑖𝑗𝑘 𝐼𝑘

[1.5]

(ε is a symbol that specifies the symmetry properties of this relation, and does not have a ‘value’
in and of itself.)
IZ in the equation for μ above is the value of the observable corresponding to the ‘Z’ angular
momentum operator, which can be physically interpreted as a projection of the angular
momentum onto the z-axis of the external field. It has the eigenfunctions traditionally denoted
1

{|𝛼⟩, |𝛽⟩} and the associated eigenvalues ±2 ħ.
𝐼𝑍 |𝛼⟩ =

1
2

𝐼𝑍 |𝛽⟩ = −

ħ|𝛼⟩
1
2

ħ|𝛽⟩

[1.6a]
[1.6b]

The Hamiltonian of the spin-½ system that has been introduced into an external field now has a
term corresponding to the presence of this field, and the ‘energy’ E as described above. Since
this term arises from the presence of B0, we’ll call it H0:
5

𝐻0 = − 𝛾 𝐵0 𝐼Z

[1.7]

This operator H0 is related to the operator IZ only by the constant factors γ and B0, which means
that it commutes with IZ, and will have the same eigenstates – its introduction only changes the
distribution of the system between these eigenstates, and the way that they evolve in time.
At any given moment, the state of a spin- ½ particle can be described by the wavefunction:
|𝜓⟩ = cα |𝛼⟩ + cβ |𝛽⟩

[1.8]

This equation simply expresses that the particle is described by a linear combination of its two
eigenstates. The coefficients c quantify the degree to which each eigenstate is ‘inhabited’, and
depend on their relative energies. In the absence of an external field or other source of ‘energy’
to perturb them, these coefficients c are equal, and the system inhabits the states equally. In
the presence of B0, one state becomes preferentially populated.
The evolution in time for this system is given by:
|𝜓 (𝑡)⟩ = exp(−𝑖 𝑯 𝑡) | 𝜓 (0)⟩ [1.9]
Where |𝜓 (𝑡)⟩ for any t (including 0) is of the form indicated above. H is the Hamiltonian in
question. At present, in the presence of B0 our H is H0.
This means that, as soon as we put a spin -1/2 system into an external field, its dynamics are
described by the following equation:
|𝜓 (𝑡)⟩ = exp(−𝑖𝛾𝐵0 𝐼𝑍 𝑡) |𝛼⟩ + exp(−𝑖𝛾𝐵0 𝐼𝑍 𝑡) |𝛽⟩

[1.10]

Expression of these exponential terms as sinusoidal functions allows us to see that this
represents a system of two states, each of which are subject to rotation about the Z axis. The
6

frequency of this rotation, which is a function of γ and B0, is known as the Larmor frequency4,
and generally denoted as ω0.
The two states have energies + ½ ħ 𝛾 𝐵0 and - ½ ħ 𝛾 𝐵0 , making the energy difference between
them
𝛥𝐸 = ħ 𝛾 𝐵0

[1.11]

Thermodynamics relates the population distribution of an ensemble between states to the
difference in energy between those states and the temperature of the system. The probability,
P, of a spin or other physical entity populating a state with an associated energy E at
temperature T is dictated by these quantities and a distribution parameterized by the Boltzmann
constant, kB (or just k in small font):
−𝐸

𝑃(𝐸) ∝ 𝑒 𝑘𝑇

[1.12]

Given that E = ± ½ ħ 𝛾 𝐵0 , we can calculate the equilibrium net magnetization – a sum of all
spin vectors that are distributed according to the Boltzmann distribution-- of a sample in a field
of strength B0:

𝑀0 =

𝑁𝛾 2 ℎ2 𝐵0
16 𝜋2 𝑘𝐵 𝑇

[1.13]

where N is simply the number of spins in the sample. While Equation 1.13 gives the theoretically
exact value of the magnetization, in practice the sensitivity of the NMR experiment (i.e. the
experimental value for M0) depends on factors including coil loading and tuning and other

4

Named in honor of Joseph Larmor, whose theorem predicted the general existence of precession.
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physical aspects of the set-up. Thus, Equation 1.13 is frequently written expressing a
proportionality rather than an exact equality.

1a.3 Physical and chemical factors mediating net magnetization M0 and Larmor
frequency ω0
Before adding more terms, we consider how the variables presented so far affect these two
aspects of the spin system-- population splitting between eigenstates, and the precession of
these eigenstates around the Z-axis-- as these parameters translate to key considerations in the
NMR experiment. Given that we are concerned here with biomedical (i.e. mostly water) imaging
and spectroscopy at ultrahigh field, we can compare the values of M0 of pure water (55 M) at 3
T and 7 T:

𝑀0 =

𝑁𝛾 2 ℎ2 𝐵0
16 𝜋2 𝑘𝐵 𝑇

2

=

(110∗6.022∗1023 )(2.675∗ 108 )2 (2.626∗ 10−34 ) ∗𝐵0
16 𝜋2 (1.381∗ 10−23 )∗293

= 0.195 * 10-18 * B0

= 0.585 * 10-18 J/T at B0 = 3 T and 1.365 * 10-18 J/T at B0 = 7 T.
In addition to the linear dependence on field strength, the magnitude of M0 has a quadratic
dependence on gyromagnetic ratio. Let’s consider the same calculations using the deuterium
gyromagnetic ratio 𝛾 2 = 0.41 *108 rad/s*T instead of 2.675 *108 for the proton:
𝑀0,2𝐻,3𝑇 = 0.0137 * 10-18 J/T

𝑀0,2𝐻,7𝑇 = .0321* 10-18 J/T

From this calculation we can understand that detecting the signal from one NMR-active nucleus
to another can be very different experiments: deuterium NMR at 3T is about 100 times less
sensitive than proton NMR at 7T. Lastly, we should note the inverse dependence on
temperature. This is a variable that we can’t modify in vivo, but the increased sensitivity
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achieved with lower temperatures is an extremely important aspect of NMR experiments
outside of medical contexts.
In addition to the polarization or sensitivity, a difference in gyromagnetic ratio or field strength
will change the Larmor frequency of the spin system. At a given field strength, this has the
important practical consequence that different physical coils (or ‘dual tuning’ of a single coil) will
be required for generating and receiving the MR signal from different nuclei. Also, the absolute
frequencies (in Hz) involved in an MR experiment at 7T will be 7/3 times higher than those at 3T.
This is of great pertinence when considering the interactions of these RF fields (now at
frequencies approaching microwaves) with the human body. First of all, now that they are
higher frequency, there is a potential for inducing rotational transitions in molecules8,9 which
subsequently cause heating, and we must be careful not to input too much of such energy into
the human subject. Also, the shorter wavelength means that standing wave patterns resulting
from the interaction with anatomical structure become more troublesome10,11. This is largely the
origin of the inhomogeneity of B1 in brain imaging at 7T which will be discussed extensively in
Chapter 2.
One extremely useful fact of nature is that the electron cloud of the molecule itself causes very
small changes in the B0 ‘experienced’ ‘locally’ by individual atoms within a compound. In other
words, two protons that are not in the same position relative to the rest of the atoms in the
molecule are experiencing a slightly different B0 from each other due to the ‘shielding’ they
experience as a result of the presence of the electrons, which, as moving charges, generate
some small field in and of themselves. The degree of this effect can be predicted from theory by
calculating the chemical shift tensor, σ and manifests itself in the NMR spectrum as separate
resonances. (See Figure 1b.3 which shows the electrostatic potential of glutamate. The
9

chemical shift tensor of a molecule is closely related to the electrostatic potential, as both
depend on the density of the electron cloud in space.) This ‘shielding’ quantified by σ scales B0,
external to

a B0, effective felt by a particular nucleus.
𝐵0,𝑒𝑓𝑓 = (1 − 𝜎)𝐵0

[1.14]

Although rigorously 𝜎 is a tensor with respect to space and the internal molecular coordinates,
in solution state (which generally includes biological tissues), the ‘tumbling’ motion of the
molecule with respect to the field averages σ to a scalar quantity. There are, however, certain
biological contexts (i.e. highly ordered tissues) in which the directional dependence of σ, or
chemical shift anisotropy, is still relevant and can even be exploited to gain certain information.
An ensemble of spins within a sample which occupy an identical chemical environment and
share a single Larmor frequency are called an ‘isochromat’, from the Greek meaning ‘same
color’. The variability in chemical environment and therefore chemical shift gives rise to multiple
isochromats –“spins of different color”-- in a single molecule.
In accordance with Equations 1.10 and 1.14, the absolute difference between the Larmor
frequencies ω resulting from variable σ -- known as chemical shift dispersion-- is greater at
larger field. This means that our ability to detect individual nuclei in a molecule-- or those in
different molecules in the same solution -- whose Larmor frequencies are similar also improves
at higher field strength.

1a.4 Expressing H0 (and subsequent calculations) in the rotating frame of reference
Everything that happens further in an NMR experiment is going to take place amidst the
‘background’ motion of this precession caused by B0, the dominant ‘force’, (similar to all of the
motions on earth take place against the ‘background’ of our motion around the sun). It’s
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therefore convenient to proceed in mathematical treatment of the NMR experiment by
considering a ‘rotating frame of reference’12. In the mathematics of quantum mechanics which
we have been using, shifting our calculations over to this rotating frame means that we must
apply a rotation operator, expressed in terms of the new ‘reference frequency’ at which the
frame itself is rotating, ωref, to the Hamiltonian and the wavefunction, respectively:
𝑯𝒓 = exp(𝑖𝜔𝑟𝑒𝑓 𝑡𝐼𝑧 ) 𝑯 exp(−𝑖𝜔𝑟𝑒𝑓 𝑡𝐼𝑧 ) − 𝜔𝑟𝑒𝑓 𝐼𝑧
|𝜓 𝑟 ⟩ = exp(i 𝜔𝑟𝑒𝑓 𝑡𝐼𝑧 ) | 𝜓 ⟩

[1.15]

[1.16]

This expression for the Hamiltonian still needs whatever the original (before the rotating frame
transformation) Hamiltonian, H, to be inserted to be evaluated fully. We’ll start with H0 and then
move to H1 for inclusion of the RF field.
Corresponding to the notation of the main magnetic field as B0, we can call the Hamiltonian
term arising from it H0, and the frequency of the induced precession, ω0. Using this notation and
referring to Equations 1.1-1.3, the Hamiltonian term arising from B0 is given by:
𝑯𝟎 = − 𝛾 𝐵0 𝐼 Z or 𝑯𝟎 = 𝜔0 𝐼Z

[1.17a, 1.17b]

That gives us:
𝑯𝒓𝟎 = exp(𝑖𝜔𝑟𝑒𝑓 𝑡𝐼𝑧 ) 𝜔0 𝐼𝑍 exp(−𝑖𝜔𝑟𝑒𝑓 𝑡𝐼𝑧 ) − 𝜔𝑟𝑒𝑓 𝐼𝑧 [1.18]
ω0 is a constant, so we can move it outside the operator expression:
𝑯𝒓𝟎 = 𝜔0 exp(𝑖𝜔𝑟𝑒𝑓 𝑡𝐼𝑧 ) 𝐼𝑍 exp(−𝑖𝜔𝑟𝑒𝑓 𝑡𝐼𝑧 ) − 𝜔𝑟𝑒𝑓 𝐼𝑧

[1.19]

This first term is a succession of three operators, but the rotation operator which we just
introduced commutes with IZ, which allows us to permute the order of the terms:
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𝑯𝒓𝟎 = 𝜔0 𝐼𝑍 exp(𝑖𝜔𝑟𝑒𝑓 𝑡𝐼𝑧 ) exp(−𝑖𝜔𝑟𝑒𝑓 𝑡𝐼𝑧 ) − 𝜔𝑟𝑒𝑓 𝐼𝑧

[1.20]

At which point the rotation operator and its complex conjugate multiply to give 1, and we are
left with the simple expression
𝑯𝒓𝟎 = 𝜔0 𝐼𝑍 𝜔𝑟𝑒𝑓 𝐼𝑧 = ( 𝜔0 − 𝜔𝑟𝑒𝑓 ) 𝐼𝑧 = Ω𝐼𝑧

[1.21]

the physical interpretation of which is that the motion of the system (according to our new way
of looking at it) will be defined by the difference in frequency between the motion of the frame
of reference and the Larmor frequency induced by B0. At this point, the only reason we would
have done this transformation is in order to purposely set ωref = ω0, such that this Hamiltonian
now equals zero, and-- at least as a result of B0-- the net magnetization is “not moving at all”. In
accordance with the earlier analogy, this is akin to stating that someone is “not moving” while
they are standing still on Earth.
Fascinatingly, the physical implementation of the NMR experiment mirrors this mathematical
treatment of transformation to the rotating frame. The NMR signal induced in the receive coil is
combined with the transmit signal carrier frequency – which will be ω0—and only the resulting
difference signal is detected.
Returning to the wavefunction itself:
|𝜓 (𝑡)⟩ = exp(−𝑖𝛾𝐵0 𝐼𝑍 𝑡) |𝛼⟩ + exp(−𝑖𝛾𝐵0 𝐼𝑍 𝑡) |𝛽⟩
|𝜓 𝑟 ⟩ = exp(i 𝜔𝑟𝑒𝑓 𝑡𝐼𝑧 ) | 𝜓 ⟩
where ωref = ω0 = − 𝛾 𝐵0
After we applied the rotation operator, we’re back to having
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[1.23]

[1.22]

|𝜓 𝑟 ⟩ = |𝛼⟩ + |𝛽⟩

[1.24]

which is what we expect: the eigenstates of the system subjected to B0, once we assume
rotation, can go back to being treated as the same eigenstates we had in the first place.

1a.5 The applied radio frequency (RF) field: B1
Now we consider the effect of introducing another field: radiofrequency field B1. From a
practical standpoint, B1 has an extremely important role in the NMR experiment: it rotates, or
‘nutates’ the net magnetization into a position where it can be detected by the receive coils.
Upon prolonged application, it also has an additional effect, which is negligibly small in most
‘regular’ NMR experiments but is the lynchpin of the CEST experiment: ‘saturating’ the
magnetization, or decreasing the signal from the net magnetization that we would otherwise
detect in the presence of B0. This effect will be discussed separately in Chapter 1b.
B1 differs in physical properties from B0 in three important ways:
a) it is much, much smaller (weaker) and largely applied for a brief period (few ms)
b) it oscillates in time and space (in the same frequency range as radio raves), rather than being
static like B0.
c) the directions of both of its components are perpendicular to B0: we can describe them as
being along the x and y unit vectors, instead of z
Nutation can be understood by looking at the Hamiltonian term arising from B1 analogously to
the one arising from B0.
Mathematically, we can describe B1 as:
𝐵1 (𝑡) = 𝒙 𝐵1 (𝑡) cos(𝜔𝑟𝑓 𝑡) − 𝒚 𝐵1 (𝑡) sin (𝜔𝑟𝑓 𝑡)
13

[1.25]

where x and y are the respective unit vectors. B1, like
B0, is a magnetic field with a certain directionality; so,
like B0, it will also induce precession to some degree,
although in this context we give this physical

Note: ωrf in which ‘rf’ is an
abbreviation for ‘radio frequency’
is not to be confused with ωref, in
which ‘ref’ stands for ‘reference’,
to describe our rotating frame.

phenomenon a different name: “nutation”. The B1 Hamiltonian corresponds to this, although it
now contains the time dependence and directionality of B1: instead of some static ‘B = B0’, we
have B = cos (ωrft) + sin(ωrft). The constant used to express the magnitude of the ‘nutation’
(analogous to precession, but along this axis instead) is denoted ω1, and is a function of the
magnitude of this applied, oscillating field and, as with ω0 , the gyromagnetic ratio.
We can then write down the Hamiltonian term arising from B1:
𝑯𝟏 (𝑡) = 𝜔1 [cos(𝜔𝑟𝑓 𝑡 + 𝜑)𝐼𝑥 + sin (𝜔𝑟𝑓 𝑡 + 𝜑) 𝐼𝑦 ] [1.26]
Doing some algebra which begins with application of the cyclically commuting operator identity,
we can again show that if we’ve chosen ωref = ωrf, then the Hamiltonian (now including the terms
arising from both B0 and B1) is
𝑯𝒓𝟎,𝟏 = 𝜔1 [cos(𝜑)𝐼𝑥 + sin (𝜑) 𝐼𝑦 ] + Ω𝐼𝑧

[1.27]

φ is the phase of the pulse, which would be exactly 0 for a pulse along the x axis and, π/2 for
one along y. If ωref = ωrf = ω0, then the final term is zero, and this equation describes only
constant rotation (the one called ‘nutation’) around a transverse axis. This corresponds to a)
choosing a reference rotation that corresponds to the Larmor frequency, and then delivering an
RF pulse that also corresponds to the Larmor frequency (i.e. is ‘on resonance’). If one of the
above have to be false (that is, you need to perform a calculation for off-resonant RF), it is
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probably easiest to set ωref = ωrf and have non-zero Ω. In this case, the magnetization will nutate
around an oblique axis, with an angle from the Z-axis given by
θ = arctan (ω1 /Ω)

[1.28]

And the flip angle, which is the integral of the action of B1 over the duration of the pulse, is given
by
𝛼 = √𝜔12 + 𝛺2 ∗ 𝑡

[1.29]

Note that this quantity actually becomes larger with increased offset. However, what we detect
the projection of the magnetization onto the transverse axis, and this quantity does not increase
as much with nutation if the axis of that nutation is ‘less perpendicular’ to the z axis.

1a.6 Additional useful formalisms
The density operator is a mathematical way of representing very large ensembles of identical (in
the sense that they are subject to the same Hamiltonian or other operators and can be
expressed in the same basis set) quantum mechanical entities. Of course, such very large
ensembles of quantum mechanical objects are exactly what we’re concerned with in the NMR
or MRI experiment. The density matrix is a probability-weighted sum over individual state
densities, where the diagonal elements represent the populations of the eigenstates |𝛼⟩ and
|𝛽⟩, and the off-diagonal elements are the coherences (linear combinations or superpositions)
which we detect as ‘transverse’ magnetization5.

5

There are other, more complex ‘things’ that these off-diagonal elements can represent, but discussion of
these coherences will be omitted here. The reader is referred to a more authoritative text, e.g. Dr.
Brown’s book listed in the bibliography.
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For our two-state system, the structure of the density matrix, usually denoted ρ, is as follows:
𝜌𝛼𝛼
𝝆 = |𝜓⟩ ⟨𝜓 | = (𝜌

𝛽𝛼

𝜌𝛼𝛽
𝜌𝛽𝛽 )

[1.30]

Thus, in a situation where we have no transverse magnetization whatsoever, the value of this
density matrix is:
𝜌𝛼𝛼,0
𝝆𝟎 = (
0

0
𝜌𝛽𝛽,0

) [1.31]

where the |𝛼⟩ component of all spins are contributing to the value 𝜌𝛼𝛼 and the |𝛽⟩ component
of all spins, to the value 𝜌𝛽𝛽 . Our net magnetization is 𝑀0 = 𝜌𝛽𝛽,0 - 𝜌𝛼𝛼,0 .
It should be pointed out that the density operator does not uniquely specify the ensemble: we
have no idea from this representation what the individual spins are doing which contribute to
the sum. This is an important point when we consider the action of relaxation (see next section).
There are two ways for a sum of something to be equal to zero: either it does not exist (i.e., all
individual elements are equal to zero and therefore the sum is zero, too), or the ‘things’ exist in
and of themselves, but they have arbitrary sign and the sum of them is zero. After we create the
coherences using the RF pulse, we have nonzero elements in the 𝜌𝛼𝛽 and 𝜌𝛽𝛼 positions. The
population of these states has drained population from the 𝜌𝛼𝛼 and 𝜌𝛽𝛽 states, so our Z
magnetization has decreased. In order for us to continue to have nonzero elements of 𝜌𝛼𝛽 and
𝜌𝛽𝛼 , the individual components contributing to these sums must stay in phase with each other.
But quite soon after we turn off the RF pulse, this situation deteriorates, which we call T2
relaxation. If T2 relaxation is complete, we return to a situation where the density matrix has the
𝜌𝛼𝛼
structure ( 0

0
𝜌𝛽𝛽 )-- however, these are not the 𝜌𝛼𝛼,0 and 𝜌𝛽𝛽,0 that we had before the
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pulse. While their sum may vanish quickly, only after a while (as so-called T1 relaxation occurs),
do the 𝜌𝛼𝛽 and 𝜌𝛽𝛼 components individually drain to zero and repopulate the 𝜌𝛼𝛼 and 𝜌𝛽𝛽
states. T1 and T2 relaxation will be discussed further in the next section.
The version of the Schrodinger equation which deals with density matrices instead of individual
wavefunctions is called the Liouville-von Neumann equation, and has an equivalent structure:
𝑑
𝑑𝑡

𝝆 = −𝑖 [𝑯, 𝝆]

[1.32]

When using this equation to calculate the trajectory of an ensemble of spins (for example, under
the manipulation of an RF pulse), it’s useful to organize our calculation in terms of what are
called product operators. Product operators are to the density operator as a basis set is to a
wave function: they are an orthonormal set which spans the space of the entity of interest. The
number of operators needed to fully describe a particular system is determined by the number
of independent spins: each type of spin that needs to be considered independently introduces
four degrees of freedom, so the number of basis operators will be 4N. If we’re concerned with a
single isochromat (N = 1), the basis operators will be the angular momentum operators IX, IY and
IZ defined above along with the identity matrix, I.
For systems with more spins, we have to perform a matrix operation called the Kronecker
product (hence the name) on these single-spin operators to generate the bigger operators (that
is, matrices with more rows and columns) that we need for treating such systems. These
mathematics are vital to understanding the NMR experiments done for deducing
macromolecular structure, whose usefulness lies in detecting the coupling between many spin
systems. They are also useful even in simpler systems to model the effect of a specific RF pulse.
Namely, in addition to decreasing the dimensionality of the problem, they frame all calculations
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in a context where identities specific to cyclically commuting operators can be applied. This
reduces complex mathematical operations to simple ones analogous to rotation about an axis.
In addition to the basic commutation definition supplied above, the identity
𝑒 −𝑖𝜃𝑨 𝑩 = 𝑩 𝑐𝑜𝑠 𝜃 + 𝑖[𝑨, 𝑩]𝑠𝑖𝑛 𝜃

[1.33]

is frequently made use of when calculating the effect of various Hamiltonian terms (the RF
pulse, J-coupling, etc.) on the spin system.

1a.7 Relaxation (as per Bloch)
Suppose that after some duration of the RF pulse, it turns off and no relaxation occurs – and for
a while, we simply have a net magnetization vector with X, Y and Z components which is
precessing around the Z axis at a particular frequency. If a receiving coil is present, this
magnetization will induce an electromotive force in the coil whose amplitude varies in a
sinusoidal fashion, in accordance with the instantaneous angle between that magnetization and
the detector. A Fourier transform of this detected signal --- which is a function over time-- will
give a delta function with the peak located at the frequency of the rotation. This is the most
basic possible version of an NMR measurement: we have ‘detected’ the Larmor frequency of the
magnetization.
In physical reality, there are no delta functions in frequency, because nothing is of infinite
duration in time: systems ‘relax’ from the state which they are in. The effect of applying the B1
pulse was to take polarization that existed with respect to the Z direction, and temporarily
transfer it to the XY plane. We know that the equilibrium state of the spin ensemble with
respect to the Z axis is to have a slight polarization, because of B0. However, the equilibrium
state of the spin ensemble with respect to the X or Y axes is to be evenly populated. Once the
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magnetization has XY components (or ‘coherences’ in the density matrix treatment to follow),
this polarization will diminish. Also, now that the B1 field is turned off, the XY components
themselves are subject to decay.
To some degree, the physical origins of these relaxation mechanisms can be understood and
examined from the point of view of quantum mechanics. However, a simple phenomenological
model was put forward in 1946 by Felix Bloch12 in which he treated the NMR phenomenon as
classical electromagnetic induction arising from dampened oscillations. His approach was that
decay or relaxation of mostly unspecified origin can nonetheless be captured by rate constants
and used in this form to model the signal which arises in experiment. What follows is a
summary and paraphrasing of the contents of the first parts of Sections 3 and 4 of Bloch’s
seminal paper, the text which effectively launched the modern era of theory and experiment in
nuclear magnetic resonance. Please note that where Bloch made use of the letter ‘H’ to refer to
the external field, I have substituted this with ‘B’ to maintain consistency with earlier notation.
Bloch begins his treatment of ‘Nuclear Induction’ with the observation that “the quantummechanical expectation value of any quantity follows in its time dependence exactly the classical
equations of motion”, and writes down the following equation for the net magnetic polarization
vector M for a nucleus with gyromagnetic ratio γ experiencing an external field B, according to a
classical picture of torque:
𝑑𝑴
𝑑𝑡

= 𝛾 [𝑴 𝑥 𝑩]

[1.34]

where the symbol ‘x’ here represents a cross product between these two vector quantities. He
goes on to elaborate the case where B1, the oscillating field, is on-resonance with the Larmor
frequency of precession around B0, arriving at “a solution for which the polarization rotates
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around the z-direction, i.e., around the strong field [B0] and in such a way that it lies at any
instant in the common plane of this field and the effective rotating field.” This is the origin of the
common visualization of the magnetization vector “spiraling down” upon application of the RF
pulse. Just as in our quantum mechanical treatment above, Bloch arrives using this classical
picture at the result that, in the presence of B0 and B1 only, the solution to the equations of
motion is a net magnetization that exhibits precession about B0 and nutation about B1.
Before even writing down equation 1.34, Bloch notes that this solution assumes the following:
1) No forces are acting on the nuclei except for the external fields B0 and B1. Here he
enumerates the following ‘sub-assumptions’:
1a) The electrons associated with these nuclei are not having any appreciable effect.
1b) The interaction between neighboring nuclei can be neglected.
1c) Thermal effects (i.e. losing energy to the surroundings because of random motion,
so called by analogy to an object giving off heat) are negligible; the system retains the energy
that it has as a result of the B0 and B1 terms and does not ‘relax’.
2) B0 and B1 are macroscopically homogeneous over the field of view.
In summary, assumption 1a) is usually reasonable; to address the real-life failure of assumptions
1b) and 1c), he introduced two additional terms to equation 1.34 (Bloch’s equation 11), giving us
the form of the ‘Bloch equations’ as they are most usually applied today, which make use of the
two relaxation parameters T1 and T2, to be discussed in detail shortly:
𝑑𝑴
𝑑𝑡

= 𝛾 [𝑴 𝑥 𝑩] −

(𝑴𝒛 −𝑴𝟎)
𝑇1
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−

𝑴𝒙 +𝑴𝒚
𝑇2

[1.35]

More specifically: Assumption 1a, regarding the independence of nuclear and electronic spins, is
reasonable in most molecules, but not in the case of radicals or other circumstances where an
unpaired electron spin is present. Bloch cites the pioneering work of Rabi on this interaction
between nuclear and electronic spin, which is known as hyperfine coupling. It is of interest to
note that today, this interaction is exploited amongst the strategies for generating dynamic
nuclear polarization, as it is possible to transfer the very strong polarization of an electron spin
system to a coupled nuclear one13 .
Neglecting the hyperfine interaction, we are left with two important effects to deal with: in
Bloch’s terminology, “Thermal agitation” and “Internuclear action”. While they both involve
some kind of random perturbation of the spin system, they differ essentially in that a “thermal
agitation” can actually change (decrease) the total energy of the spin system, while
“internuclear action” describes a shuffling of energy to different degrees of freedom, rather
than a change in the total amount.
Bloch points out that the ‘source’ of energy in the spin system in the first place is the presence
of the B0 field, and thus interactions of the first type, which have to do with the total energy of
the system, are necessarily those which cause some change in the z-component of the
magnetization (MZ). Wherever MZ happens to be at the moment, in the presence of any such
“thermal agitations”, it will follow a course from its current value back to M0, the equilibrium
polarization defined by field strength and gyromagnetic ratio. The rate of this process is
captured by the constant he called T1.
All effects of the second kind – “internuclear actions”—can be understood as some kind of
“effective irregularity” (Bloch’s words) in the field. While not ‘changing the energy of the
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system’ – because they have no effect on the relationship of the spin system to the field, which
is along the z-direction – these “irregularities” cause “smearing” of the exact orientation of the
transverse components with respect to space, leading their vector sum to eventually approach
zero. Explaining his treatment in quantum mechanical terms, Bloch indicates these are
interactions which ‘destroy the phase relation’ of the ‘coherent mixture of states’. These
processes were likewise captured by the constant T2.
Presumably, Bloch settled on a regular monoexponential function to describe these dynamics
based on experimental observation. He in fact does not give direct justification for this choice of
function, other than to write that, “we shall now introduce these terms….chosen so as to
complicate the analysis as little as possible. For this purpose we shall assume that…the change in
Mx and My will likewise be of an exponential character.” All subsequent evidence suggests that
this was a successful approach.
Nowadays, the respective types of relaxation captured by T1 and T2 are frequently referred to as
‘spin-lattice’ and ‘spin-spin’ coupling. Beyond this, mechanistic specification of their origins is
nebulous, and they are generally used as phenomenological quantities which –in a fortuitous
application completely unforeseen by their ‘inventor’—turned out to have diagnostic use in
medical magnetic resonance imaging.

1a.8 Exploiting variations in B0, local to perform imaging and spectroscopy
We can now understand that, rather than a delta function, the linewidth of the peak in our
‘spectrum’ is going to reflect the fastest rate of decay of this magnetization. In our binary
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categorization of relaxation phenomena following Bloch, this will be T2.6 This basic NMR signal,
which will be a sinusoidal signal dampened by an exponential described by T2, is called the ‘Free
Induction Decay’, or FID. We now turn to the question of how to acquire two types of
information beyond detecting a single resonance: namely, either a ‘spectrum’ of resonances, or
an actual picture.
1a.8.1 NMR Spectroscopy
Earlier, we introduced the small, “parts per million” differences in the B0 “felt” by each nucleus
as a result of its chemical environment – that is, the electron shell of the other nuclei in the
molecule. These small differences, or chemical shift, in the effective local field cause
corresponding differences in Larmor frequency, which can be used to differentiate between
nuclei in different chemical positions.
We can expand our picture of the free induction decay measurement of the single spin to
include several spins in a molecule with varying frequencies (multiple isochromats). It is
important to note that, in order to be able to detect all of the spins present in the sample, we
must begin with an excitation pulse that is sufficiently broad (along the frequency axis) to excite
all of them. A detailed discussion of excitation pulse shape in spectroscopy is beyond the scope
of this report; the reader is referred to Chapter 5 of de Graaf14.

6

In practice, the decay of the signal generally occurs more quickly even than would be predicted by
theory examining the dynamics and coupling of the molecule(s) in question. This ‘observed’ rate of
relaxation is referred to as T2*, and arises from what are essentially imperfections in the experiment:
namely, small deviations in B0 that are caused by the magnet itself, or introduced or exacerbated by the
magnetic susceptibility properties of the sample. For example, interfaces between two tissue types
present a sharp change in magnetic susceptibility which perturbs B0, local and decreases the observed T2* in
that region.
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Once a transverse component has been introduced to the net magnetization vector of each
isochromat, these components will precess about the Z axis at different frequencies. Our receive
coil now detects not a single frequency of damped oscillation, but a sum of every frequency
which has been excited, in amplitude proportional to the population (or concentration, in
chemical terms) of each. This signal, upon Fourier transform, then results in a spectrum with
multiple peaks. In a pure sample, this NMR spectrum provides a “fingerprint” so unique that it
has become the standard method in the chemistry laboratory for identifying products of
chemical reactions. Sophisticated experiments exploiting extensive magnetic coupling – known
as “multidimensional NMR”-- expand NMR spectroscopy from identification of small molecules
to solving the structures of macromolecules like proteins and RNA, as in refs 15,16.
A number of considerations make this experiment – measurement of the NMR spectrum – less
straightforward in vivo than it is in an analytical chemistry setting. The first and overwhelmingly
important of these is the presence of a dominant water signal. In analytical NMR, deuterated
solvents are used to avoid detection of anything but the molecule of interest. In a living
organism, the solvent is regular, proton-based water, and its concentration is orders of
magnitude higher than any other contribution. In order to detect other resonances, this water
resonance must be suppressed. Generally, this is accomplished by various strategies of
saturation or excitation and dephasing. Suppression of water in in vivo spectroscopy is not a
trivial problem, as it is difficult to design pulse sequences which affect the water resonance
exclusively. For this reason, techniques like metabolite cycling which avoid water suppression
remain an active area of research17.
Secondly, living tissue is a semi-solid matrix, rather than a true solution state. This means that all
types of coupling and relaxation will occur more extensively. Furthermore, inhomogeneity of the
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main field (B0) as well as of the transmit field (B1) may be non-negligible in an irregularly shaped
sample. Modern pulse sequences for imaging and spectroscopy strive to be robust to the
consequent variability in excitation, but achieve this only for inhomogeneities of a limited
degree. Finally, in most cases the desired data is a localized spectrum: that is, one in which the
signal is derived only from the sample volume in a prescribed region of space. This can be
accomplished by spatially selective excitation schemes as in the PRESS18, STEAM19 and LASER20
sequences, which will be discussed briefly in the next section.
1a.8.2 MR Imaging: Gradients, Encoding and Pulse Sequences
B0, local can also be manipulated in a controlled fashion and on a much larger scale by gradient
coils, which create macroscopic gradients dB0/dx , dB0/dy, dB0/dz. In this way, the relationship
between B0 and Larmor frequency is exploited to achieve localized measurements, and thereby
images – in this case, derived from the dominant signals of water and fat. This strategy is called
‘spatial encoding’. In practice, frequency encoding per se is only used to ‘encode’ a single
dimension, while slice-selective excitation and phase-encoding are generally used for the other
two.
Spatial encoding by field gradients was first proposed by Paul Lauterbur in 197321. Slice selective
excitation was introduced by Garroway, Grannell and Mansfield22, while phase and frequency
encoding, inspired by work in the multi-dimensional NMR by Ernst and others, was introduced
subsequently23. Credit is also due to Mansfield for the introduction of the popular echo-planar
imaging (EPI) technique24, the most extensive application of which is probably functional
magnetic resonance (fMRI) imaging of the brain. Another landmark event in the development of
modern clinical radiology was the realization by R. Damadian that the relaxation times first
described by Bloch can be used to discriminate healthy from cancerous tissues25.
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1a.8.3 Magnetic Field Gradients and Spatial Encoding
The following equation describes how the Larmor frequency ω is modified by the presence of
the gradient field G at position r of the axis along which the gradient is applied.
𝜔(𝑟) = 𝛾 𝐵0 + 𝛾 𝒓 ∙ 𝑮

[1.36]

The spatial encoding of a three-dimensional object can be reduced to a two-dimensional
problem by selecting one dimension specifying a plane (or a ‘slice’ – MR lingo for a plane of
finite thickness) with the excitation pulse in the presence of a gradient. In other words, from an
information standpoint, we’re ‘filtering’ the excitation to magnetization defined by two
dimensions, and then ‘filtering’ the detection of that magnetization to differentiate between the
remaining two. The key to doing this is to have the gradient turned on (i.e. create a spatiallydependent distribution of frequencies) both during the excitation by RF pulse, and during the
acquisition of the FID.
One might imagine that by application of additional, perpendicular gradients through the slice,
perhaps a complete 3D spatial determination could be achieved. However, the spatial location
of each particular frequency cannot be uniquely determined in this manner, because of
symmetry. This can be understood by analogy with a multiplication table: if one wants to
identify one of the squares by saying that it contains the number 27, it is ambiguous as to
whether we are describing square (9,3) or (3,9). To overcome this, an iterative technique
(termed ‘back-projection’, by inheritance from its origins in X-ray tomography, in beams actually
traverse an object) was used as per the insight of Lauterbur to solve this image reconstruction
problem in the early days of MRI. Nowadays, the more efficient strategy of combing frequency
with phase encoding is generally preferred.
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Suppose that upon frequency encoding we will have ‘stripes’ of the excited slice with
frequencies A, B and so on. Conceptually, we now want to define a system of perpendicular
stripes such that each spot in this excited grid can be identified uniquely. Phase encoding uses
the same strategy as the above-described frequency encoding – the application of an additional
linear gradient – but to a slightly different effect. Instead of applying the linear gradient (and
thereby modifying the Larmor frequency) during the acquisition itself, the phase encoding
gradient is applied for a short time prior to the acquisition. While this gradient is applied, the
spins experience precession around a slightly different Larmor frequency for a short time only.
The effect of this is that, although they have returned to their “original” frequency by the time
of the acquisition (in this case, whatever frequency is dictated according to their location by the
frequency encoding gradient), their phase φ in this sinusoid will be different. Repeated
application of a variable-strength phase encode gradient and acquisition of the resulting signals
results in a collection of signals representing the algebraic problem φiA + φiB , where i
represents the iteration over phase gradients and A, B are two (of many) signals of variable
frequency whose contributions need identification in the last dimension. The contribution of
each signal can be determined uniquely by doing mathematics analogous to solving a pair of
equations {φiA + φiB = 1, φjA + φjB = 2} for the unknowns.
Conceptually, all of the magnetic resonance information present in an MRI volume can thus be
thought of as having some location in the space (phase, frequency) as defined by the signal
gathered when these two gradients were applied. This ‘space’ (in the mathematical sense) is
called ‘k-space’, and is useful to describe the order in which we collect the information in the
image. It happens to be the Fourier Transform (FT) of intensities of the image in real space, in
the same way that a diffraction pattern is the transform of a crystal structure or the information
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needed to create a hologram is FT of the optical image. Depending on the pulse sequence, the
informational content in k-space may be filled in in a different order.
The imaging pulse sequence can be designed such that the contrast in the resulting image
predominantly reflects different physical properties of the spins in each voxel: we can ‘weight’
the amplitude of the signal in the image for T1, T2, or just the number of protons present in the
voxel (known as a “proton density weighted” image). A detailed discussion of imaging pulse
sequences and acquisition strategies will not be included here, except for a brief explanation of
the basic gradient-echo and related fast low-angle shot or FLASH sequence upon which our
gluCEST sequences are based and a few key sequences for localized spectroscopy. Specialized
acquisitions required for the CEST experiment will be discussed in Chapter 1b, in the section The
CEST Experiment in Practice.
Gradient echo. It might seem that, armed with the strategies of spatial encoding described
above, one could perform magnetic
resonance imaging using the FID signal itself.
This is possible, but can be disadvantageous
for reasons having to do with the decay of
the signal as defined by the T2 or T2*
envelope. Namely, optimal signal-to-noise
ratio will be achieved if the peak signal
amplitude coincides with the acquisition of
the ‘center’ of k-space, the {frequency,
Figure 1a.1. Basic (unspoiled) gradientecho pulse sequence, from S. Shah (see
General Bibliography )

phase} space which defines our localization
scheme. However, depending on the
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acquisition scheme, the center of k-space is often not collected first with respect to time after
the RF pulse. In order to cause the peak signal amplitude to recur when the center of k-space is
being measured, gradients or RF pulses can be used to induce an ‘echo’ of the FID.
The physical explanation of this phenomenon is that any dephasing that is caused by events that
are non-random, defined functions of time (e.g. interactions caused by static electronic
structure of the molecule or substance) can be reversed. A popular analogy is that of runners or
racecars at a starting line that move at various defined speeds: when the race begins, they will
spread out over space relative to each other. However, if one had some way to make everyone
suddenly stop and go backwards at the same velocity, one would expect all participants to be ‘in
phase’ at the start line again after an equal amount of time.
There are two ways to do this to the spins in an MR experiment: ‘flip’ the system with another
RF pulse to generate a mirror image of the current phase picture (this is called ‘spin echo’), or
use gradients. The latter method, called ‘gradient echo’, works by first applying a gradient to
purposely dephase the spins – that is, much faster than they would be dephased ‘naturally’ by T2
decay – and then applying the same gradient in reverse to generate the echo. This allows for
acquisition of the echo faster than in the case of using a 180° RF pulse. Together with the use of
spoiler gradients and sometimes in combination with spin echo techniques, gradient echo is
among the strategies used for accelerating acquisition, as in the popular fast low-angle shot
(FLASH) sequence described below.
Spoiled gradient echo, including FLASH
The faster one accelerates image acquisition, the more strategies must be employed to keep the
signals from different points in k-space separate from each other. Using a low flip angle (so that
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the magnetization has less “distance to travel” back to full recovery) is one strategy to avoid
contribution from residual magnetization between k-space points. Furthermore, fast, repeated
excitation and signal acquisition can be kept ‘clean’ from residual signal from the last iteration
by a strategy called ‘spoiling’, defined as the ‘disruption of transverse coherences that may
persist from cycle to cycle in a GRE sequence’26. The CEST sequences used in this thesis are
based off of the Siemens product version of FLASH27, which is a spoiled gradient-echo sequence
where the spoiling is primarily accomplished by spoiler gradients, with additional spoiling
achieved by modulating the phase of the RF carrier frequency. It is likely that the strategy for
the latter implemented in FLASH is based off of the work of Zur et al, who offered a formula for
RF phase-cycling to eliminate unsolicited coherences arising from ‘resonance’ of various
harmonics28.
PRESS, and LASER for localized spectroscopy
As in imaging, the basic strategy of generating a localized NMR spectrum is to manipulate the
spins so that excitation, phasing, or both are selective for a particular frequency and therefore a
particular volume.
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One popular sequence for single-voxel spectroscopy is Point Resolved Spectroscopy or PRESS,
introduced by P. Bottomley 18. It is a double spin-echo sequence: slice selective excitation is
followed by two (also slice selective, for orthogonal slices) refocusing pulses. This generates two
echoes, the second of which contains the desired signal which is localized in all three
dimensions. The correct localization of the full spectrum relies on a sufficiently broadband
refocusing pulse; otherwise, so-called chemical shift displacement errors will occur, in which the
signal from
Figure 1a. 2. semi-LASER pulse sequence diagram, from ref [21], which
introduced this technique. A 90° slice selective pulse is followed by four
adiabatic full passage (AFP) pulse which refocus the magnetization with
respect to the other two dimensions.

different
resonances
are arising
from
different
adjacent
volumes.
The major
limiting
factor of

PRESS is that the refocusing pulses must be of limited bandwidth to accommodate limitations on
total RF power. At higher field strength, the necessarily narrow bandwidth of these refocusing
pulse causes a chemical shift displacement error that could be interpreted as unacceptably
large.
An alternative pulse sequence is Localization by Adiabatic Selective Refocusing, or LASER. The
basic concept of the LASER sequence is that excitation and spatial selection are separated into
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two different steps. After exciting the entire sample with a 90° pulse, slice-selective refocusing is
achieved by six (one pair per dimension) 180° adiabatic full passage (AFP) pulses. Use of these
very broadband AFP pulses mitigates the issue of chemical shift displacement error. However,
like PRESS, the performance of LASER is also limited by the allowable magnitude of RF power. A
‘compromise’ on this front manifested in the development of the semi-LASER sequence, in
which a ‘regular’ slice selective excitation pulse is followed by only four, instead of six, AFP
refocusing pulses20. A chemical shift imaging implementation of the semi-LASER sequence is
employed in the experiments described in Chapter 6.
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1b: The Chemical Exchange Saturation Transfer Experiment
1b.1 Overview and strategy of the experiment
These next sections will provide a conceptual overview of the physics relevant to CEST. The
reader is encouraged to return to this narrative explanation when reviewing the mathematical
expressions in the subsequent section, ‘Phenomenological Modeling of the CEST experiment’.
Overwhelmingly, standard forms of Magnetic Resonance Imaging (MRI) detect the NMR signal
from water, which forms a huge fraction (~70%) of the human body. Chemical Exchange
Saturation Transfer (CEST) is a specialized MRI modality which seeks to indirectly detect the
presence of specific molecules or metabolites which may exist only at millimolar concentrations
in vivo by exploiting their interaction with the surrounding bulk water - -specifically, their
propensity to undergo a process called chemical exchange. Briefly, chemical exchange is the
process of nearby molecules ‘trading’ labile protons, where labile describes the chemical
properties determining whether this proton is likely to ‘come off’. (See discussion below.)
In the previous section, we introduced the notion that extended application of the RF pulse (or
B1 field) could induce a temporary ‘saturation’, or decrease, of the NMR signal in the spin pool. It
turns out that this saturation and consequent signal depression is transferable from one pool of
spins in a sample to another. Nuclear spins interact with the B1 field in a frequency-specific
manner, and thus any RF pulse applied for the purposes of inducing the MR-saturated state can
be made specific to a particular spin system, to whatever degree that a) the Larmor frequency of
that isochromat is unique (i.e. it is the only thing contributing to the resonance in that part of
the spectrum) and b) it is possible to narrow the frequency bandwidth of the RF pulse itself.
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In CEST, such a frequency-selective pulse is delivered to a resonance of the molecule of interest.
When this pool of protons with a now non-equilibrium distribution of spin states exchanges
from its original molecule to the water surrounding it, the water signal itself is now harboring
this non-equilibrium state, and upon measurement exhibits a decreased net magnetization and
NMR signal. The magnitude of this CEST effect on the water signal will depend on:
a) the concentration of the saturated target metabolite
b) the efficiency or degree of saturation
c) the rate of exchange between that molecule and water
d) the relaxation properties of the water
Note that the relaxation properties of the target molecule itself contribute to (b), the efficiency
of saturation. Since exchange is effectively a form of relaxation, (b) and (c) are not independent.
This point will be discussed further in the next section.
In this way, an experiment can be designed which consists of two basic steps: saturating the
molecule of interest, and then detecting the water signal. Pulse sequences for any type of CEST
experiment reflect this: they contain a ‘magnetization preparation’ module in which the
saturation is performed, and an acquisition or ‘read out’ module in which the water signal is
used to generate an image. In some cases, these modules may be interleaved to varying
degrees. It is important to note that the acquisition module must be of a form which produces a
proton density weighted image, as the CEST effect essentially manifests as a decrease in the
‘concentration’ of protons in that voxel of the image.
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Figure 1b.1. Illustration of CEST phenomenon
and its measurement, from Kogan, Hariharan
and Reddy, 2013 a) RF at the Larmor frequency
of the labile proton induces saturation in this
population. Exchange with water transfers this
saturation to the water pool. b) The proton
NMR spectra of the sample, exhibiting a
decrease in the water signal when the
saturation pulse is applied. c) The Z-spectrum,
plotting the change upon saturation at a
particular frequency (black) and the
‘asymmetry’ spectrum, which subtracts one
side of the Z-spectrum from the other to
eliminate the symmetric direct saturation
peak, leaving only the peak of interest
reflecting the contribution of exchange (red).
d) Pulse sequence schematic of the CEST
experiment: saturation followed by readout.
We can walk through the mechanism of the CEST experiment as follows (see Figure 1b.1)1. First
of all, a measurement of the 1H NMR signal of water might give a spectrum similar to those
shown in red or blue in 1b.1b. Exchangeable protons exist on some molecule dissolved in this
water – in this case, attached to the nitrogen in glutamate -- and resonate at some Larmor
frequency, ω. An RF pulse is applied at frequency ω (here, 3ppm relative to water) which
saturates the NMR signal of this population of protons. These protons exchange with the bulk
water which they’re dissolved in. This transfers the saturation of this portion of the signal to the
water resonance (panel a). When the water NMR signal is detected again, it gives a smaller peak
(panel b, red line) than it did without the saturation, or with saturation that is off-resonance
from the metabolite of interest, as is indicated by the blue line. (The significance of performing
this second saturation at precisely -3ppm will be discussed in the next section.) We can make a
plot that shows the magnitude of this signal decrease as a function of the frequency of the
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saturation pulse, called the Z-spectrum7 (panel c, black line). To quantify the effect of the
saturation due to exchange, we frequently report the subtraction of one side of the Z-spectrum
from the other (panel c, red line), to eliminate the contribution of effects that are not of
interest, such as the direct saturation of water itself at 0ppm.
While it is difficult to think of a better pictorial representation of the CEST phenomenon,
illustrations such as that in Figure 1b.1a can be a bit misleading in that they suggest a ‘labeling’
of individual hydrogen atoms, as in the case of experiments which substitute hydrogen for
deuterium. However, it is important to keep in mind that the NMR signal that is temporarily lost
upon saturation is a result of changing the sum of all of the magnetic moments. Thus one could
not, unlike in case of the isotope labeling, actually point to one proton or another in a chemical
structure and state that “this proton is saturated while this one isn’t”, although this might be
the idea gleaned from such a graphic.

1b.2 Generation and analysis of the Z-spectrum
As illustrated in
Figure 1b.1b and
1b.1c, a so-called
Z-spectrum can be
generated by
sweeping over
Figure 1b.2 The Z-spectrum: B1 dependence and Lorentzian fitting.
From Windschuh et al 2015 [ref. 2].
7

frequencies of

It appears that the term ‘Z-spectrum’ originated from the work of R.G. Bryant, in the context of crossrelaxation spectra, as in Hinton DP, Bryant RG. Magn Reson Med. 1996;35(4):497-505. The term was then
adapted, presumably by Wolff, Balaban and others, to describe the magnetization transfer arising from
chemical exchange.
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the applied saturation pulse (the x-axis of the Z-spectrum) and measuring the magnitude of the
post-saturation water signal (the y-axis). While the Z-spectrum illustrated in Figure 1b.1 is
schematic, Z-spectra gathered from a human brain are illustrated by Figure 1b.2a, from
Windschuh et al 20152.
Other than the frequency of the saturation pulse, the second important parameter which
characterizes it is amplitude; this amplitude is generally referred to as ‘saturation B1’ -- or just
‘B1’ when the context is clear. Figure 1b.2a nicely illustrates how the Z-spectrum evolves with
varying B1 power, although the range of saturation B1 amplitudes shown here is that relevant for
the APT CEST experiment. In Chapter 2, we will discuss the dependence of the CEST signal on B1
as relevant to the gluCEST experiment, which requires a B1 amplitude more than double the
maximum indicated on the plot in Figure 1b.2a.
Note that in a CEST image, since the water signal has a magnitude in every pixel, every single
pixel has its own Z-spectrum. (In practice, there may be some cases where averaging over
several pixels is performed.) Once the series of images comprising the Z-spectrum is acquired,
there are two main approaches to quantifying the CEST signal at the frequency offset of interest,
which are respectively illustrated by Figures 1b.1 and 1b.2. Panel C of Figure 1b.1 illustrates the
approach of “magnetization transfer asymmetry”: one side of the black ‘spectrum’ is subtracting
from the other, resulting in the red line. In this approach, which is the one used in the work
presented here, it is not assumed that we can assign all contributions to the Z-spectrum, but
rather only that the contribution at a particular frequency offset is dominated by the signal of
interest. The asymmetry approach is based on simple subtraction of directly measured signals
and does not require fitting; thus it does not necessitate collecting the entire Z-spectrum
beyond the frequency ranges of interest on each side of water, although some additional
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bandwidth is needed to allow for B0 inhomogeneity correction. (See The CEST Experiment in
Practice. )
Alternatively, another popular approach is to collect the entire Z-spectrum and fit the respective
contributions with Lorentzian functions, not unlike the standard approach for spectroscopy
data. This is the favored method of several practitioners, as in the work of M. Zaiss3 and A.
Singh4. Some works making use of Lorentzian fitting claim that in this way, they have overcome
the challenges of specificity inherent in the CEST experiment. However, this assumes that all
contributions to the Z-spectrum are known (i.e., that the basis set used for fitting is complete),
which is difficult to demonstrate.

1b.3 The challenge of specificity in the CEST experiment
Indeed, a major shortcoming of CEST is the ambiguity arising from the combined (and often
inseparable) effects of the above-listed factors (a-d) along with the limited degree of truly
frequency-selective excitation. The major categories of specificity-related challenges to CEST
and strategies for their mitigation are as follows:
--Excitation of species other than the target metabolite
Two subcategories of this problem are: a) other metabolites (which exchange or cross-relax)
resonating in the same region of the spectrum as the target metabolite can also be excited; b)
water itself can become directly excited because of the very large magnitude (and therefore
width) of its resonance peak. Mitigation: a) It is best practice to perform phantom experiments
in which one attempts to adjust the power, shape and frequency of the saturation pulse to
optimize conditions such that the dynamic range of the signal predominantly depends on the
concentration of only one of the overlapping metabolites. . However, separation of those
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molecules which have both similar chemical shifts and proton exchange rates can still remain
quite challenging, and assumptions about relative contributions are often made on the basis of
concentration. b) Use of higher field strength increases the chemical shift dispersion between
water and the target metabolite, and shimming minimizes the width of the water peak,
decreasing the degree of direct saturation
--Inhomogeneity or insufficiency of the saturation-inducing radiation
At 7T, the RF used has comparable wavelength to human anatomical dimensions. Because of
this, standard transmit/receive head coils produce a high degree of inhomogeneity in B1
amplitude, arising from standing waves. Furthermore, absolute saturation power is limited by
safety considerations. Mitigation: Addressing this problem with respect to gluCEST is the subject
of Chapter 2, the introduction of which covers the challenge more generally. Also relevant is
section 2.1, in which use of high dielectric pads is explored.
--Relaxation properties (T1) can be confounded with the CEST effect
This is an entirely intrinsic property of the CEST phenomenon, which is clearly expressed
mathematically in Equation 1.38 of the next section. Mitigation: This is also perhaps the most
resolvable amongst these issues, as it can be understood theoretically and corrected for. This is
the basis of the commonly used AREX approach developed by Zaiss et al. 5,6
--Variability in exchange rate is difficult to separate from concentration
The main issue here is exchange rate dependence on pH. Theoretically, this is very difficult to
deconvolute, as these two terms – exchange rate and concentration -- always appear as the
product [rate*concentration].
Mitigation: Deciding whether variability in the CEST contrast is due to variability in
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concentration or pH is generally a question of reasonable interpretation of the physiological
context; e.g., if pH is known to be variable in a tumor, this may be the appropriate interpretation
of the CEST maps in that case, as in ref 7 . Unfortunately, such pathology may also be the context
of our interest in the target metabolite. This relationship between pH and exchange rate
presents a very real challenge for certain CEST applications, although in other contexts, it is
exploited as the main contrast of interest 8–11.

8–11

.

1b.4 The saturation pulse
The physics of the CEST saturation pulse is an excellent example by which to illustrate the
equivalency of the quantum mechanical and classical pictures of NMR. In optical forms of
spectroscopy-- in which there is no option of a “classical” model—‘saturation’ of a transition
explicitly implies that the two state populations have been equilibrated and thus the dominance
of absorption over relaxation which forms the basis of our interaction with the system no longer
holds.
Translation of this quantum mechanical notion directly to the CEST experiment does at first
glance appear to explain the phenomenon: we have applied an excitation pulse sufficiently long
such that it decreases our ability to interact with the system (i.e. observe or detect the
magnetization). However, there is a layer of complication in the NMR experiment that has no
analog in most forms of optical spectroscopy, which is the presence of transverse
magnetization. In an optical experiment, we may create some coherent superposition states,
but the only thing we ever detect is either the absorption or emission of a photon resulting from
a transition between two eigenstates of the system. In contrast, in NMR, what we are detecting
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is the presence of the superposition coherence itself 8 by way of what Bloch first dubbed ‘nuclear
induction’. Thus, if we perform saturation which decreases the signal, it follows that we are in
fact perturbing our ability to detect this particular state.
In his 1946 paper, Bloch explains that, “it is essential, from this point of view, that we are dealing
with a “coherent mixture” of states, i.e. that the relative phases of the wave functions,
corresponding to the different states, do not undergo any changes. It can be expected, and will
be shown later, that any cause which tends to destroy the phase relation, such as the interaction
between neighboring nuclei, will diminish the actual observable value of the rotating
component.”
This concept of “phased” and “dephased” magnetization is the key bridge between quantum
mechanical and classical models that allows us to understand and model the CEST experiment
using only classical equations à la Bloch, in which the individual states |𝛼⟩ and |𝛽⟩ do not appear
at all. (See Phenomenological modeling of the CEST experiment: Bloch-McConnell equations.)
However, we can ‘translate’ between them by understanding the relationship between the
transverse magnetization and the elements of the density matrix: when we perform saturation
using an RF pulse, what we’re essentially doing is temporarily ‘storing’ spin angular momentum
as unphased transverse magnetization --𝜌𝛼𝛽 or 𝜌𝛽𝛼 which sum to zero -- giving us an 𝑀𝑍
where both 𝜌𝛼𝛼 and 𝜌𝛽𝛽 are less than 𝜌𝛼𝛼,0 and 𝜌𝛽𝛽,0 . 9 When we rotate this net 𝑀𝑍 into the

8

This is a very key difference between these two experimental fields that for some reason is rarely
pointed out explicitly, although I think doing so would help enhance the general understanding of the
relationship between NMR “spectroscopy” and its half-siblings in other areas of chemical physics.
𝜌
9
However, using RF radiation in this way, we are not able to actually manipulate the ratio 𝛼𝛼 itself. This is
𝜌𝛽𝛽

in contrast to experiments involving dynamic nuclear polarization via coupling to electron spin, in which
single quantum transitions affecting the distribution between eigenstates are effected by irradiation of
the electronic resonance.
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transverse plane to detect it in the acquisition or readout module, we detect a lower signal than
we would detect in the presence of the original 𝜌𝛼𝛼 and 𝜌𝛽𝛽 , which will be restored only after T1
relaxation has occurred.
Conceptually, we can trace through the process of saturation as follows: Before the saturation
pulse begins, the net magnetization of both species – metabolite and water—is longitudinal and
of equilibrium magnitude. We now turn on a frequency selective saturation pulse that uniquely
affects the metabolite. The RF pulse begins to rotate (nutate) the metabolite magnetization,
giving it a transverse component in addition to a longitudinal component. As time goes on, this
component is increasing according to some function cos(θ)10, where θ itself represents the
nutation and is a function of time defined by the pulse properties. Let’s pause and think about
what is happening during every instant of this process: namely, in terms of T1 and T2 relaxation.
The RF pulse acts on longitudinal magnetization, converting it to transverse, while T1 relaxation
causes this transverse magnetization to decay and repopulate the longitudinal component. In
the presence of an RF pulse, the system will eventually reach a steady state when the product
[T1*amount of transverse magnetization] is equal to the product [effect of RF pulse * amount of
longitudinal magnetization]. Meanwhile, T2 relaxation – anything that dephases transverse
magnetization and causes its signal to decay – is constantly occurring, and generally at a faster
rate than T1 . If the action of T1 relaxation that returns transverse magnetization to the
longitudinal component is equalized by the action of the saturation pulse which does the
opposite, then as the saturation pulse progresses, more and more of the magnetization
undergoes the dephasing known as T2 relaxation and is ‘accumulating’ in this unphased

10

It should be clarified that the saturation pulse induces many multiples of 360° rotations of the net
magnetization. This visualization is appropriate for any given period of this rotation.
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transverse pool. Only when the RF pulse is turned off and T1 relaxation dominates will the signal
begin to increase to its original magnitude. If there were no exchange, then if we were to
measure MZ of the metabolite before T1 relaxation is complete, we would find that MZ of the
metabolite would be less than its original value.
Consider now that during this process, metabolite protons are being exchanged with water
protons. While a proton is resident on the metabolite and subject to the local B0 arising from its
electronic configuration, it resonates at ω0 and is subject to the action of the saturation pulse.
After being exchange to water, the proton is subject to a different B0, effective, has a different
Larmor frequency, and is not subject to the action of the pulse. Suppose the saturation pulse
lasts for 1 second, and the rate of exchange between the metabolite and water is 1000Hz, or 1k
exchanges per second. This means that during the saturation pulse, each molecule of metabolite
on average will have harbored 1k individual protons at the site of interest which, at the instant
of residence on the metabolite, were subjected to the nutation of the pulse. These 1k protons
subjected to the saturation pulse (with zero net longitudinal magnetization) are stored on water
pool thereby reduce the water signal amplitude. Eventually, it’s the water protons we’re going
to measure to “see” how they were affected by this saturation process.

1b.5 Effect of exchange rate
Now we can consider what the effect would be of this exchange rate being faster or slower. On
the one hand, we can understand how CEST can give rise to amplification of the signal per
molecule over spectroscopy: when we do spectroscopy, we get one unit of ‘signal’ per proton of
interest – in other words, our signal depends on (a) –although relaxation and exchange affect
the lineshape, the time evolution, and ultimately the signal magnitude. But in CEST, our ‘signal’
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is derived from a product of factors a, b, c and d enumerated above. If (c) is very large, this can
amplify the signal generated by the presence of the molecule. However, this also means that
each proton is subject to the effect of the saturation pulse for less time. If the total nutation
induced on a single proton is less, then the corresponding saturation of the population’s signal is
also less. In other words, a fast rate of exchange, while in principle amplifying the signal-perconcentration, also decreases the efficiency of the saturation. In a hypothetical limiting case,
exchange would be happening so fast that no nutation occurs at all during that time, and the
CEST effect doesn’t manifest. In order to avoid approaching this situation, a fast-exchanging
metabolite requires a higher power RF pulse with a higher nutation frequency.
Another way to think about this is that in the fast-exchange case, the linewidth of the resonance
targeted by the saturation itself is very broad. It is common to all forms of spectroscopy that the
lineshape of a resonance - -that is, the intensity of that ‘absorption’ over the frequency axis —is
related to the lifetime of the states involved12. Because of the Fourier relationship between time
and frequency, longer lifetimes correspond to narrower lineshapes (the limiting cases being that
an infinitely long lifetime yields a delta function, and an infinitely short one, a flat line). In NMR,
the lineshape of a resonance is generally defined by the T2 of that resonance: the longer the T2,
the narrower the linewidth. Effectively, T2 of any species is shortened by the presence of
exchange, as expressed by Equations 1.38 and 1.39 in the section to follow.
At some point, if two resonances are sufficiently close and exchange is sufficiently fast – leading
to broad lineshapes-- they coalesce, and we lose the ability to detect them separately at all. This
also means that we lose the ability to excite them separately with an RF pulse. So far in our
discussion, we have been assuming that there is frequency-selective excitation of the metabolite
only, leaving the water protons unperturbed. However, if the lineshape of the metabolite
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resonance is sufficiently broad, its separation from water in the spectrum begins to deteriorate,
which means that an RF pulse targeting this metabolite will affect water, too. The practical
consequence of this is that the faster the exchange of the metabolite of interest, the further the
resonance has to be from water in the NMR spectrum, or otherwise the ability to perform
frequency-selective excitation and thus CEST is lost.
With regards to the focus of this thesis, it should be emphasized that at clinically standard field
strengths (1.5 or 3 T), the exchange of the glutamate amine proton with bulk water is too fast
relative to the chemical shift dispersion of frequencies and gluCEST is not possible.
On the other side of the exchange rate continuum from glutamate and gluCEST are amide
protons, forming the target of interest in APT CEST. They have been estimated to exchange at a
rate of ~30 Hz13, which is about 50-fold more slowly than the glutamate amine protons. While
this sharply decreases the saturation efficiency in time, it also means that a sufficiently long
pulse at low power can generate the desired signal from amide-based exchange. This has the
practical consequence that APT CEST, unlike gluCEST, is possible at the more widely available 3 T
field strength.
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1b.6 Transfer of saturation from one species to another
The general thinking public may imagine molecular structures to be static, but in fact they are
not. Chemical exchange is the phenomenon of protons becoming liberated from their structural
position in one molecule and winding up involved in another. The likelihood of this process
occurring with respect to any given proton on any given molecule is governed by the pKa, which
depends on the local and overall electronic
Figure 1b.3. Electronic structures give rise
to chemical exchange phenomena . Top:
Electrostatic potential of glutamate.
Bottom: Schematic of glutamate’s labile
protons and their corresponding pKA.

structure of the molecule. pKa quantifies the
propensity of a proton to ‘leave’ its
attachment to another atom, in units related
to the pH of the solution required to cause the
transition . A proton detaching from a
molecule it participates in leaves that
molecule in an anionic state; an additional
proton attaching to a molecule in which it
does not structurally participate creates a
cation. The likelihood of either of these events
happening is therefore determined by the
stability (absolute energy) of the resulting
electronic configuration.
Because carbon makes for an extremely

unstable ion, protons attached to carbons are rarely perturbed in biochemical contexts, with the
exception of reactions that are heavily stabilized by enzymatic environments. The spontaneous
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‘exchange’ of protons in solution occurs only amongst protons attached to heteroatoms oxygen
and nitrogen, such as in the zwitterionic forms of the amino acids.
In glutamate, there are two carboxylic acid groups and one amine group which proffer such
protons. We can see from the chart in Figure 1b.3 that the two -OH protons have low pKa, while
the removal of the third proton (to the -NH2 group) has a high pKa11. These electrostatic
potentials and pKas translate to the fact that, at biological pH, the most likely state of the
glutamate/glutamic acid molecule at any instant is to have the carboxyl groups deprotonated
and the amine group protonated. Although the amine group is likely to have three protons
resident at any given instant, the protons of this group are likely to be in constant flux between
this position on the amine group and one of the surrounding water molecules. As explained
above, we can take advantage of this phenomenon in glutamate or another exchanging
molecule to ‘transfer’ the saturation that we incurred from the glutamate amine resonance to
the bulk water resonance, ‘carried’ by these protons.

1b.7 Other forms of CEST
While glutamate-weighted CEST “gluCEST” is the focus of this thesis14, it behooves us to briefly
summarize other forms of CEST modalities demonstrated to date. At the highest level of
classification is the distinction between paramagnetic and diamagnetic CEST contrast15,16. With
the exception of deoxymyoglobin17, ‘paraCEST’ contrast agents are all exogenous. While the
drastic chemical shifts afforded by coupling to a paramagnetic ion greatly enhance the
specificity of this experiment, concerns about toxicity have limited the translation of paraCEST

11

References for Figure 1b.3: (top)
https://pubs.rsc.org/en/content/articlehtml/2017/nj/c6nj03939a?casa_token=oyR8Kr7JNLYAAAAA:yV9oOdET972S1G1w_mIjOqN_5qUnhGoVkv5Typo0TWi1s0Hqd3tYFF3j5rucswEBZeoITh3613tWQ
(bottom) https://slideplayer.com/slide/5675684/
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to use in human beings. Diamagnetic CEST, which follows the mechanism so far described, can
be performed targeting either exogenous or endogenous molecules. Examples of exogenously
introduced but highly biocompatible CEST agents are glucose18,19 and artificial sweetener, as
demonstrated by Bagga et al. 20
Endogenous CEST – and most diamagnetic CEST approaches in general-- fall into three main
categories, corresponding to three commonly found types of exchangeable protons in
biochemistry: amine (-NH2), amide (-NH), and hydroxyl (-OH) groups15. There are also
exogenously introduced molecules which can function as CEST contrast agents, behaving in
accordance to similar physics but without the complications of mechanisms arising from
involvement in macromolecular structures16.
Other than glutamate, the major amine-based CEST is that of creatine21, with a signal centered
at 1.8ppm. Importantly, the amine protons of creatine exchange much faster than the
equivalent ones on phosphocreatine, allowing for specificity of this signal. Creatine is present in
the brain in non-negligible amounts and is included in our simulations of brain gluCEST;
however, the primary application of CrCEST as an independent modality has been in skeletal
muscle 22,23 and heart24.
Amide protons are quite ubiquitous in biochemistry, with perhaps the most notorious instance
being the amide bond in the backbone of the protein structure. CEST which probes the signal
centered at 3.5 ppm is known as APT CEST, and is the most broadly applied CEST modality in
current practice. While the origin of its signal is difficult to pinpoint, it has been demonstrated to
have import in clinical radiology of brain tumors and other pathology 25–28 and has recently been
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translated to commercial sequence implementations. Given its much slower exchange rate, APT
CEST is possible at the 3 T field strength, which has facilitated its proliferation to date.
Lastly, hydroxyl groups are exploited as CEST agents in glucose and derivative biomolecules
including lactate, glycogen, glycosaminoglycans and myoinositol20,29–33. Glycogen and
glycosaminoglycans exist as polymers, which can complicate interpretation of the
concentration:signal relationship. This ‘yield’ depends not just on concentration, but on
accessibility of exchangeable protons to bulk water, and the architecture of these molecules
would be challenging to replicate in phantoms.

1b.8 Other effects which appear in the Z- spectrum
In addition to this chemical exchange of protons from identifiable molecules, there are some
additional, less precisely assigned phenomena by which magnetization in neighboring molecules
can be ‘passed around’. They strongly affect the CEST experiment and also have importance as
imaging contrast mechanisms in and of themselves. These are the so-called semi-solid
Magnetization Transfer (MT) and the Nuclear Overhauser Effect (NOE). Exactly what
mechanism(s) arising from what resonance(s) these effects are detecting is usually unclear, but
the appearance of multiple distinct signals-- including from non-exchangeable protons-- in the Zspectrum has been reported extensively13,16,34. Briefly, these phenomena can be described as
follows:
Semi-solid magnetization transfer: This effect, commonly known as ‘MT’, arises from the fact
that ‘bound’ water molecules in the solvation shell of large macromolecules – forming a ‘semisolid’ matrix, as perhaps in the cytoplasm— may have a different resonant frequency from those
in the bulk solvent, as a result of their extensive hydrogen bonding. Also due to hydrogen
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bonding and electronic interaction with the solvated macromolecule, these bound waters
undergo slow exchange, and are saturated in the vicinity of -2.4ppm relative to water at low B1
powers. However, due to the fact that MT arises from bound water molecules in a variety of
physico-chemical contexts, the effect is very broad both in terms of the frequency and
saturation power dimension.
NOE: While sweeping through the frequency spectrum, certain resonances are saturated which
arise from non-exchangeable protons. These resonances, however, have still been observed to
give rise to a decrease in the water signal, presumably through cross-relaxation, the mechanism
of single quantum transition described by the NOE. These non-exchangeable protons, including CH2 or CH3 groups – are probably located on protein sidechains or in lipids. When attempting to
interpret these signals specifically, one should keep in mind that, as with chemical exchange, a
cross-relaxation interaction requires that this proton be accessible to the bulk water. This crossrelaxation, which is not affected by pH, can be distinguished by appropriate experiments from
true CEST effects, as chemical exchange is highly pH-dependent, as discussed above.
In modeling the CEST experiment, we incorporate all such interactions into the Bloch-McConnell
equations (see next section), in which they are treated as simple first-order exchange using rate
constants reported in the literature.

1b.9 Phenomenological modeling of the CEST experiment: Bloch-McConnell equations
In 1958, Harden McConnell had the insight that rather than getting entangled with
spectroscopist-style derivations of lineshapes12, anyone interested in modeling the effect of

12

This is not my comment from the peanut gallery, but is stated rather explicitly by McConnell himself in
the first paragraph of his paper: “This reduces the previous rather involved derivations of (line-shape
reaction-rate) formulas [several works cited] to almost trivial algebraic operations…”. If the reader is
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chemical exchange in an NMR experiment could simply add some terms to the Bloch equations
(introduced in Chapter 1a)35. These terms capture the “passing” back and forth of magnetization
between pool A and pool B, which may each have their own intrinsic relaxation rates T1 and T2.
While McConnell’s seminal paper was not intended to treat the specific experiment of
saturation transfer, his equations have been put to this purpose extensively by the CEST theory
community.
The so-called Bloch-McConnell equations solved numerically to simulate the CEST experiment in
this work are based on the treatment of D.E. Woessner36 , whose notation of these equations is
as follows:
[Equations 1.37, A-E]
𝑑𝑀𝑥𝑎
= −(𝜔𝑎 − 𝜔)𝑀𝑦𝑎 − 𝑘2𝑎 𝑀𝑥𝑎 + 𝐶𝑏 𝑀𝑥𝑏
𝑑𝑡
𝑑𝑀𝑥𝑏
= −(𝜔𝑏 − 𝜔)𝑀𝑦𝑏 − 𝑘2𝑏 𝑀𝑥𝑏 + 𝐶𝑎 𝑀𝑥𝑎
𝑑𝑡
𝑑𝑀𝑦𝑎
= (𝜔𝑎 − 𝜔)𝑀𝑥𝑎 − 𝑘2𝑎 𝑀𝑦𝑎 + 𝐶𝑏 𝑀𝑦𝑏 − 𝜔1 𝑀𝑧𝑎
𝑑𝑡
𝑑𝑀𝑏𝑎
= (𝜔𝑏 − 𝜔)𝑀𝑥𝑏 − 𝑘2𝑏 𝑀𝑦𝑏 + 𝐶𝑎 𝑀𝑦𝑎 − 𝜔1 𝑀𝑧𝑏
𝑑𝑡
𝑑𝑀𝑧𝑎
𝑑𝑡

=

𝑀0𝑎
𝑇1𝑎

− 𝑘1𝑎 𝑀𝑧𝑎 + 𝐶𝑏 𝑀𝑧𝑏 + 𝜔1 𝑀𝑦𝑎

𝑑𝑀𝑧𝑏
𝑑𝑡

=

𝑀0𝑏
𝑇1𝑏

− 𝑘1𝑏 𝑀𝑧𝑏 + 𝐶𝑎 𝑀𝑧𝑎 + 𝜔1 𝑀𝑦𝑏

unfamiliar with the arduous exercise of lineshape description in spectroscopy, they are cordially invited to
peruse the textbook of Reference 9.
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where
𝑘1𝑎 =

1
𝑇1𝑎

+ 𝐶𝑎

[1.38]

𝑘2𝑎 =

1
𝑇2𝑎

+ 𝐶𝑎

[1.39]

T1a and T2a are the longitudinal and transverse relaxation times of pool A in the absence of
exchange, ωa is the Larmor frequency of pool A, ω is the frequency of the RF radiation
comprising the saturation pulse (which may or may not be equal to either ωa or ωb) , ω1 is the
nutation rate induced by the RF of the saturation pulse, and Ca is the rate of spins leaving pool A
by chemical exchange (likewise for all terms relating to pool B).
In the case of perfect saturation of pool B and no direct saturation of Pool A, the net rate of
change of the Z magnetization of pool A in this two-pool system is the difference between the
rate of exchange (which drains magnetization) and the rate of T1 recovery. The steady state is
described by the situation when these two rates are equal:
𝐶𝑎 𝑀𝑍𝑎 =

(𝑀0𝑎 −𝑀𝑍𝑎 )
𝑇1𝑎

[1.40]

At this time, the ‘Z value’, or MZ/M0, is given by:

𝑍=

𝑀𝑍𝑎
𝑀0𝑎

=

𝜏𝑎
𝑇1𝑎 + 𝜏𝑎

[1.41]

where τa is the reciprocal of Ca, and represents the lifetime of a proton in Pool A (i.e., how long
it’s there before getting exchanged to pool B. )
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The effect of direct saturation on Pool A can be described directly by Bloch’s original equations,
considering that Δω in this case represents the difference between the Larmor frequency of
Pool A and the applied radiation (which will be at the Larmor frequency of Pool B):
𝑀𝑍𝑎
𝑀0𝑎

=

1
𝜔2 𝑇 𝑇
1+ 1 12 22
1+𝛥𝜔 𝑇2

[1.42]

For Pool B, this expression simplifies to
𝑀𝑍𝑏
𝑀0𝑏

=

1
1+ 𝜔12 𝑇1 𝑇2

[1.43]

Now from the mathematical perspective, we can again appreciate why faster exchanging
molecules must be further from water. The difference between MZ/M0 for Pool B (our real effect
of interest) and MZ/M0 for Pool A (direct saturation) is determined entirely by the term 𝛥𝜔2 𝑇22,
where this T2 is that of Pool A. The bigger this term, the small the denominator on the RHS of
equation W25, and the closer this MZA/M0A is to 1. This represents the Mz of Pool A not
changing as a result of direct saturation, which is the desirable outcome. Fast exchange with the
solute Pool B leads to lower effective T2, which would cause this term to be smaller if Δω were
the same. As exchange rate increases, the frequency dispersion Δω has to increase
proportionally to the decrease in T2 in order for this term, and thus the relative contribution of
direct saturation, to remain the same.
Given the form of these functions, we can see that the maximum CEST effect will be detected
when the system is at steady state. However, in practice this is not always feasible, as it may
require deposition of more RF power than is considered safe in human imaging. It has recently
been shown that measurements at varying points in the rise to steady state (i.e. varying
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durations of the saturation pulse) can be calibrated in post-processing to derive the maximum
steady state value37.
Our implementation of these equations to model the gluCEST measurement in brain has six
rather than two pools, representing bulk water (a), so-called ‘bound water’ in the solvation shell
of macromolecules (bw), amide protons on protein backbones (b), aliphatic and similar protons
(which may participate in cross-relaxation (c), rather than true chemical exchange) the amine
protons on creatine (d), and those of primary interest on glutamate (e). These pools (bw, b, c, d,
e) are all treated as pool B is in Woessner’s notation: that is, their only interaction with the rest
of the system is by exchange of magnetization with bulk water, and not with each other. The
matrices representing the ‘pulse on’ and ‘pulse off’ (relaxation) operations in this system of
differential equations are shown in Figure 1b.4 with the vector representing net magnetizations
of all species specified as B. Our numerical solution solves this system using the matrix
exponential, as in Woessner 2005; however, we implement the mathematical operation in C
rather than in Matlab for accelerated calculation. For more discussion of simulation parameters,

Figure 1b.4. Matrix representations of the Bloch-McConnell differential equations
describing the dynamics of a six-pool spin system where solute pools are coupled by
chemical exchange to a ‘bulk’ solvent pool. The first and overwhelmingly largest of the five
‘solute pools’ is labeled ‘bw’ for ‘bound water’. The two operators represent the physical
situations of the RF pulse being on (pulse) or not (relaxation).
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results, and application to development of B1 inhomogeneity correction in gluCEST, please see
Chapter 2. For complete documentation of these Bloch-McConnell simulations, please see
Appendix A.

1b.10 The CEST experiment in practice
From the above discussion, one might suppose that the CEST experiment consists of a single
sequence: saturation at the frequency of interest, followed by read-out of the proton density
weighted image. However, in practice the following considerations extend the CEST acquisition
to a multipartite affair. The first of these (a) was illustrated by Figure 1b.1 in the previous
section.

a) The need to eliminate the effect of direct saturation (and arguably other broad, mostly
symmetric contributions) requires at least two acquisitions, on either side of the water peak.
b) Even if the analysis of choice is asymmetry, rather than Z-spectrum fitting, additional
frequency offsets must be acquired to make the measurement robust to inhomogeneities in B0.
c) A B0 map must be acquired to report on those inhomogeneities.
d) A B1 map must be acquired if we are going to attempt correction for this inhomogeneity, too.
e) Any maps which are auxiliary to the B1 correction implemented are also needed: in the
present approach, the T1 map from MP2RAGE. In our group’s previous approaches, this was an
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MT sequence. The following flowchart, reproduced from Chapter 2, illustrates the various steps
in acquisition and processing of a gluCEST experiment as is done in all chapters of this thesis:

Figure 1b.5. Acquisition and post-processing of a gluCEST measurement, as per Cember et al
2021.
The steps referred to in the top row (orange and purple boxes) will be explained in more detail
below. The remaining steps, introduced by the author, are the subject of Chapter 2.
1b.10.1 The raw CEST acquisition
The CEST acquisition itself will include several repetitions of the basic saturate-read sequence,
varying the frequency of the saturation pulse to create a ‘spectrum’ (the Z-spectrum) of images
which essentially contain the information MZ/M0(Δω). There are two basic options for analyzing
this data further: if enough offsets were collected, the Z-spectrum through each voxel can be fit
to a Lorentzian function, which is the approach of many groups in the CEST community.
Alternatively, as in the approach presented here, only a subset of these Z-spectrum points can
be collected, sufficient to correct each ‘side’ of the spectrum for B0 inhomogeneity. In Figure
1b.6, these multiple offsets are symbolized by the top row of ‘images’ of varying ‘contrast’. The
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final ‘B0 corrected CEST images’ for each side of the Z-spectrum (bottom right in Figure 1b.6) are
symbolized in the orange box in Figure 1b.5.
1b.10.2 B0 map: WASSR
Accurate asymmetry-based quantification of CEST depends very strongly on correction of the
acquired Z-spectrum (or sub-spectrum of points) for inhomogeneity in B0. As in most other MRI
applications, the dominant signal in the Z-spectrum is water: in this case, it is the strong
decrease in that signal as the RF pulse gets closer to the resonant frequency of water itself-considered in CEST as ‘0 ppm’—causing the signal to become more and more saturated. Since
this so-called direct saturation peak is so salient, its center can be used as the reference to
determine the exact resonant frequency of water in a particular voxel in the presence of small
voxel-to-voxel inhomogeneities in B0 which cause the Larmor frequencies of every component
of the spectrum to shift. The strategy of using a separate, specialized CEST-type acquisition
specifically for this purpose was
Figure 1b.6. Schematic of ‘image synthesis’ approach to
B0 correction. In this illustration, each square represents
a ‘pixel’ in the 2x2 image.

first introduced in Kim et al
2009, who coined the term
Water Saturation Shift
Referencing , or WASSR38. Like
the CEST acquisition, the
WASSR acquisition sweeps over
several frequency offsets,
applying a saturation pulse
followed by a proton-density-

weighted imaging module. Generally, the saturation pulse used in the WASSR scan is of
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significantly lower power and shorter duration (as the target molecule is bulk water itself, not an
exchanging solute or metabolite), and the frequency offsets or Z-spectrum points are sampled
more finely, e.g. in the range of ±1.0 ppm.
1b.10.3 Correcting CEST data for B0 inhomogeneity
The exact location of the water center frequency as determined by interpolating the points of
the WASSR acquisition is used to generate a map of B0 inhomogeneity over the field of view,
where the value of each pixel represents the relative shift of the water center frequency from its
nominal location of 0 ppm. The partial Z-spectrum itself is also interpolated for each pixel from
the CEST acquisition images. The correct value for each pixel is then determining by “shifting”
along this interpolation curve from the nominal offset frequency by the amount indicated by the
B0 map. In this way, the final corrected images are ‘synthesized’ by the B0 correction algorithm
from the array of images acquired in that neighborhood of offset frequencies. In the schematic
of Figure 1b.6, this process is symbolized by the correct color square being chosen for each
‘pixel’ of the B0 map; if there were no B0 inhomogeneity, the correct image would simply be the
one labeled ‘CEST acquisition, Δ0ppm’.
Figure 1b.7 illustrates the concept using example Z-spectra (blue) and the resulting calculation
of asymmetry (green, red). Suppose our resonance of interest is at -1ppm. From the left plot,
which illustrates the spectrum measured in a voxel with no B0 shift, we can read off a value of
0.3 for the asymmetry at -1ppm, calculated by subtracting the value at -1ppm (0.6) from the
value at 1ppm (0.9). The plot on the right represents a voxel in which there is a 0.5ppm shift in
B0 which we do not account for. In other words, we believe 0.5ppm to be “0 ppm”, and perform
the subtraction as if this were the case. We now get an erroneous 0.6 as the asymmetry at
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1ppm – because instead of the correct calculation, we subtracted what is actually the value at 0.5ppm from that at 1.5ppm.

Figure. 1b.7. Illustration of inaccurate CEST asymmetry calculation due to uncorrected B0
shift. The green line is the correct CEST asymmetry calculation for this Z-spectrum. The red
line is the resulting value from performing the calculation without B0 correction on the
shifted data.
1b.10.4 B1 mapping
Our approach to generating B1 maps is based on the paper by Volz et al, 201039. At the time of
that work, a number of B1 mapping techniques existed, but faced a general problem of
lengthiness. As applied to CEST or MT imaging, this is especially problematic, as the main
sequence itself is also time-consuming. The basic strategy is to acquire two images, each with a
magnetization preparation pulse which induce flip angles α0 and α1, respectively. The imaging
module which directly follows it should yield an image that is proportional to the ‘prepared’
longitudinal magnetization . In the simplest case if α0 = 0 (which has cosine of 1), then dividing
one image by the other results in the quantity cos (α1). If αref is the nominal flip angle defined on
the scanner interface, then the relative B1 = α1/ αref.
1b.10.5 MP2RAGE for T1 mapping
It was recognized early on that gluCEST would require correction for B1 inhomogeneity and that
this correction may need to be tissue-specific14,40. A new and improved method for this
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correction, the focus of Chapter 2 of this thesis, makes use of T1 mapping to characterize voxels.
The sequence used for this purpose is the Siemens product sequence MP2RAGE. This sequence
uses two turbo-FLASH GRE readouts between two 180° inversion pulses. The first readout
produces an image which is mostly T1-weighted; the second, mostly proton density weighted 41.
Reconstruction and analysis using both of these images can produce a quantitative T1 map,
which is the image of interest in our acquisition.

A final note on the acquisition of CEST data is that achieving as good a shim as possible - -that is,
a narrow lineshape of the water resonance – over the field of view is an extremely important
factor in the sensitivity of the CEST experiment. From our earlier considerations, we saw that
lineshape as a result of exchange plays a large role our ability to detect CEST differentially from
direct saturation of water, with the theoretical underpinning that exchange effectively shortens
T2. By the same token, local inhomogeneities in the B0 field also shorten T2, and will pose the
same problem.
One may suppose that our B0 correction somehow deals post facto with this effect, but in fact it
does not: one can correct for the water center frequency being shifted in any particular pixel,
but not for the broadening of the lineshape that occurs due to the T2 shortening caused by this
B0 inhomogeneity. Because this effects the magnitude of the measured CEST effect and can
confound results, it is best practice for the experimenter to record the linewidth of the water
resonance upon acquisition.
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1c: In vivo glutamate measurement: biochemical significance and current state
of the art
1c.1 Neurobiological context of glutamate
Glutamate is one of the twenty standard proteinogenic amino acids in eukaryotes1. In
vertebrates, it also functions as a neurotransmitter. Likewise in some invertebrates, although
with greater variability.2,3) In the current context, our interest is in the role of glutamate as the
primary excitatory neurotransmitter in the mammalian, and particularly human, brain.
Glutamate is synthesized during the TCA cycle of core oxidative metabolism, from which it can
be syphoned off for use in protein construction or neurotransmission. Importantly, it serves as
the chemical precursor for gamma-aminobutyric acid (GABA), which is the main inhibitory
neurotransmitter – the molecule that “does the opposite” of glutamate. Thus on both a
chemical and functional level,
these two metabolites and
their relative concentrations
and effects in the nervous
system are closely linked.
Figure 1c.1 The
glutamatergic synapse. The
cyling of glutamate (Glu)
and glutamine (Gln)
between the glial cell and
the presynaptic neuron is
illustrated with the arrow.
From Popoli M, Yan Z, McEwen
BS, Sanacora G. Nat Rev
Neurosci. 2012;13(1):22-37.
doi:10.1038/nrn3138.
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As it participates in such a central metabolic process, glutamate is present in all cell types, but its
auxiliary processes are quite specialized in different types of neurons. One useful way to
organize and understand the dynamics of glutamate in the nervous system is the ‘four
compartment model’: blood and plasma, glutamatergic neurons, GABAergic neurons, and
astroglia4,5. The role of blood in this narrative is to supply glucose as input to glycolysis and the
TCA cycle, and then to receive glutamine which is effluxed from the astroglia to maintain
nitrogen homeostasis in the brain.
Glutamatergic neurons are the locus of glutamate’s action as an excitatory neurotransmitter.
Inside this type of neuron, glutamate is concentrated in so-called pre-synaptic vesicles near the
membrane, in preparation to be released into the excitatory synapse. The depolarizing stimulus- or action potential-- causes an influx of calcium. This triggers calcium-dependent vesicle fusion
to the membrane, releasing glutamate into the synapse.
Once glutamate has bound to the receptors on the post-synaptic neuron, its job is done, and it
must be cleared from the synapse for ‘recycling’. There are three key protein types involved in
this mechanism:
a) the glutamate receptors on the post-synaptic neuron which bind the glutamate
b) the glutamate transporters, which exist both on the post-synaptic neuron and the astroglia in
the vicinity of the synapse
c) the enzyme glutamine synthetase, located in astroglia, which converts glutamate to
glutamine.
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Thus, astroglia play a key role in the conversion of glutamate to glutamine, which they transport
back to the glutamatergic neuron, which again converts it to glutamate. This process is known as
the glutamate-glutamine cycle.
In GABAergic neurons, GABA is synthesized from glutamate by the enzyme glutamate
decarboxylase. In symmetry to the glutamate/glutamine cycle, there is a GABA/glutamine cycle
in which astroglia take up the GABA released into the synapse, converted it to glutamine, and
restore this glutamine to the GABAergic neuron. The concentrations of glutamate, glutamine
and GABA in the brain are approximately 10mM, 3mM and 1mM, respectively5.
Glutamate as a neurotransmitter is at the center of neural function in health and disease. In a
healthy brain, glutamate signaling is particularly central to the function of the hippocampus and
its neighboring structures in the medial temporal lobe, the locus of learning and memory
formation4,6–8. Changes in the glutamate/GABA balance may underlie the larger-scale
electrophysiologic effects known as “potentiation” and “depression”, which have both
physiological and pathological relevance9. Dysregulation of glutamate is thought to underlie
neurophysiological conditions like epilepsy10 and neuropsychological conditions such as
schizophrenia4.
One important model that has come to light in the recent era of research on neurodegeneration
is the excitotoxicity hypothesis11–14. This model maintains that an excess of glutamate in the
synapse, which can arise due to dysfunction in any of the above steps, is toxic to neurons, and
that this glutamic accumulation induces the neuronal death manifesting in several diseases15.
Lastly, any metabolic pathology or genetic variation which affects core oxidative metabolism
may be coupled to neurological function if flux through the glutamate-related pathways are
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perturbed. This includes everything from rare conditions such as
hyperinsulinemism/hyperammonemia16 to the universal considerations of how diversity in
baseline metabolism may influence an individual’s susceptibility to cognitive decline with age.
The ability to image glutamate in vivo advances our understanding of normal brain physiology
and function, sheds light on the etiology of disease, reports on the efficacy of treatment
approaches, and in some cases, can even inform surgical decisions. Unfortunately, until now,
detecting glutamate in a specific and non-invasive fashion is a largely underdeveloped
technology. For decades, the only option was to perform single-voxel spectroscopy, which
detects glutamate only weakly in comparison to other metabolites and has limited spatial
resolution. Recently, spectroscopic imaging and molecular imaging techniques like CEST – largely
made possible by advances in scanner magnetic field strength-- have begun to open technical
doors to imaging this important molecule.
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1c.2 MR-based detection of glutamate
In vivo magnetic resonance spectroscopy (MRS) has been practiced in the field of medical
imaging since the early days of MRI. In the brain, the largest peaks visible in the NMR spectrum

Figure 1c.2: NMR spectra of glutamate (A) and glutamine (B) [ref]. From de Graaf (ref. 5)
are N-aceteyl-asparate, choline and creatine. The ability to detect glutamate reliably for many
years remained elusive. Other than being of relatively low concentration compared to the “big
three”, a major challenge on this front is the high degree of spectral similarity between
glutamate and glutamine. As we can see in Figure 1c.2, the spectra of glutamate and glutamine
both contain three main resonances, each with complex splitting patterns. These correspond to
the hydrogens indexed as H2, H4 and H3, in order from ‘downfield’ to ‘upfield’. Glutamate and
glutamine differ structurally from each other only after carbon no. 4, attached to which is a
carboxylic acid moiety in glutamate and an amide in glutamine. Therefore, it is this H4
resonance which begins to differentiate glutamate from glutamine – but only at field strengths
where chemical shift dispersion is sufficiently high. According to de Graaf, these resonances are
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“visually separated” only 7T field strength or higher; in the absence of this clear separation,
individual quantification of glutamate and glutamine depends on mathematical fitting to the
amorphous lineshape known as ‘Glx’ in the lower-field spectrum. The protons of the amine
group on these molecules exchange too quickly to appear in the NMR spectrum, however, the
amide protons on glutamine exchange more slowly and can be detected with sufficient spectral
bandwidth.
These three adjacent carbons and their affiliated protons H2, H3 and H4 are strongly coupled,
responsible for the extensive splitting of the spectrum. In addition to defining the lineshape, the
strong scalar coupling affects the relaxation properties of these spins: T2 relaxation arises
precisely from such interactions. The presence of this strong coupling dictates the choice of
optimal sequences for spectroscopic detection of such molecules. Specifically, the tendency of Jevolution to quickly destroy phased magnetization and detectable resonances makes long echotime sequences prone to signal loss. de Graaf’s book recommends that localization by adiabatic
selective refocusing, or LASER, is an ideal sequence for spectroscopy of glutamine and
glutamate, as opposed to the more canonical spectroscopy sequences PRESS or STEAM, in which
the measurement may be plagued by the deleterious effects of spin-spin relaxation. For more
about the LASER sequence, please see Chapter 1a.
In the best case scenario, a well shimmed, high-SNR (meaning either large volume or many
averages) single voxel spectrum at 7T may provide a measurement in which one has confidence
in the fit and resulting quantification of glutamate and glutamine separately. Arguably, such
results can even be expanded to spectroscopic imaging, as in recent work by Hingerl et al17, to
introduce spatial resolution to the measurement. In this thesis, the work presented in Chapter 5
makes use of spectroscopic imaging, but does not claim to distinguish the various components
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of the Glx resonance. Under any conditions, the sensitivity and specificity of spectroscopic
approaches to detecting glutamate in vivo, particularly with any degree of spatial resolution,
remain somewhat dismal.
The detection of glutamate by CEST is not wholly straightforward, either (see Chapter 1b).
However, as explained in Chapter 1b, the very mechanism of CEST provides it with the
advantage of amplification due to exchange, and some degree of specificity resulting from the
variable exchange-rate dependent contributions. The overwhelming advantage of using gluCEST
as opposed to spectroscopy lies in the incomparable spatial resolution. Because the presence of
glutamate is being detected by proxy through the water resonance, the resolution of the
gluCEST image approaches the resolution possible in a ‘regular’ structural image. In practice, the
in-plane resolution used is somewhat lower than a structural image, in order to achieve
adequate SNR. Furthermore, the limitations of time and ability to correct for inhomogeneities
have so far constrained gluCEST in humans to less than full-brain acquisitions. However, exciting
findings to date provide a strong impetus for continued development of this technology, and
indicate its potential to provide truly unique pictures of neurometabolism.

1c.3 Summary of human and animal gluCEST applications to date
Since its introduction in 201218, gluCEST has led to a number of intriguing preclinical and clinical
imaging studies. It has been applied extensively in rodents and humans, to a limited degree in
primates, and interest has even been expressed in using gluCEST to probe the mysteries of
aquatic invertebrate neurophysiology3. Preclinical applications in rodents include the study of
Parkinson’s Disease19,20, Huntington’s Disease21–23 , the general etiology of tau pathology24,

73

Freidrich’s Ataxia25, inflammation, encephalitis and traumatic brain injury26–28, and cancer
metabolism29 . Alzheimer’s Disease has been studied using gluCEST in primates30 and humans31.
Further human clinical applications have demonstrated that gluCEST can serve as a powerful
biomarker in the monitoring of neurological and psychiatric conditions where other forms of
non-invasive physiological information are very sparse. These include epilepsy10, schizophrenia
and related psychoses32–34, glioma35, hyperinsulinemism/hyperammonemia (HIHA) 16 and
multiple sclerosis 36.
One gluCEST application that has yet to be translated to clinical studies is spinal chord imaging
of neuropathologies –such as Friedrich’s Ataxia, as in Pépin’s murine study25. However, spinal
chord gluCEST imaging has already been successfully demonstrated in healthy human
volunteers37, suggesting that the possibility is open for expansion of gluCEST clinical applications
to all of the central nervous system. Only a few published studies have tried to truly capitalize
on the spatial resolution of gluCEST to push the envelope of fine-grained regional analysis. In the
preclinical realm, this includes the work of Pépin38 and Crescenzi 39, who augment their
investigations with corresponding histology. In human beings, perhaps the leading example of
this to date is Cai et al 2013, who used a single-slice sagittal gluCEST acquisition to capture and
analyze gluCEST signal in a number of subcortical regions40. However, with this limited-volume
acquisition, analysis of very small structures like hippocampal subfields was not possible.

1c.4 Summary of advances presented in this thesis
The results herein represent technical improvement of the gluCEST measurement (Chapters 2,
5A), and findings in the realms of aging (Chapter 3), potential therapeutic mechanisms (Chapter
4), and neurochemistry of the healthy brain (Chapter 5) . The final chapter diverges from CEST to
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present an additional modality for studying the dynamics of glutamate metabolism, in which the
conversion of glucose to glutamate can be indirectly observed (Chapter 6). More specifically:

It was emphasized in Chapter 1b that fast-exchanging metabolites require high B1 power for
successful and valid CEST measurements. Unfortunately, the 7T head coil provides very
inhomogeneous B1 field, which means both that a) there are regions in which sufficient
saturation power for gluCEST may not be achieved, and b) even where in principle the threshold
for sufficient saturation has been crossed, it is not homogeneous over the field of view, and this
needs to be corrected for so that different regions of the image can be compared properly. The
work in Chapter 2 provides an improved strategy for (b) and also demonstrates that actually (a)
generally occurs only rarely, and the apparent total loss of signal in some regions of the image
arises from flip angle loss in the acquisition module.
Chapter 3 focuses on the gluCEST measurement in the aging brain. Upon application to gluCEST
in older subjects, it was found that more reasonable results are achieved when B1 correction
‘surfaces’ are used which are very roughly age-matched (±10 years) to the subject. We
hypothesize that this may reflect decreased lipid content in the brains of older people relative to
younger, and therefore a different contribution to the NOE resonance that would arise from
these molecules. These preliminary results are presented in Chapter 3A.. The gluCEST results to
date from a study on older adults with an without Mild Cognitive Impairment (MCI), which thus
far are inconclusive, form the content of Chapter 3B. This investigation, while ongoing, provides
an excellent case study of the challenges of the gluCEST measurement, and an illustration of
why it would be preferable to use a 3D, rather than 2D acquisition.
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In Chapter 4, we use 2D gluCEST to examine the brains of healthy volunteers before and after
they have received continuous theta burst stimulation (cTBS), a type of non-invasive transcranial
magnetic stimulation (TMS), to the left motor cortex. We find small but strongly statistically
significant decreases (p < 1e-4) in gluCEST on the order of 0.1-0.3% CEST contrast (where the
baseline average is around 7-8%-- thus this represents a 1-3% change) in most of the left
hemisphere of stimulated subjects. Some less statistically significant changes (p < 1e-2) were
detected sporadically in the right hemisphere and in subjects who received a placebo
stimulation, but these appear to be spurious. To the best of our knowledge, this work is the first
of its kind to use molecular imaging to study the effects of TMS in a spatially resolved fashion.
In Chapter 5, the 3D gluCEST measurement is acquired in the medial temporal lobe of healthy
volunteers. Upon segmentation and regional analysis, we find that the dentate gyrus has an
extremely statistically significant elevation of gluCEST compared to other subfields of the
hippocampus and remaining medial temporal lobe. (The highest p-value in this comparison was
6e-4 for the difference between CA2/DG, with the next highest being 9e-12 for CA3/DG). This
finding makes sense in light of current understanding of neurophysiology, which hypothesizes
that the DG is the most prominent locus of neurogenesis, and was preceded by an analogous
finding in the work of Crescenzi et al in murine experiments. However, we believe this to be the
first time that this neurometabolic phenomenon has ever been detected in human beings. The
supplementary information to Chapter 5 contains additional material relevant to our progress
from 2D to 3D gluCEST.
Chapter 6 explores the application of a newly developed spectroscopy and spectroscopic
imaging technique41 in human beings. Here, instead of gluCEST, we use proton spectroscopy to
detect the metabolism of glucose into glutamate and glutamine in a dynamic fashion. The
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lynchpin of this experiment is that subjects have ingested a large amount of glucose in which
one proton is replaced with deuterium, which is invisible to the proton NMR measurement. In
this way, we are able to detect the “missing” proton and thus the conversion of their ingested
glucose into neurotransmitters in the brain. This technique, dubbed qMRS, can serve an
excellent complement to gluCEST, as it provides dynamic, albeit lower-resolution information
about neural glutamate.
In addition to these research chapters, two Appendices provide full, user-friendly
documentation for the Bloch-McConnell simulations and gluCEST post-processing code used in
this thesis, much of the original version of which was developed by Dr. Anup Singh and Dr. Hari
Hariharan, but with minimal documentation or comment. These appendices are fully auxiliary to
the research results themselves, but included here as a strategic effort to avoid their loss to
posterity.
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Chapter 2: An improved method for post-processing
correction of B1 inhomogeneity in gluCEST images of
the human brain
2.1 Introduction
CEST is a suite of magnetic resonance imaging techniques which generate
contrast weighted by the presence of endogenous or exogenous metabolites, mediated
by hydrogen exchange with bulk water1–4. Like many MRI applications, CEST has been
greatly advanced by the adoption of ultra-high field strength ( > 7T) magnets. However,
with higher field strength, radio frequency (RF) B1 field inhomogeneity becomes an
increasingly salient phenomenon, as the RF wavelength becomes comparable to the
dimensions of the human body and head5–8. This inhomogeneity in the B1 field is
problematic for the accuracy of CEST measurements and particularly, as discussed
below, for glutamate-weighted imaging (gluCEST)9. Unlike in the acquisition of a
traditional T1 or T2-weighted image -- in which the role of B1 is simply to rotate the net
magnetization to measure the inherently variable recovery-- the contrast in a CEST
experiment is actually created by so-called ‘saturation B1’ in a ‘magnetization
preparation’ module prior to acquisition. Thus, in a CEST experiment, the variable
amplitude of B1 results in inhomogeneous saturation and resulting contrast in addition
to different flip angles during the acquisition module.
B1 inhomogeneity can in some cases be mitigated by the use of paddings with
high-dielectric or ferroelectric gels, and recently, the primary hardware-based approach
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to mitigating B1 inhomogeneity has been the introduction of parallel transmit (PTX). The
literature includes many implementations of PTX, including with some application to
CEST imaging10–12. However, it appears that while PTX has had success at “B1 shimming”
or alleviating inhomogeneity, it has not been demonstrated to maintain high (B1, rms >
3µT) absolute B1 power over the field of view. While it could be argued that PTX has
reached a state which obviates the need for post-processing correction in low-power
modalities like amide proton transfer (APT) CEST (see Figure 2.S2), our data suggests
that in the case of gluCEST, parallel transmit, dielectric padding and post-processing
correction will all be required to produce high-quality volumetric images.
Our previous post-processing correction of gluCEST data for B1 inhomogeneity
relied on segmenting all non-CSF brain tissue into one of two categories – gray and
white matter – for each of which it was assumed that a single calibration curve to the
gluCEST maps could be applied13,14. These calibration curves were generated by
collecting calibration data (repeated CEST experiments) at varying nominal B1 strengths,
e.g. {1.5, 2.0, 1.5, 3 µT}, doing a binary segmentation for gray and white matter based
on MTR asymmetry maps, and then fitting many ROIs of “gray matter” and many ROIs of
“white matter” en masse to a third-order polynomial. However, using this method we
felt it necessary to collect calibration data for each new experimental protocol focusing
on a particular brain region, having noticed that the B1 calibration curves calculated for
each slice tended to vary. Upon closer inspection, it was clear that this was arising from
heterogeneity amongst tissues in the slice that would be grouped together by this
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binary segmentation (see Figure 2.S1). The calibration data from individual pixels, or
even ROIs, could rarely be satisfactorily fit to a polynomial function; apparent “goodness
of fit” was arising from the spread of pixel values. In areas of low B1, these functions
were particularly inadequate.
A recent article has emphasized the dependence of CEST contrast on T1 15. While
the work in [15] focuses on amide proton CEST at 3.5 ppm, the authors’ conclusions are
equally valid for gluCEST at 3.0 ppm, although the dependence of contrast on T1 values
diminishes as B1 power increases. Our investigations of CEST at 3.0 ppm corroborated
the observation that the Z-spectrum is a steep function of T1 at low saturation power,
thus leading to our decision to bin pixels for correction according to T 1 values. When a
binary segmentation and B1 correction are applied, as in earlier works, that assume all
pixels to be either “gray” or “white” matter regardless of T1 heterogeneity, inaccuracies
are introduced which can either falsely increase or decrease the apparent gluCEST
contrast.
In this paper, we provide an improved method for correcting gluCEST images in
the brain for B1 inhomogeneity. Three key advantages of this new method are a) a more
accurate description of the functional form CEST3.0ppm(B1, saturation) informed by BlochMcConnell simulations and confirmed by experimental data; b) retention of the original
signal-to-noise ratio (SNR) achieved in the positive and negative offset images by
correcting these points in the Z-spectrum separately rather than correcting their
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subtraction; c) fine categorization of brain tissue based on T 1 maps, rather than binary
classification into gray and white matter.

2.2 Methods
2.2.1 Bloch-McConnell Simulations

Our simulations model the effect of the saturation pulse by finding numerical solutions
to a six-pool Bloch-McConnell equation (Bloch equations modified to include chemical
exchange)16. The six pools represented include: bulk water, bound water (water
associated with or in the solvation shell of macromolecules), NOE-active protons (likely
aliphatic protons from lipids and proteins), amide protons which exchange from protein
backbones (APT), creatine and glutamate. Chemical exchange and cross-relaxation are
both treated as coupling (off-diagonal) elements between the relevant metabolite and
bulk water magnetization. No off-diagonal elements representing any type of
interaction that may couple magnetization directly between the five “solute” pools
solute are included. Other matrix elements include saturation B1, relaxation rates, and
offset frequency relative to the water resonance. The calculation includes two sets of
coupled differential equations -- “pulse on” and “pulse off”—which are identical except
for the inclusion of ω1. A Hamming-windowed pulse shape is used as in 9 .Simulation
parameters are enumerated in Table S1 and example simulations shown in Figure 2.S2.
2.2.2 Image Acquisition and Standard Post-Processing Procedures

All images were obtained on a Siemens 7.0T MAGNETOM Terra scanner (Siemens
Healthcare, Erlangen, Germany) outfitted with a single volume transmit/32 channel
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receive phased array head coil (Nova Medical, Wilmington, MA, USA). All volunteers
used in gathering B1 calibration data were healthy subjects ages 24-69, scanned with
informed consent under an approved institutional regulatory board protocol. The
general structure of a CEST-weighted acquisition is as follows: ‘magnetization
preparation’ followed by ‘readout’. B1 calibration data was collected with a single-slice
CEST sequence with the ‘readout’ module based on gradient-recalled echo with the
following parameters: TR/TE = 4.7/2.3 ms, 10 flip angle, 5 mm slice thickness, with 0.75
x 0.75 mm2 in plane resolution over a 156 x 192 mm2 field of view. Magnetization
preparation was achieved using eight 3.1µT RMS amplitude, 95 ms Hamming-window
shaped pulses with 5 ms inter-pulse delay applied at offset frequencies {±1.8, 2.1, 2.4,
2.7, 3.0, 3.3, 3.6, 3.9, 4.2} ppm relative to water. CEST-weighted images were corrected
for the B0 field distribution using a water saturation acquisition (WASSR)17 and B1 field
maps were generated as in 18. T1 maps used are from the Siemens product sequence
MP2RAGE. These auxiliary images had identical resolution and field of view as the CEST
acquisition, although the B1 map was smoothed before application of the B1-dependent
correction to avoid numerical inconsistencies. A flowchart of the full CEST acquisition
and post-processing procedure, including the B1 correction as described in this paper, is
given in Figure 2.2.
2.3 Theory: Simple Parameterization of the Functional Form of MZ/M0 (B1, sat)
Simulations allowed us to examine the form of the function Mz/M0 (B1, saturation) and the
resulting function CEST3.0ppm (B1, saturation), including its dependence on many other
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parameters. We were interested in identifying a simple, low-parameter mathematical
expression that could describe the function Mz/M0 (B1, saturation) generated by virtually
any simulation conditions. Assuming that our simulations accurately recapitulate the
CEST experiment, we should then be able to fit our experimental calibration data to this
function.

The general form of this equation was inspired by the theoretical treatment of the CEST
and MT effects given in Zaiss et al, 2015 19. Equation 5 in this work is an expression for
the water Z-magnetization (denoted MZ in the present paper) after the saturation pulse:

𝑧(∆𝜔) =

𝑐𝑜𝑠2 𝜃 ∗ 𝑅1𝑎

[2.i]

𝑅1𝜌 (∆𝜔)

Where Δω is the offset frequency of the saturation, R1a is the longitudinal relaxation rate
of bulk water, and R1ρ is the longitudinal relaxation rate in the rotating frame, to which
CEST and other effects may contribute. This work continues by providing expressions for
MT and CEST contributions to R1ρ:

𝐶𝐸𝑆𝑇
𝑅𝑒𝑥
= 𝑓𝑏 𝑘𝑏𝑎 𝜔2+𝑘
1

𝜔12
𝑏𝑎 (𝑘𝑏𝑎 +𝑅2𝑏 )

𝑀𝑇
𝑅𝑒𝑥
= ⋯ + 𝜔12 (𝑟2𝑎 + 𝑘𝑐𝑎 + 𝑟1𝑐 ) [2.ii, 2.iii]

where the first term of equation 2.iii is quite complex but also includes a quadratic term
of ω1, which represents the magnitude of the RF pulse used for the saturation or
‘magnetization preparation’ module. Regardless of the values of any constants (k, r), or
the relative weights of these contributions (MT, CEST), according to this treatment the
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function Z(Δω, ω1) – that is, net magnetization as a function of the frequency and
amplitude of the saturation pulse – will be an even function of ω1. Thus, needing only
the simplest possible phenomenological functional form for our purposes, we
investigated the possibility of using only a few even terms of ω 1 to describe MZ(ω1 ). To
determine an appropriate form, we performed many iterations of six-pool BlochMcConnell simulations with various parameters and tested whether a given minimalparameter functional form was able to robustly fit these very high dimensionality
simulations.

We attempted such fitting with the following simple equations:
𝑀𝑧
𝑀0

𝑀𝑧
𝑀0

𝑀𝑧
𝑀0

(𝐵1 ) = 1 +

(B1 ) = 1 +

(B1 ) = 1 +

𝑀𝑧
𝑀0

1
𝜷∗𝐵1 2 +1

𝜶∗B1 2
𝜷∗B1 2 +1

1
𝜷∗B1 2 +1

(B1 ) = 1 +

[2.1a]

[2.1b]

− 𝛾 ∗ B1 2

𝜶∗B1 2
𝜷∗B1 2 +1

− 𝛾 ∗ B1 2

[2.1c]

[2.1]

We found that while equation [2.1b] is able to fit Mz/M0 (B1, saturation) quite closely in
most situations, Equation [2.1] outperforms it to a slight degree. When fitting real
calibration data from human brains, we found that parameter γ could even be held
constant after a first iteration of fitting to determine its value, but still improves the fit.
87

Our results suggest that this parameter is largely capturing the contribution of direct
saturation to the decrease in MZ/M0. Note that the value of parameter α is always
negative, giving these functions a maximum of 1, corresponding to the physical situation
of being subject to no saturation.

For clarity, we would like to emphasize that we are not ‘fitting the Z-spectra’. (This is
done during the B0 correction, but that is independent of the B1 correction at hand.) The
‘Z-spectrum’ refers to the function Mz(ω, B1 = constant), but the function addressed
here and fit by Equation [2.1] is Mz (B1, ω = ± 3.0 ). This can be thought of as a crosssection of the Z-spectrum at a particular frequency offset (in this case, either ±3.0ppm
relative to water).

2.4 Acquisition and Use of Calibration Data

Overview. (See Figure 2.S3 for schematic). For each set of calibration data (collected on
a single subject), CEST images at 4-6 nominal saturation B1 values were acquired, as well
as WASSR images, B1 maps, T1 maps, and reference (no saturation) images. Each pixel
within the brain ROI was sorted into one of 26 bins based on its T 1 value. After B0
correction, pixels in a particular mask were then fit to Equation [2.1] for both the
positive and negative offset data. This results in two separate "Correction Surfaces”, one
for positive and one for negative saturation offset, for Mz as a function of B1 strength
and T1 value, parameterized by three parameters-- α, β, γ -- for each T1 bin. After
parameter values with the two-free-parameter fit were obtained for all three calibration
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data sets, a weighted average of these parameter values was calculated (α and β for
each T1 bin, with γ at a static value, and M0 set to 1 ). The weighting was done according
to the reciprocal of the residual norm, such that the parameter values from fits with
lower residual norms (better fits) contributed more to the final value.(See Figure 2.S4
for examining fits and residuals.) Before this, the residual norm itself (as returned by
Matlab’s lsqcurvefit) was normalized for the value of M0 (corresponding to the
magnitude of the data) used in the second fit and the number of points in the vectors.
Evaluating Equation [2.1] with each of these parameter values gives positive and
negative offset correction surfaces. Finally, these surfaces were smoothed along the T 1
axis with a Gaussian filter with a kernel size of 2, and the resulting surface was refit to
Equation [2.1], giving the final “smoothed” correction surfaces. The positive-offset one
is shown visually in Figure 2.1B, and a complete list of parameters for both surfaces are
displayed in Table 2.S2E. The final correction surface used in the results presented was
generated from calibration data gathered on three healthy male subjects ages 25, 38
and 68.

2.4.1 Fitting of calibration data with four free parameters. Calibration data was acquired

and handled according to the process shown in Figure 2.S3, including being fit to
Equation [2.1] with four free parameters {α, β, γ, M0)} using Matlab’s lsqcurvefit (see
Tables 2.S2A-D for parameters of the lsqcurvefit function). The data was sorted such
that only points with relative B1 > ~0.2 were included in the fit, in order to avoid noise
and variability caused by B1 of the acquisition module being very low. (In correction of
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actual experimental data, this effect is mitigated by applying a linear correction for flip
angle in acquisition B1 --See Figure 2.2.)
Fitting of calibration data with two free parameters. It was then observed that over all
T1 bins variability in parameter γ was low, and it was frozen to a static value in order to
stabilize the other fitting parameters. M0 was also given a fixed value over certain bins
for each data set, to account for the initial signal magnitude differences between tissue
types. Constraining parameters γ and M0 in this way resulted in the three data sets
having similar values of the remaining two free parameters, α and β, as a function of T 1
value.
2.4.2 Generation of final correction surface by residuals-weighted average

[2.1*]

𝑀𝑧,𝑃𝑁,𝑏
𝑀0

(𝐵1 ) = [1 +

𝛼𝑃𝑁,𝑏 ∗𝐵1 2
𝛽𝑃𝑁,𝑏 ∗𝐵1 2 +1

− 𝛾 ∗ 𝐵1 2 ]

Equation [2.1*] is the functional form found to describe the value of M Z after a
saturation pulse of amplitude B1 at a particular frequency offset, now expressed with
subscripts indicating ‘positive’ 3.0ppm (P) and ‘negative’ -3.0ppm (N) frequency offsets
for the saturation pulse. In the gluCEST experiment, the saturation frequencies are
measured in pairs symmetric around the water resonance, referred to as “positive” (P)
or “negative” (N) offset. We describe this as a family of functions depending on T 1 value,
which we discretize into bins b. Therefore, each T1 bin b has two particular functions
Mz/M0 (B1, saturation) – one for saturation applied at = +3.0 ppm , P, and one for saturation
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applied at -3.0ppm, N-- described in our approach by two free parameters, αP, b and βP,b
or αN, b and βN,b , respectively.
In this paper, three different calibration data sets were fit to Equation [2.1] to
determine this family of functions, or the “correction surface”. Because M0 (the net
magnetization of water, measured in arbitrary units by the signal intensity of a proton
density weighted image) can vary between experiments, pixels acquired on different
subjects at different times were not combined before fitting; rather, three different
correction surfaces were determined, and their parameter values were combined using
a weighted average to produce the final surface. Because of the varying number of
pixels in each bin, differing B1 distributions, and other experimental factors between
subjects, the quality of the data and resulting fit for any given T 1 bin was somewhat
variable between data sets. This average was therefore weighted such that binwise fits
with lower residuals were given more weight than those with higher residuals:

𝑅𝑈,𝑃𝑁,𝑏 =

𝑅𝑒𝑠𝑈,𝑃𝑁,𝑏
2
𝑀0,𝑈,𝑏
∗ 𝑛𝑇,𝑏

Where U indicates a particular data set out of three, hereon denoted as {U,V,W}. This
quantity R is the residual norm (quantifying the quality of the fit) normalized by the
value of M0 used for this bin and the number of points it includes. The following algebra
was done to convert this quantity into a coefficient to weight the contribution of that
parameter value for that bin in its contribution to the weighted average:
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𝑆𝑃𝑁,𝑏 =

1
𝑅𝑈,𝑃𝑁,𝑏

𝑇𝑈,𝑃𝑁,𝑏 =

+

1
𝑅𝑉,𝑃𝑁,𝑏
1

∗

+

1
𝑅𝑊,𝑃𝑁,𝑏

1

𝑅𝑈,𝑃𝑁,𝑏 𝑆𝑈,𝑃𝑁,𝑏

Thus:
𝛼𝑃,𝑏 = 𝑇𝑈 ∗ 𝛼𝑈,𝑃,𝑏 + 𝑇𝑉 ∗ 𝛼𝑉,𝑃,𝑏 + 𝑇𝑊 ∗ 𝛼𝑊,𝑃,𝑏
𝛽𝑃,𝑏 = 𝑇𝑈 ∗ 𝛽𝑈,𝑃,𝑏 + 𝑇𝑉 ∗ 𝛽𝑉,𝑃,𝑏 + 𝑇𝑊 ∗ 𝛽𝑊,𝑃,𝑏
𝛼𝑁,𝑏 = 𝑇𝑈 ∗ 𝛼𝑈,𝑁,𝑏 + 𝑇𝑉 ∗ 𝛼𝑉,𝑁,𝑏 + 𝑇𝑊 ∗ 𝛼𝑊,𝑁,𝑏
𝛽𝑁,𝑏 = 𝑇𝑈 ∗ 𝛽𝑈,𝑁,𝑏 + 𝑇𝑉 ∗ 𝛽𝑉,𝑁,𝑏 + 𝑇𝑊 ∗ 𝛽𝑊,𝑁,𝑏

2.5 Results
Bloch McConnell simulations allowed us to understand why sufficient B1 power is
necessary for gluCEST imaging, given the proton exchange rate of the metabolite of
interest. In contrast to the more widespread technique of APT imaging, accurate
gluCEST imaging requires a high and constant B1 power. B1 strengths below
approximately 1.25µT are insensitive to glutamate; they almost exclusively reflect
differences in water and lipid properties (See Figures 2.5 and 2.S2).
Another key advantage of simulations in this case is the ability to isolate
individual terms from each other, which would be challenging, if not impossible, to do in
phantom experiments. Our simulations contain six contributing “populations” or terms:
bulk water, which is subject to direct saturation (DS); “bound” water, which has a very
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short T2 and undergoes proton exchange with the bulk water (magnetization transfer, or
MT); exchangeable protons on protein amides, creatine, and glutamate; and aliphatic
protons from lipids and proteins, which exhibit NOE-type cross-relaxation with the bulk
water protons (See Table 2.S1 for simulation parameters.) Mathematically, our
treatment of the supposed cross-relaxation is identical to the other terms representing
true chemical proton exchange.

Figure 2.1 provides an illustration of how each of these terms contributes to
Mz/M0 (B1, saturation) and how this function manifests itself in actual brain data. In Figure
2.1A, simulated values of Mz/M0 are shown as solid markers, in series according to the
terms included in the simulation. The simulations – which themselves have ~40
potentially free parameters-- were then fit with Equation [2.1]. Specifically, the plot

Figure 2.1. Origin and application of Equation 2.1: Fitting Bloch-McConnell simulations and
T1-binned brain data with a simple parameterization of the function MZ/M0 (B1, sat). A.
Simulated data (six pools, see Table S1 for list of parameters) fit with Equation 2.1. B. Data
from human brain gathered by repeated acquisition of CEST at 3.0ppm at varying nominal B1,
binned by T1 value and fit with Equation 2.1.
Simulated gluCEST contributions fit ith E 1

B1 ‘Calibration’ Data from healthy human
brain

after saturation pulse at

ppm

1
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illustrates the relative shapes of bulk water direct saturation (DS) and bound water
magnetization transfer (MT), as well as illustrating the effect of introducing the
exchanging glutamate pool (gluCEST) in each case. We found that the three variables
used to parameterize this surface vary smoothly with simulation parameters as well as
with T1 bins (see Figure 2.S5), indicating that the T1 value does in fact reflect the physical
parameters – bound water content, lipid content, etc. – determining the shape of this
function.
Having identified this simple and robust expression for Mz/M0 (B1, saturation) using
simulations, we proceeded to use this function to fit real ‘calibration’ data collected
from human subjects. As explained above, this calibration data was used to generate
surfaces (as in Figure 2.1B) over the dimensions {B1, T1} parameterized by {α,β} of
Equation 1 for both sides of the Z-spectrum which are relevant to the gluCEST
measurement : ±3.0ppm relative to water. The shape of the individual functions M z/M0
(B1, T1 ) comprising the surface shown in Figure 2.1B reflect the expected form based on
simulation. Namely, very high T1 bins are those which contain a large partial volume of
CSF, and the curve in this part of the surface resembles the simulation dominated by
direct saturation (orange and yellow lines in Figure 2.1A). As T1 decreases, we move into
the realms of gray and then white matter, which become increasingly dominated by
contributions from bound water magnetization transfer (MT: green, blue, and purple
lines in Figure 2.1A), and NOE. NOE is not included in the simulations shown in Figure
2.1A, and is not a major contributor to the data shown in Figure 2.1B, as this is the
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positive offset (+3.0ppm) surface, while the center of the NOE contribution is on the
other side of the water peak. GluCEST imaging data was then corrected for B1
inhomogeneity using these surfaces, as described above (see Methods) and outlined in
Figure 2.2.
We evaluated the success of this approach by comparing its results with our
previous method, identifying the limits of our ability to correct gluCEST images for low
B1 amplitude, and comparing this performance with what might be expected from
theory and simulation. Figure 2.3 shows three examples of gluCEST images, comparing
Figure 2.2. Full schematic of gluCEST acquisition and post-processing using B1 correction
based on MZ(B1, T1) surfaces. The top row of boxes represents images acquired directly or
with additional, existing post -processing steps during the experiment: raw CEST images
(then subject to B0 correction based on WASSR acquisition); B1 map (based on flip/crush
acquisition); T1 map generated by MP2RAGE. Subsequent steps proceed as indicated by
arrows, to arrive at the final output, a fully “B1 corrected” gluCEST image (green box). The
same example image with no correction for B1 inhomogeneity is shown in the gray box.
Please note that the images provided in this schematic are not intended for close
inspection or evaluation, but are intended only to add concreteness and aid the reader in
following the description of the process.
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the B1 post-processing correction described in this paper (final column, 4) with the
previous method (second column, 2). The first row (A) shows a deep, oblique transverse
slice which we often use for investigations of the hippocampus and neighboring areas in
the medial temporal lobe. In this slice, B1 is high in the center of the brain but falls off
steeply
in the
distal
anterior
regions
(see B1
map in
column
3). Using
the
previous
correction
Figure 2.3: Image comparison with previous correction method. Each row of this figure
corresponds to an image taken from a healthy control subject in various experiments. Top:
lower axial slice from a 53-year old female (Example A). Middle: upper axial slice from 32-yearold male (Example B). Bottom: coronal slice from 74-year-old female (Example C). The first
column from the left shows the T1 map (MP2RAGE), over which the other images are displayed
with partial transparency in the subsequent columns. The second column shows the gluCEST
map (filtered with a Gaussian filter of kernel size 2), as produced with the previously published
B1 correction. The last column shows the gluCEST map as produced with the surface-based
correction presented in this paper, while the third shows the relative B1 map. The scale for the
gluCEST images (in ‘jet’) is 0-12%, negative-normalized asymmetry; for the B1 maps (in ‘hot’), 0100% of the nominal B1 RMS, 3.1uT.
96

method, signal loss is apparent in these regions, particularly on the left side A similar
problem is encountered when imaging this region of the brain in the coronal view
(bottom row, C). Use of the new correction method yields similar results to the previous
method for high B1 portions of the image, but “rescues” more of the low-B1 portion

Figure 2.4. Example histogram-based comparison of performance of ‘Old’ and ‘New’ B1
correction methods in areas of high and low B1. Histograms show the distribution of
gluCEST values for two different "zones" of the featured slice, as color coded in the center
images. The T1 values corresponding to these zones are listed in the table, along with the
mean and standard deviation of gluCEST values when calculated with the two different B1
corrections. The left half of the figure presents results from pixels where relative B1 > 0.5
("High B1"), while the right half of the figure shows data where relative B1 < 0.5 ("Low B1").
Gray histogram bars in the background correspond to the distribution computed with the
“old” processing method, colors, to “new”.
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from extremely low CEST contrast. This result is demonstrated quantitatively in Figure
2.4.
The middle row (B) of Figure 2.3, featuring an upper axial slice, illustrates a somewhat
different situation. Here, relative to the “old” image, the newly corrected image has
higher gluCEST overall, and better contrast between different tissues. Inspection of the
B1 map will show that in this slice, B1 tends to be uniform but somewhat low (70-80% of
the nominal value). In this case, improvement in image quality can be mostly attributed
to the finer binning of T1 masks. Pixels in the very center of white matter tracts do not
have identical T1 values to pixels closer to gray matter, and gray matter pixels likewise
have a gradient of intensity towards the periphery of the cortical tissue where partial
voluming begins to occur with CSF. Ignoring this subtle but important gradient results in
“smearing” of tissue contrast when correcting in the region of relative B1 = 75-100%,
where the contrast (B1) function approaches linearity.
Figure 2.4 provides histograms comparing the distribution of gluCEST values in
selected tissue layers in the brain slice shown, illustrating that with the new correction,
the low-B1 and high-B1 gluCEST distributions are much better reconciled. We attribute
this improvement in very low-B1 areas primarily to the fact that we are now correcting
positive and negative sides of the Z-spectrum separately. The +3.0ppm and -3.0ppm
images each have SNR sufficient to clearly distinguish brain structure in these regions;
however, a subtraction of the two often does not. By correcting the images acquired on
each side separately, we are retaining a greater portion of the CEST contrast that arises
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from non-glutamate sources, which is needed to make these areas comparable to the
rest of the image. Figures 2.S7, A-C provide additional histograms comparing the results
of these two correction approaches.

The plot that forms the background of Figure 2.5 illustrates simulated CEST
contrast upon saturation at 3.0ppm for conditions emulating human brain tissue.
Varying glutamate concentration gives rise to increasing variation in measured contrast
as B1 power increases within the plotted range, which reflects the allowable B1 power in
the 7T headcoil. These simulations suggest that B1 strengths below approximately
1.25µT are insensitive to glutamate, and almost exclusively reflect differences in water
and lipid properties. Thus, one should expect that below a certain B1 power, no postprocessing correction is able to restore contrast to a gluCEST image, as the contrast
simply has not been adequately created by the saturation pulse.
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Our results upon acquiring and correcting a series of gluCEST images at varying
nominal saturation B1 power indeed reflect this (Figure 2.5, inlaid images and
histograms). In the images shown in Figure 2.5, gluCEST at 3.0ppm was purposely
collected at lower nominal B1, similar to the procedure for acquiring calibration data. In
each case, we performed correction of the image as if it had been acquired with the
optimal B1 of 3.1µT, in order to understand the limits of the correction strategy. Above

Figure 2.5. Evaluation of MZ (B1, T1) surface-based correction for varying B1 strength;
comparison with simulation. Background: simulation of CEST contrast at 3.0ppm in whitematter-like physical conditions, with varying glutamate concentration. Foreground: GluCEST
images collected at purposefully varying nominal saturation B1 {0.7, 1.3, 1.9, 2.4 and 3.1 μT},
with attempted correction for B1 inhomogeneity. Colored distribution in histograms
correspond to four different tissue layers (combinations of 4-5 of the T1 bins used for
correction). It is clear that contrast between these layers is insufficient when nominal B1 is
only 0.7µT, despite attempted correction. Simulations indicate that this is the expected
result, as dynamic contrast resulting from variable [glutamate] is vanishing at this B1 power.
The correction performs reasonably well for areas where absolute B1 > ~1.25µT, provided
that the flip angle in this region is sufficient for the acquisition module.

the red arrow are shown an image and corresponding histogram of gluCEST values
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collected at a nominal saturation B1 of 0.7µT. It is clear both from visual inspection of
this image as well as the corresponding histogram that contrast which might otherwise
exist in this image has been irrecoverably forfeited by lack of saturation power. This
result corresponds to the simulated situation indicated by the red arrow, in which
varying concentrations of glutamate do not yet give rise to variations in CEST contrast at
3.0ppm. Note that in this plot, the varying glutamate concentrations have been
simulated in "tissue" that has otherwise identical properties. If these properties - -such
as bound water or lipid content-- are changed, the location of the local minimum of this
CEST (B1) curve changes. This corresponds to the residual tissue contrast visible in this
low-B1 image. As might further be expected from simulation, images and corresponding
histograms collected at saturation B1 powers of 1.3, 1.9, 2.4 and 3µT -- show good
agreement upon B1 correction, with the 1.3 µT image still lacking some of the contrast
which arises at higher powers.
One will note that, with the current approach, large "blue" patches of very low
CEST signal remain in parts of these images despite apparently successful correction for
saturation B1. This signal loss actually originates from low flip angle during the
acquisition module, rather than insufficient saturation (see Figure 2.S6 for further
explanation). No matter what the nominal saturation B1, the head coil used produces a
non-trivial flip angle deficit in these regions, which our current correction approach does
not adequately handle. We are exploring hardware, pulse sequence and post-processing
methods to address this issue, which is beyond the scope of this report.
101

2.6 Discussion
In this paper, we’ve presented a new way to correct for B1 inhomogeneity in
gluCEST measurements in the brain based on categorization of pixels by T1 value and a
simple function describing the response of their saturated signal, Mz, to variation in B1
strength. Our description of this function is based on the results of Bloch-McConnell
simulations and fitting to calibration data gathered in three volunteers, with additional
subject scans used for evaluation of the new approach.
Perhaps the most direct precedent in the literature for this type of correction is
that of Windschuh et al, 2015 20 who used various functional forms to fit the B1dependence of Z-spectrum components at ±3.5ppm in order to correct the APT CEST
signal for B1 inhomogeneity. By using only three CEST acquisitions per subject at various
B1, they were able to achieve high quality images in the upper axial slice shown in their
figures. We acknowledge that a pixel-by-pixel fitting for each subject is, time permitting,
an optimal solution. However, for gluCEST imaging, the nominal B1 power is about
three-fold higher than for APT CEST, and thus the absolute spread of B1 power over the
field of view is commensurably enlarged. The pixel-wise fitting we performed to
generate the calibration data presented here did not work well with fewer than five
input points, suggesting that a method for gluCEST analogous to that used for APT CEST
in [20] would require five, rather than 2-3, B1 acquisitions in order to achieve acceptable
results. In most experimental cases, due to scan time constraints on patients,
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circumstances strongly favor acquiring as few CEST acquisitions as possible. Thus, our
approach retains the possibility of acquiring only one.
While our group has not yet attempted to use parallel transmit in CEST
measurements, the capacities of PTX have been explored and documented by others
(see refs. [10-12]). As mentioned above, the ‘problem that was solved’ by PTX – and
what is indeed relevant for many imaging applications, including lower-power CEST
modalities – is homogeneity of B1 over the field of view. But homogeneity per se is not
the main challenge with respect to gluCEST; rather, the challenge is to have sufficiently
high B1 in absolute terms. In a gluCEST experiment, one would rather have a higher
degree of inhomogeneity – which can be corrected for-- with as much of the image as
possible at a higher saturation power. The limiting factor with regard to B1 is SAR, and
implementation of PTX does not overcome this.
We have, on the other hand, explored the use of high-dielectric padding to
mitigate the B1 drop-off. The effects of these pads is certainly beneficial, but by no
means obviates the need for post-processing correction; rather, the effect is simply to
move a greater fraction of the image into the regime for which we believe that this
correction is valid. At the time of this study, institutional approval for use of this padding
was limited, but they will be incorporated in future studies.
The authors of [20] also point out correctly that a calibration-based approach
cannot be assumed applicable in a disease state, where the composition of brain tissue
is unknown. For these cases, we are currently taking an intermediate approach: gluCEST
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is acquired at 2-3 B1 points, and these data are mapped to existing correction surface
"libraries" using a quantitative similarity metric. Further work in this direction is in
progress.
To this end, another tactic we are exploring for accurate gluCEST imaging,
particularly in pathological cases, is multi-dimensional pixel classification: instead of
binning only by T1 values as in the present paper, pixels can be sorted using additional
information gathered from scans which are already included in the clinical protocol,
such as the several types of contrast returned by a multi-echo MP2RAGE sequence21.
This information can serve as a "prior" from which, like in the present case with T1 bins,
certain assumptions about lipid and bound water contributions can be made more
safely. It is worth noting that in the present strategy the choice of any precise number of
T1 bins is somewhat arbitrary; however, the general approach of using a number of T1
bins in this neighborhood ( 20+ ) is based on quantitative evaluation of fit performance.
Figure 2.S4B explores the dependence of the goodness of fit of Equation 1 to
experimental data as an increasing number of T1 bins are used.

While the proposed method improved results upon the previous method in
almost all cases, we also came to notice that gluCEST images give more reasonable
results when the correction surface applied was generated by fitting data from subjects
of roughly the same age group (± 10 years) as the experimental subject. This
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observation was presented recently22 and will be elaborated in more detail in future
work.
Despite these advances, it is important to note the inherent limitations of
correcting any CEST measurements − and particularly measurements of fast exchangers
like glutamate-- for areas of low saturation B1. With proper calibration factors in hand, it
is always possible to correct the signal back towards a value that appears reasonable for
a particular tissue type. However, theory tells, and simulations demonstrate, that at
very low saturation B1 values (< ~1uT) CEST contrast at 3.0 ppm is only weakly
dependent on glutamate concentration. Therefore, for any particular experimental and
tissue parameters, there will be a saturation B1 limit below which calculated CEST
contrast between two pixels is predominantly due to tissue structural properties (lipids,
bound water). We emphasize that for gluCEST measurements it is advisable to use as
high of a nominal B1 as possible to ensure that all parts of the CEST images are acquired
in a regime in which post-processing B1 correction is capable of yielding a valid
quantification.
Conclusions
Using a phenomenological equation, Bloch-McConnell simulations, and experiments on
healthy subjects at 7T, we demonstrated an improved B1 correction approach for
gluCEST imaging of the human brain. This method improves contrast and quantitative
accuracy upon our previous B1 correction, making a larger difference in lower B1 areas.
105

This method takes into account the subtle T1 differences between pixels and retains
more of the SNR of the original, pre-correction measurement, decreasing the noise in
the resulting image. While this method is demonstrated in the context of gluCEST, the
same general strategy for determining accurate phenomenological correction functions
is expected to apply to CEST imaging of other metabolites in the brain such as creatine23,
myo-inositol 24, lactate25 and sugars 26.
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2.7 Supplementary Information

Figure 2.S1. Introduction to the problem of correcting GluCEST for B1 inhomogeneity. A. T1
map (MP2RAGE) of an oblique axial slice of interest in several research protocols. B. Map of
typical B1 strength over this slice, relative to a nominal B1 of 3.1µT. Color bar shows B1
strength relative to the nominal value. C. GluCEST map over the slice, uncorrected for B1
inhomogeneity. Color bar scale is -10-10% asymmetry D. Histogram of T1 values over this
slice. Red bars indicate the only T1 ranges taken into account in the former correction
method. E. Example of CEST contrast as a function of saturation B1 in ROIs visually identified
as “gray matter” or “white matter”. Such hand-drawn ROIs were previously fitted with thirdorder polynomials which were then used to correct all pixels that fell within a range defined
by a binary (gray/white) segmentation. The line segment connecting the points in this plot is
a visual aid only, and not does represent any form of fit.
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Table 2.S1. Simulation parameters, unless otherwise noted
Parameter description
General parameters
Pulse shape
Pulse duration
B1 strength
Pulse offset, w/reference to
water resonance
Pulse duty cycle
Total water concentration
Pool 1: Bulk water
Concentration [2 * H2O, bulk]
T1
T2
Chemical shift offset
Pool 2: Bound water
Concentration [2 * H2O, bound]
T1
T2
Chemical shift offset
Exchange rate with bulk water
Pool 3: Protein amides
Concentration [1H, APT]
T1
T2
Chemical shift offset
Exchange rate with bulk water
Pool 4: NOE-active protons
(lipids, etc.)
Concentration [1H, NOE]
T1
T2
Chemical shift offset
Cross-relaxation rate with bulk
water
Pool 5: Creatine
Concentration [1H, Cr]
T1

Value (s)
Hamming window
800ms
3.0ppm
99.8%
70 - 90 M
50 – 80 M
1.7s
80 – 90 ms
0ppm
10 - 20 M
1s
2e-5s (20us)
-2.4ppm
20Hz
70mM
1s
1ms
3.5ppm
30Hz

1-5M
1s
0.5 – 1ms
-3.4ppm
1 – 5 Hz

32mM
1
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T2
Chemical shift offset
Exchange rate with bulk water
Pool 6: Glutamate
Concentration [1H, Glu]
T1
T2
Chemical shift offset
Exchange rate with bulk water

10ms
1.8ppm
800Hz
15-36mM
1s
10ms
3.0ppm
1800Hz

Bibliography, Simulation Parameters:
1. Zhou J, Payen JF, Wilson DA, Traystman RJ, Van Zijl PCM. Using the amide proton signals of
intracellular proteins and peptides to detect pH effects in MRI. Nature Medicine. August
2003;9(8):1085-1090.
2. Zhou J, Wilson DA, Sun PZ, Klaus JA, Van Zijl PCM. Quantitative Description of Proton
Exchange Processes between Water and Endogenous and Exogenous Agents for WEX, CEST,
and APT Experiments. Magnetic Resonance in Medicine. May 2004;51(5):945-952.
3. Van Zijl PCM, Yadav NN. Chemical exchange saturation transfer (CEST): What is in a name
and what isn't? Magnetic Resonance in Medicine. April 2011;65(4):927-948.
4. Sled JG, Pike GB. Quantitative Imaging of Magnetization Transfer Exchange and Relaxation
Properties In Vivo Using MRI 2001.
5. Mougin OE, Coxon RC, Pitiot A, Gowland PA. Magnetization transfer phenomenon in the
human brain at 7 T. NeuroImage. January 2010;49(1):272-281.
6. Hua J, Jones CK, Blakeley J, Smith SA, Van Zijl PCM, Zhou J. Quantitative description of the
asymmetry in magnetization transfer effects around the water resonance in the human
brain. Magnetic Resonance in Medicine. October 2007;58(4):786-793.
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Figure 2.S2. Simulations of contrast as a function of saturation B1, comparing gluCEST
and APT CEST. Simulations illustrate that, in contrast to the more widespread technique
of APT imaging, accurate gluCEST imaging requires a high and constant B1 power. Figure
A shows the simulated CEST contrast from saturation at 3.5ppm as a function of
B1 strength for different concentrations of amide protons. The plot illustrates that CEST
at 3.5ppm will comparably detect differences in [APT] for a broad range of B1 power,
starting at around 0.7µT. This sensitivity is quantified in Figure B, where the slope of the
difference in CEST signal from two concentrations is plotted against the B1 power used.
The slope is relatively stable from 1-4 µT, meaning that experiments done anywhere
within this range and corrected linearly (or even not at all) for B1 inhomogeneity can be
expected to generate consistent results. Figure C shows the CEST contrast at 3.0ppm
(gluCEST) and illustrates its ability to detect differences in the concentration of
glutamate. In sharp contrast to APT CEST measurements, B1 strengths below
approximately 1.5µT are insensitive to glutamate; they almost exclusively reflect
differences in water and lipid properties. Figure D illustrates that optimal gluCEST
contrast is actually achieved with the highest possible B1. (We have been unable to use
B1 stronger than ~3.5µT in human experiments, due to SAR limitations.)
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Figure 2.S3. Schematic: generating MZ(B1, T1) correction surfaces from calibration data.
For each set of calibration data, CEST images at 4-6 nominal saturation B1 values were
acquired, as well as WASSR images, B1 maps, T1 maps, and reference (no saturation) images.
Each pixel within the brain ROI was sorted into one of 26 bins based on its T1 value. After B0
correction, pixels in a particular mask were then fit to Equation 1 for both the positive and
negative offset data. This results in two separate "Correction Surfaces”, one for positive and
one for negative saturation offset, for Mz as a function of B1 strength and T1 value,
parameterized by three parameters-- α, β, γ -- for each T1 bin.
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Tables 2.S2, A-E. Tables relating to fitting and generation of correction surfaces
A. Initial values and parameter bounds used for fitting simulated data:
Parameter
α
β
γ
M0

Initial value
1
1
0
1

Lower Bound
-1000
0
-1000
-1000

Upper Bound
1000
1000
1000
10,000

B. For fitting experimental data, first iteration (all parameters free):
Parameter
α
β
γ
M0

Initial value
-2.25e-5
1.85e-5
8e-7
2000 (Based on
experimental M0
image intensity)

Lower Bound
-1e-3
1e-7
-1
-100

Upper Bound
1
1
1e-5
10,000

C. For fitting experimental data, second iteration (parameter D and E fixed):
Parameter
α
β
γ
M0

Initial value
-2.25e-5
1.85e-5
6e-7
variable

Lower Bound
-1e-3
1e-7
same as initial value
same as initial value

Upper Bound
1
1
same as initial value
same as initial value

D. Data was fit using the Matlab function lsqcurvefit() with the trust-region-reflective algorithm.
The following options were changed from the default:
Option
Function tolerance
Step tolerance
Max. function evaluations
Max. iterations

Value for fitting simulations
1e-18
1e-12
10,000
10,000
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Value for fitting experiment
1e-12
1e-12
1,000
10,000

Figure 2.S4: Fitting performance of Equation 1 and dependence on number of T1 bins A.
Example fits with residuals from two T1 bins. B, C. Dependence of fitting performance on
number of T1 bins. To generate these plots, the following was done in an iterative fashion,
for N = 1-25: calibration data was sorted into N number of T1 bins, and fit to Equation 1
(analogous to examples in Figure A). The residual norms were divided by the number of
pixels in the resulting bins, so that this function is not convolved with y = 1/x. It can be
seen that in fact, Equation 1 works best for tissue with low T1 (white matter),
intermediately well for gray matter, and least for tissue with very high T1 (always included
in the highest T1 bin per iteration), indicating high partial voluming of CSF. The white
outlines in the colormap indicate the traces which are plotted in B.
A
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B

C
C
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E. Fitting parameters for weighted-average-derived correction surface, smoothed

Bin
no.
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26

T1
LB
1001
1062
1104
1138
1171
1204
1238
1274
1311
1350
1391
1433
1473
1517
1561
1605
1648
1694
1742
1796
1852
1914
1987
2078
2200
2408

αP
1e-3*

βN
1e-3*

βP
1e-3*

γN
1e-4*

γP
1e-4*

M0

UB

αN
1e-3*

1062
1104
1138
1171
1204
1238
1274
1311
1350
1391
1433
1473
1517
1561
1605
1648
1694
1742
1796
1852
1914
1987
2078
2200
2408
2999

-0.3846
-0.3137
-0.2557
-0.2052
-0.1619
-0.1462
-0.1346
-0.1173
-0.1001
-0.0851
-0.0738
-0.0639
-0.0569
-0.0515
-0.0475
-0.0437
-0.0391
-0.0346
-0.0306
-0.0259
-0.0218
-0.0179
-0.0136
-0.0095
-0.0067
-0.0043

-0.2791
-0.2214
-0.1763
-0.1389
-0.1092
-0.1007
-0.0943
-0.0838
-0.0732
-0.0636
-0.0571
-0.0508
-0.0467
-0.043
-0.0403
-0.0376
-0.0342
-0.0306
-0.0275
-0.0239
-0.0206
-0.0174
-0.0138
-0.0102
-0.0076
-0.0053

0.5407
0.4487
0.371
0.301
0.2408
0.2165
0.2001
0.1755
0.1506
0.1286
0.112
0.0972
0.0871
0.0792
0.0738
0.0685
0.0612
0.0539
0.0477
0.04
0.0331
0.027
0.0202
0.0143
0.0101
0.005

0.3736
0.2991
0.2389
0.1877
0.147
0.1341
0.1254
0.1111
0.0964
0.0833
0.0744
0.0659
0.0605
0.0558
0.0526
0.0492
0.0443
0.0391
0.0348
0.0296
0.0246
0.0204
0.0154
0.0111
0.0079
0.0042

0.006
0.006
0.006
0.006
0.006
0.006
0.006
0.006
0.006
0.006
0.006
0.006
0.006
0.006
0.006
0.006
0.006
0.006
0.006
0.006
0.006
0.006
0.006
0.006
0.006
0.006

0.006
0.006
0.006
0.006
0.006
0.006
0.006
0.006
0.006
0.006
0.006
0.006
0.006
0.006
0.006
0.006
0.006
0.006
0.006
0.006
0.006
0.006
0.006
0.006
0.006
0.006

1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
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Figure 2.S5. (next page) Fitting parameters vary smoothly with both simulated (AC) physical parameters and with real T1 values (D). A represents the value of the
three fitting parameters {α,β,γ} in five series of simulations as a colormap. In these
simulations, only the direct saturation of water is simulated, and the T2 of this bulk
water is varied. This variation is clearly captured in parameters α and β of Equation
[1]. B shows an analogous series of simulations, but rather than altering the T2 of bulk
water, the changing variable is the presence of bound water (responsible for the 'MT'
effect), which is being introduced increasingly from top to bottom rows. Again, we
see that this change is captured by the values of parameters α and β. C again begins
with the 'direct saturation only' case and introduces the pool of slow "exchanging"
protons which we attributed to cross-relaxation from lipids or similar aliphatic
protons. Interestingly, this effect is captured overwhelmingly by parameter β. D
represents the parameters values displayed in Table 2E visually as an analogous
colormap (αN, βN parameterize the negative offset surface; αP, βP, the positive offset
surface.

Example of slice sorted by T1 bins.
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A

Decreasing bulk water T2

α

β

γ

Direct saturation only, T2 = 85ms

Increasing bulk water T2

B

Direct saturation only, T2 = 85ms

α

β

γ

Increasing concentration
of bound water protons

CD

Direct saturation only, T2 = 85ms

α

β

γ

Increasing concentration
of lipid aliphatic protons

D
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Figure 2.S6: Comparison of surface-based B1 correction on different slices indicates that limiting
factor is flip angle B1, rather than saturation B1 power.
One will note that from Figure 5 of the main text that large "blue" patches of very low CEST signal remain in slice
A despite apparently successful correction for saturation B1 in terms of reconciling images generated by lower B1
and higher B1 acquisitions. This signal loss actually originates from low flip angle during the acquisition module,
rather than insufficient saturation. This is clear upon more careful consideration of the presented results: At 3µT,
even areas where relative B1 is, for example, 0.5, have an absolute B1 amplitude of 1.5µT. This approximately
corresponds to areas of the 1.9µT image where relative B1 is 0.8. We see that in these regions, gluCEST contrast
can be well restored with our correction for saturation B1. Thus, it is not a saturation B1 amplitude of 1.5µT
which is causing the lack of signal in the "blue" regions of the 3µT image, but rather the fact that no matter what
the nominal saturation B1, the head coil used produces a non-trivial flip angle deficit in these regions, which our
current correction approach does not adequately handle. We are exploring hardware, pulse sequence and postprocessing methods to address this issue, which is beyond the scope of this report. This can also be observed by
comparing the success of correcting Slices A and B, which have very different relative B1 distributions.
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Figure 2.S7, A-C : Expanded histogram-based analysis of correction performance in example slices: comparison of high and low B1 areas, tissue types, old and new
methods. Histograms show the distribution of gluCEST values for different "zones" of the slices shown in Figure 3 of the main text, as color coded in the image. The T 1
values corresponding to these zones are listed in the table, along with the mean and standard deviation of gluCEST values when calculated with the two different B 1
corrections. The colors of the histogram bars correspond with the colors of the pixels in the color -coded image: roughly, the yellow mask is pure white matter; green, gray
matter on the border with white matter; cyan, inner layer of gray matter; blue, outer layer of gray matter; violet, gray matter on the border of CSF. In the top two rows, gray
histogram bars in the background correspond to the distribution computed with the “old” processing method, colors, to “new”. In the bottom row, the same information is
rearranged for comparison: the distributions from the green, cyan and blue masks are plotted together, but results from old and new processing are separated. The left half
of the figure presents results from pixels where relative B1 > 0.5 ("High B1"), while the right half of the figure shows data where relative B1 < 0.5 ("Low B1"). In the center
table of values, the top half of the table holds results from 'old' processing, and the bottom from 'new', as indicated by the gray and black borders matching the
corresponding histograms.
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Chapter : GluCEST measurements of the aging brain
3A. Age-dependent variation in CEST signal at low B1 may reflect contribution of
lipids
The previous chapter presented our latest surface-based strategy for correction of B1
inhomogeneity in gluCEST images. Upon the development of this new technique, we undertook
to investigate its application to subjects of varying age. An ongoing study of older adults, to be
discussed further in the next section, provided us with gluCEST images of healthy individuals >
60 y.o.a. on which to test the updated B1 correction strategy. Fortuitously, one of the healthy
volunteers on whom we had collected B1 calibration data for generation of our surfaces was also
of the same range as many of the subjects in this investigation, namely, 69 years of age at the
time of acquisition. Other volunteers available ranged in age from 20-45 years old. This gave us
an opportunity to experiment with the use of ‘age matched’ correction surfaces to develop an
understanding of any age dependent trends in the gluCEST measurement and, in light of these,
the best practice for performing B1 correction.
Initially we encountered an unexpected finding: when using the same correction surface on all
subjects, gluCEST in the white matter appeared to be higher in older subjects (see Figure 3A.1).
This seemed like an unreasonable result, and potentially an artefact of misapplication of the
correction. Pragmatically, it was determined that the correction surfaces worked best when the
surface itself was derived from subjects broadly of the same age range as that of the target
image.
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The reason for this can be understood from the heat map style plots in Figure 3A.2. The top row
of this figure shows example CEST contrast surfaces derived from fits to data from one younger
and one older subject. Recall that at low B1, CEST asymmetry at 3.0 ppm is actually negative, a
phenomenon attributed to NOE-like cross-relaxation with lipid aliphatic chains and other

Figure 3A.1. Coronal
gluCEST images of healthy
subjects of three different
ages (25, 39 and 74
y.o.) are processed with
three different correction
surfaces. For any given
correction applied (by
row), older subjects have
higher apparent white
matter gluCEST. It appears
from our measurements
that the contribution of
lipids to the white matter
CEST signal decreases with
age, which lowers the
apparent contrast due to
glutamate in younger
people if an identical
correction scheme is
applied to all ages. In this
figure, we believe the most
accurate of the three
images shown to be that
outlined in green.

moieties centered at -3.5 ppm relative to water. 1
At low B1 in these heatmaps (minimum at approximately 1uT), lower-T1 masks exhibit a strong
negative signal, attributed to NOE contributions from lipid aliphatic chains. This “valley” is

125

deeper in the white matter of younger
subjects, likely reflecting the higher
concentration of lipids present in their
tissue. If not accounted for when
performing B1 correction, white matter
of older subjects will appear (incorrectly,
we believe) to have higher gluCEST.

Figure 3A.2. Top: CEST contrast (negativenormalized) surface derived from fits to data from
one younger (age 24) and older (age 69) subject. At
low B1 (minimum at approximately 1uT), lower-T1
masks exhibit a strong negative signal, attributed
to NOE contributions from lipid aliphatic chains.
This “valley” is deeper in the white matter of
younger subjects, likely reflecting the higher
concentration of lipids present in their tissue. If not
accounted for when performing B1 correction,
white matter of older subjects will appear to have
higher gluCEST. Bottom: T1 maps of the
corresponding subjects.

It will be noticed that the “T1 value” axis
in Figure 3A.2 begins at 1100ms for the
younger subject, but at 1150ms for the
older one. According to our
measurements, pixels with T1 value <
1150ms are almost completely absent in
subjects aged 60 and above. Increase in

T1 value with aging has been documented in earlier literature2,3, but does not appear to have
been quantified yet at ultra-high field strength. Our preliminary results on this front are
displayed in Figure 3A.3.
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At first, we supposed that the difference in CEST contrast at low B1 across different ages was
simply a reflection of the shift in T1 values; i.e. the same family of curves could be used for all
subjects for a given absolute T1. However, inspection of Figure 3A.2 illustrates that this is not
the case: even for a given T1 value, the dependence of the CEST signal on saturation B1 differs
with age. This supports the notion that low-B1 contrast is reflecting a physico-chemical change
distinct from that manifesting in the shift of T1 values.
As to the nature of this change, it
has been reported that the human
brain loses myelin, a tissue rich in
lipids, with aging4,5. We therefore
hypothesize that the age-dependent
differences in CEST signal at low B1
arise from a decreasing presence of
Figure 3A.3 . Histogram of white matter T1
values in the brains of healthy individuals,
measured at 7T. Green/blue distribution:
individuals 25-39. Red distribution: individuals
68-74.

lipids in older adults. NOE at 7T has
been used to examine glioma
patients 6,7, but little has been

reported about its use in other contexts. While the purpose of this data collection and analysis
was not observation of the NOE effect per se, we believe that the age-dependent differences we
observe in this function may be the first detection of brain lipid decline in aging populations by a
magnetization transfer-based technique. This signal, while detected incidentally in the present
results, could in the future be measured explicitly as an indicator of brain health and aging
progression.
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3B. Glutamate Weighted Imaging (GluCEST) as a Biomarker of Cognitive
Function: Preliminary Findings from GluCEST MRI in Older Adults
3B.1 MCI and AD: Additional Background
Alzheimer’s disease (AD) is the sixth leading cause of death in the US8. Its characteristics include
the progressive memory loss, decline in other cognitive skills, and adverse behavioral changes.
The hallmark brain neuropathologies of AD include accumulations of extracellular amyloid-
(A) plaques and intracellular neurofibrillary tangles (NFTs) formed by aggregates of all 6 tau
protein isoforms. These proteinopathies cause early synaptotoxicity and neurotransmitter
alterations, gliosis, and ultimately loss of neurons and gross brain atrophy9–13. Mounting
evidence indicates that early cognitive changes in AD may result from the dysregulation of
excitatory glutamatergic neurotransmission by soluble A oligomers, leading to tau
phosphorylation and glutamate over stimulation of extra-synaptic N-methyl-D-aspartate
receptors (ENMDARs) and synaptic alterations8. It has been shown that synapse loss, rather
than A plaques or NFTs, is the best correlate of memory deficits in AD 14,15. Previous work in
animals from our lab has demonstrated that decreasing gluCEST signal is correlated with
synapse loss16. In this study, our goal is to extend use of this technique to image the brains of
human patients experiencing cognitive decline.
Experimental protocol: We will now discuss the findings to date of the gluCEST study of MCI and
healthy aging in older adults. The gluCEST images gathered in this study were corrected with the
‘age matched’ correction surface, as in the final row of Figure 3A.1. All other acquisition and
post-processing is as described in Figure 1b.5 and the Methods section of Chapter 2.

128

3B.2 Analysis
T1 and T2-weighted images are used to perform segmentation of Medial Temporal Lobe
structures using the Penn Memory Center (PMC) atlas available in ITK-SNAP’s Distributed
Segmentation Service 17–19. CEST images are registered to the T2 weighted images and thereby
the segmentation map. Functions from the c3d library available in ITK-SNAP are then used to
calculate thresholded averages over pixel assigned to a particular segment.

3B.3 Results and Discussion
Figure 3B.1 shows ten gluCEST maps gathered in older adults: five healthy controls (top row)
and give presenting with MCI (bottom). The regional analysis in this study focuses on the fine
gray matter structures of the medial temporal lobe, as this region is thought to be the main

Figure 3B.1: GluCEST maps of selected control (top) and MCI subjects (bottom), overlaid
onto T2-weighted structural image. Interestingly, the most striking feature visible on a large
scale is the apparent lower gluCEST in white matter of MCI subjects (darker blue color). The
only control subject with a similar value is the oldest healthy participant, at 81 years of age.
locus of cognitive and memory related function in the human brain. It is difficult to gain
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information about these small regions of the brain by visual inspection. However, interestingly,
the white matter gluCEST appears to show differences between control and MCI subjects that
are not strongly localized and visible in these coronal CEST maps. The correct interpretation of
these white matter differences is still a matter of ongoing work.
Figure 3B.2 illustrates the method of regional analysis used to inspect the gluCEST of the medial
temporal lobe structures in these subjects. On the left, the subfield segmentation is shown
overlaid with the T2 structural image used to generate it. On the right, the same structural image
is shown overlaid with a gluCEST map set with high transparency so that the anatomy can be
seen clearly underneath. Registration of the segmentation shown on the left with the gluCEST
map shown on the right allows for calculating regional averages of gluCEST values over each
anatomical segment. Accurate segmentation depends on the success of registering the
experimental scan to an existing atlas. Unfortunately, no atlas has been developed for medial
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temporal lobe subfields which is specific both to aging adults (who universally have some degree
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Figure 3B.3: Plot of anatomical volume v. gluCEST values in MCI subjects. Several segments
are plotted for five subjects (various colors). No correlation is apparent between volume and
gluCEST in this sample. The cluster of points with a larger volume is A36 of the perirhinal
cortex, which in most subjects is the largest of these subfields.
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neural atrophy) and for
7T images, which have
contrast slightly different
from 3T images. For this
Figure 3B.2. High-resolution structural segmentation of medial
temporal lobe structures used for regional analysis of gluCEST
images: visualization of computational process. The atlas used for
this investigation was specific to older adults but not for 7T
images, which caused some challenges. The converse option was
equally plagued with inaccurate results.

study, it was determined
to be optimal to use an
atlas developed
specifically for older

adults (Penn Memory Center Atlas) despite the fact that this algorithm was expecting contrast
from 3T images. In most cases, this was a suitable solution; however, some cases of
segmentation failure occurred that may have resulted in part from this discrepancy.
The structural segmentation performed also returns information about the volume of each of
these segments, calculated from the full-brain structural images (not the slim cross-section
captured by the gluCEST image). We investigated whether there was a correlation between the
volume of the full segment, and the average gluCEST measured in the sliver of this segment
captured by our acquisition slice. No such correlation was found (see plot in Figure 3B.3). If this
lack of correlation is a true finding, it could be interpreted to mean that metabolic changes
which may increase or decrease the presence of glutamate-- reflecting physiological phenomena
like excitotoxicity or synapse loss-- may occur only loosely correlated in time to structural
degradation of the neurons and surrounding tissue. Indeed, many investigators in the field have
concluded that, “by the time you see the structural loss, it’s too late”, and that real disease
progression precedes this step. Alternatively, it’s quite possible that a subtle correlation exists
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but was not detected in our current data precisely because of the fact that only a small fraction
of the structure is captured in CEST slice.
Figure 3B.4 displays the calculated mean gluCEST values in two different ways: by bar plot, in
which only the most consistently captured segments are represented, and in an ‘image’, in
which the color of the segment represents its average value in that population. Statistical tests
revealed that the average gluCEST between two of the segments had a “statistically significant”
difference between MCI and control subjects: namely, the right entorhinal cortex and the left
subiculum. However, given the lack of consistency in direction, laterality or anatomical identity
between these two results, it seems likely that this reflects abnormally high or low values in
specific subjects which, while perhaps having significance in the physiology of the individual,
does not reflect any consistent group trend.
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Figure 3B.5. Normalized histograms of gluCEST distributions in the entorhinal cortex of
young adults (blue), older adults without cognitive impairment (green), and older adults with
mild cognitive impairment (red).
Figure 3B.4 Representations of average gluCEST
values of MTL subfields. Top: Bar plot of average
gluCEST values in ROIs with sufficient coverage over
all subjects. Data is separated by laterality and by
MCI vs. control. The subfields shown include regions
A35 and A36 of the perirhinal cortex, CA1 of the
hippocampus, the entorhinal cortex (ErC) and the
subiculum. The asterisk represents segments in
which a statistically significant difference was
calculated between MCI and control subjects. Left:
ROI averages by colormap, projected onto the
anatomy of a single subject for visualization. Control
(top) and MCI (bottom). For example the elevated
average gluCEST in the right ErC and subiculum of
MCI subjects is seen in the red and orange colors
shading this anatomy in the bottom panel.

Finally, Figure 3B.5 examines the gluCEST values in one segment, the entorhinal cortex, as a
distribution. The goal of this type of analysis is to elucidate the relationship between gluCEST
changes in healthy aging as opposed to in those patients presenting with MCI. On the left, the
distribution of gluCEST values measured in the entorhinal cortex of younger subjects (blue) is
plotted together with that from older healthy subjects (green). The apparent low-magnitude left
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shift of this distribution would seem to be a reasonable result. This comparison is not entirely
rigorous, however, as the data from younger subjects was gathered using the 3D gluCEST
sequence, while the data from older subjects, the 2D sequence. While we believe the resulting
magnitude of gluCEST to be comparable between these sequences, the bigger discrepancy
which makes these data sets hard to compare lies in the number of pixels captured. It can be
seen that the blue distribution comes much closer to an idealized ‘normal’ shape, while the
green one is ‘noisy’. These distributions are normalized for comparison, but in reality the
distribution derived from the 3D CEST data contains an order of magnitude more pixels,
although it comes from a comparable number of subjects. It can be understood readily from this
plot that identification of the properties of the distribution – and thus, answers to biological
questions – can be attained much more readily with the information provided by a 3D
acquisition.
The plot on the right contains the 2D-derived data for MCI v. control subjects (the green
distribution is identical in both plots). What would appear to be the case from these
comparisons is that individuals with MCI have a greater spread of gluCEST values-- suggesting
dysregulation of normally tightly controlled processes-- while normal aging involves a slow
decline in glutamate concentration (perhaps due to hypometabolism or synapse loss), but
without extreme values in either direction.
In the current data set of older adults, the entorhinal cortex was amongst the only segments
which had a ‘smooth’ enough distribution to make any sense of such plots. This is unfortunate,
as histograms may be our best tool to interpret what in reality is likely a complex and multimodal situation: subjects with MCI may have higher gluCEST if we’re capturing the
‘excitotoxicity’ phase, or lower, if we’re capturing the ‘loss-of-synapses’ phase. There may even
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be a bimodal distribution of gluCEST values amongst these subjects, which would need a
particular large amount of data to detect cleanly. Ideally, we could even do regional analysis
based on the particular sub-classification of cognitive impairment that the patient is presenting:
for example, a deficit in verbal capacity as opposed to spatial navigation could be reflected in
changes in different respective subregions.

3B.4 Limitations of the Study
This study has imaged fewer than 20 participants to date, and employed only our 5mM, ‘2D’
gluCEST sequence (see pulse sequence parameters in 2A.1). In a 2D acquisition aiming to
capture specific, small anatomy, slice placement must be very exact, and even so, the data
acquired is very limited. Moreover, the structural degradation and variability in older brains
makes the challenge of repeated capturing of the same anatomy in each scan particularly steep.
This limited amount of information per subject makes it difficult to identify consistent trends at
the current stage of investigation; however, this ongoing work provides an excellent case study
for the challenges of the gluCEST measurement and its analysis, and a quintessential illustration
of the impetus for our expansion to 3D acquisition described in chapter 5.

3B.5 Conclusions
In summary, the complexity of neurodegeneration and consequent cognitive decline with aging
is a problem which requires the maximal amount of information to deconvolute all of the
potentially relevant variables-- this is a problem with many degrees of freedom, and thus needs
many points of input to gain insight into its ‘ground truth’. GluCEST is an incredible tool for such
a task, but it requires that we be able to image as much volume as possible. To these ends, we
hope that future work in imaging these populations of older adults will employ a 3D acquisition
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as will be presented in Chapter 5, in which excellent understandings of the distributions of
gluCEST values in particular brain segments--their means, medians, extents, and subtle
differences from each other—was achieved from the data of only ten healthy subjects.
Expanding our attainable data even to this degree could have a revolutionary contribution to the
goal of creating an ‘atlas’ of brain glutamate distributions in healthy and impaired aging.
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Chapter : Using gluCEST to probe the mechanism of
transcranial magnetic stimulation (T S)
4.1 Introduction
Transcranial magnetic stimulation (TMS) is a non-invasive brain stimulation technique which has
been deployed extensively by cognitive neuroscientists, physiologists, and clinicians1. TMS uses
electromagnetic induction to generate electrical current in the cortex of the brain, and causes
depolarization of neurons at the site of stimulation (See Figure 4.1)2,3. Specifically, TMS uses a
strong and rapidly fluctuating electrical current which is transmitted through loops of
conductive wires surrounded by a protective casing and held in proximity to the skull. The
generated current penetrates the scalp and skull, inducing electrical and subsequent chemical
changes within the cortex4,5. TMS to the motor cortex has been shown to activate cortical
interneurons and pyramidal neurons, leading to corticospinal tract activation and ultimately
inducing muscle twitches6. When applied to other regions of the cortex, TMS can interrupt
normal cognitive function and can provide therapeutic relief of complex neurobiological
disorders such as depression7,8. Given the already wide-ranging application of this technique, it
is ever more imperative for scientists and clinicians to understand the mechanisms by which
TMS influences the brain and subsequent behaviors.
To this end, multiple TMS protocols have been developed by researchers who seek to
characterize their various effects1. The focus of our study is a particular implementation known
as continuous theta burst stimulation (cTBS)9, consisting of 3–5 pulses at 100 Hz repeated at 5
Hz for 40s, a protocol considered to fall into the broader category of ‘repetitive TMS’ (rTMS).
Previous studies have shown that the use of rTMS protocols such as cTBS can induce long term
changes -- termed by neuroscientists as long-term potentiation (LTP) and long term depression
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(LTD) -- within the motor cortex or other regions of the brain10–13. The changes induced by cTBS
are typically monitored and reported by measuring motor evoked potentials (MEPs) and
believed to last up to 1 hour post stimulation14. The direction and magnitude of these changes
are thought to dependent on the pattern of the administered stimulation.15 While some models
have been recognized which describe the electrophysiologic response as a function of
stimulation pattern, the precise cellular mechanisms which are at play here are not well
understood.
Current hypotheses include the idea that changes in MEPs occur due to the modulation in
interneuron and/or pyramidal cell membrane excitability, or due to a change in the ability of
neurons to effectively communicate through their synaptic processes6. More recent studies
have pointed to membrane potentials being influenced mostly at the level of
inhibitory/excitatory interneurons within the cortex, as stimulation protocols such as cTBS are
generally not considered to be sufficiently intense to activate deeper cortical pyramidal
neurons16. cTBS is believed to specifically activate inhibitory GABAA and GABAB interneurons
within the motor cortex 14,17,18. Strong evidence of molecular changes after rTMS and cTBS come
from drug studies which have shown that the use of glutamatergic NMDA antagonists
dextromethorphan and GABA receptor agonists alter the responses to rTMS protocols19–21. More
specifically, the use of the partial NMDA agonist D-cycloserine, has been shown to modulate the
effect of theta burst stimulation22.
Interest in understanding the neurometabolic underpinnings of TMS has given rise to a number
of magnetic resonance spectroscopy (MRS) based investigations23. Multiple studies have found
that cTBS and related protocols can induce changes in MRS-measured GABA concentration24–29
or have linked TMS-based measures of electrophysiology to GABA content30,31. However, despite
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the pharmaceutical-based evidence that the glutamatergic signaling system is also involved in
TMS response, changes in glutamate have not been detected robustly in MRS studies to date of
cTBS to the motor cortex. In this study, rather than single voxel spectroscopy, we used gluCEST32
to assess the effects of cTBS on cortical glutamate. To the best of our knowledge, this technique
has not ever been previously applied to investigate TMS.
As described in the previous chapters, gluCEST relies on a different mechanism than
spectroscopy: rather than detecting the resonance of the glutamate protons directly, the
gluCEST signal originates from the interaction of the glutamate with bulk water, and the signal
measured – as in most other forms of MR imaging – is the water itself.
In this work, we capitalize on the ability of gluCEST to generate spatially resolved brain ‘maps’
weighted for glutamate to investigate the short-term neurometabolic effects of cTBS on healthy
Figure 4.1: TMS/CEST
basics.Top: Schematic
explanation of TMS coil
mechanism and gallery
photo (from Penn’s
Laboratory for Cognition
and Neural Stimulation
website), demonstrating
TMS. Bottom: Overview of
TMS/gluCEST imaging
experiment; image of
Magstim Rapid stimulator,
from manufacturer’s
website.

humans. Our study design involves sequential collection of gluCEST imaging before and after
subjects have undergone cTBS or a placebo (“sham”) stimulation. Our results suggest that we
have been able to detect transient shifts in the neurochemical profile of stimulated subjects,
which may underlie the electrophysiological and other more lasting effects attributed to cTBS.
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This is a pilot study in which only general trends amongst a small population of healthy subjects
were determined. However, we believe that this novel type of data may open doors for further
understanding the molecular mechanisms of TMS, the geometric and temporal extent of its
effects, the varying effect of different TMS protocols, and the origin of variability in response to
TMS within the population.

4.2 Materials and Methods
4.2.1 Human subjects information
15 healthy individuals (mean age = 29.5 , St.D. = 8.8 years, 5 female) were recruited for this
study. Subjects provided informed, written consent and all procedures were carried out in
accordance with the guidelines of the Institutional Review Board/Human Subjects Committee at
University of Pennsylvania. A non-invasive type of brain stimulation, TMS, was administered to
all subjects in accordance with the procedure described in 14. Subjects were randomly assigned
into either the active stimulation group (n = 10) or the sham group (n = 5). All subjects were
right-handed participants with no prior history of neurologic or psychiatric disease.
4.2.2 cTBS and sham
The TMS coil was used to find the subject’s right hand first dorsal interosseous (FDI) muscle via
the neuronavigation software Brainsight (Rogue Research, Montreal, Québec, Canada). A
subject’s resting motor threshold was determined when the FDI muscle was activated at rest
50% of the time, as determined by measured motor evoked potentials (MEPs). A subject’s active
motor threshold was determined when the FDI muscle was engaged in a motor task 50% of the
time (determined by MEPs). The resting and active motor threshold values (i.e. the machine
output when at rest or doing the active task) were noted. Subjects then participated in two
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imaging sessions ( “pre-TMS" and “post-TMS"). Between the two sessions, either active or sham
TMS was administered. In the active TMS group, we administered continuous theta burst
stimulation14 (cTBS) as described in reference [12], at 80% active motor threshold to the
identified FDI muscle target in the left motor cortex. Briefly, cTBS is a 40-second procedure of
uninterrupted theta-burst stimulation, to total 600 pulses. Stimulation was delivered with the
70mM hand-held figure-eight coil of the Magstim Super Rapid Stimulator (Magstim, Inc.,
Whitland, Dyfed, UK.). To create the sham condition, TMS was administered to the vertex,
rather to the motor target, with the coil held perpendicularly to the subject’s head (90° rotation
from normal position).
4.2.3 MRI acquisition procedure
All images were obtained on a Siemens 7.0T MAGNETOM Terra scanner (Siemens Healthcare,
Erlangen, Germany) outfitted with a single volume transmit/32 channel receive phased array
head coil (Nova Medical, Wilmington, MA, USA). All subjects underwent two sessions of MR
imaging: one prior to either cTBS or sham stimulation, and one directly following the stimulation
session. Prior to beginning the initial CEST measurement, structural and BOLD scans (fMRI) were
acquired and processed in order to locate the target region of stimulation for accurate
placement of the CEST slice. Subjects were instructed to perform voluntary motion of the first
dorsal interosseus muscle (index finger), the same motion which is induced involuntarily by the
cTBS protocol when administered above motor threshold. This voluntary motion led to a
localized BOLD signal that could be visualized and then registered to the structural image visible
on the scanner interface where slice placement is performed by the operator. The CEST slice
was then acquired in such a fashion as to maximally capture the activated region. See Figure 4.1
for illustration.
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GluCEST data was collected with a single-slice CEST sequence based on gradient-recalled echo
with the following parameters: TR/TE = 4.7/2.3 ms, 10° flip angle, 5 mm slice thickness, with
0.75 x 0.75 mm2 in plane resolution over a 156 x 192 mm field of view. Magnetization
preparation was achieved using eight 3.1µT RMS amplitude, 98 ms Hamming-window shaped
pulses with 2 ms inter-pulse delay applied at offset frequencies {±1.8, 2.1, 2.4, 2.7, 3.0, 3.3, 3.6,
3.9, 4.2} ppm relative to water. Additional acquisitions over the same field of view included a
water saturation acquisition (WASSR) for B0 mapping33, a flip/crush sequence for B1 mapping34,
and the Siemens product sequence MP2RAGE for generation of T1 maps. A ‘reference’ image
consisting of only the read-out module of the CEST sequence (with no saturation) was also
collected for each slice.
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4.2.4 Data processing and analysis
CEST-weighted images were corrected for the B0 field distribution using the B0 image generated
by the WASSR scan, as described in 32. CEST images were corrected for B1 inhomogeneity using
a recently developed procedure (detailed in chapter 2) based on B1 and T1 mapping35. T1 and T2
weighted full-brain structural images were used for segmentation by Freesurfer’s ‘Recon All’
function36 (Freesurfer: Martinos Center for Biomedical Imaging, Charlestown, MA, USA). The
output from Recon All (segmentation image) was transformed back into the original acquisition
space, and resliced to correspond to the CEST acquisition for pixelwise regional analysis.
Regional averages and distributions were calculated and visualized using in-house code written
in Matlab (Mathworks, Natick, MA, USA); statistical analysis was done using Matlab’s unpaired
T-test function. Plots and visualizations were generated using Matlab and ITK-SNAP37,38.
Good agreement was found between the in-magnet localization of M1 and the atlas-based
Figure 4.2. Illustration of CEST slice placement and regional analysis. A) CEST slice shown as
segmented by Freesurfer’s ReconAll. The precentral gyrus is shown in red. B) View of CEST
slice overlaid with structural image and BOLD results used to localize this slice before
imaging experiment. The transparent area represents the region identified by BOLD as the
targeted location. Good correspondence is observed between this real-time functional
measurement and the atlas-based segmentation performed post facto. C) Same image
overlay series as B, shown in sagittal view: CEST slice after post-processing (color) shown
intersecting the black/transparent BOLD-identified ROI.

segmentation used for data analysis. Visualizations of the CEST slice used in this experiment are
provided in Figure 4.2. Example gluCEST data masked for M1 from two stimulated subjects with
a visually apparent change in this region are shown in Figure 4.3, along with the corresponding
histograms.
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4.3 Results
While initial analysis focused on M1, in fact a highly non-localized response, manifesting in a
decrease in gluCEST signal throughout the left (ipsilateral) hemisphere, was detected in
subjects who received cTBS. Figure 4.4 shows segment-wise average gluCEST data from all
subjects, projected onto the anatomy of a single subject for visualization. Figure 4.4A shows the
average gluCEST values by segment in the baseline scan, containing data from all 15 subjects

Figure 4.3: Sample CEST maps and histograms for gluCEST in the left precentral gyrus of
stimulated subjects with apparent stronger response. Data is shown from two subjects, one
in each row. Color scale in CEST maps is 0-13%, negative normalized contrast. The slight left
shift in the histograms reflects the color change seen in the maps. The 99% confidence
interval for the mean change in the left precentral gyrus (locus of M1) for all stimulated
subjects was .13-.33% gluCEST contrast. A 0.3% decrease, for example, would correspond
to a shift from .083 to .08 on this axis.
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before they had received either the sham or real stimulation. Average gluCEST values range
from 7-9%, typical for gray matter regions in healthy subjects using this protocol. Interestingly,
there appears to be some anatomic variability in gluCEST values in this slice at baseline;
however, we did not attempt to further interpret these results, given the limited number of
subjects. Figure 4.4B shows the same data in the sham subjects (n = 5), ‘post-sham’. While there
is some noise in the data, these values generally appear to remain unchanged in comparison to
the baseline values for the whole group shown in 4.4A. In contrast, Figure 4.4C, showing the
post-stimulation (cTBS) gluCEST averages (n = 10), is quite different from the baseline and postsham results. Several segments, not only M1 (stimulation target, indicated by green arrow)
show a decrease in average gluCEST value compared to the baseline measurement.
Unpaired T-tests were performed comparing the pixelwise data of these segments between the
‘pre’ and ‘post’ scans for both groups. Table 4.1 lists the results of these T-tests in the form of
the upper and lower 99% confidence intervals of the mean change in that segment (post-pre) as
well as the corresponding P-value. Very low P-values, indicating high statistical significance, are
highlighted in bold. This includes many segments in the left hemisphere of the brain of
stimulated subjects, and one in the right hemisphere. No very low P-values (P < 1e-4) were
calculated for sham subject data. Interestingly, the left precentral gyrus – the locus of M1—is
not the segment with the greatest change in mean value, and the contralateral right precentral
gyrus is not amongst those segments in which a strongly statistically significant change was
observed. The same data is presented in bar plots in Figure 4.5.

147

Figure 4.4. Segmentwise gluCEST maps. Data from all subjects projected onto
the anatomy of a single subject for visual representation. A) average gluCEST
by segment, baseline (pre-stimulation) -15 subjects. B) post "sham" (placebo)
stimulation - 5 subjects. C) post cTBS (real) stimulation -- 10 subjects. The color
scale is identical in all maps, with settings as shown in the screenshot from ITKSNAP. Green arrow indicates the left precentral gyrus, the intended target of
cTBS in stimulated subjects. Please see the color coding in Figure 4.2 for full
listing of anatomical segments treated distinctly in this analysis.
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Table 4.1
Left
Precentral Gyrus
Caudal Middle
Frontal Gyrus
Rostral Middle
Frontal Gyrus
Superior Frontal
Gyrus
Postcentral Gyrus
Superior Parietal
Lobe
Precuneus
Paracentral Gyrus
Right
Precentral Gyrus
Caudal Middle
Frontal Gyrus
Rostral Middle
Frontal Gyrus
Superior Frontal
Gyrus
Postcentral Gyrus
Superior Parietal
Lobe
Precuneus
Paracentral Gyrus

Sham subjects
Upper
Lower
bound
bound
0.26
-0.05
0.01
-0.33

7.9E-02
1.4E-02

Stimulated Subjects
Upper
Lower
bound
bound
-0.11
-0.33
0.05
-0.16

P-value

P-value
3.5E-07
1.8E-01

0.03

-0.26

3.8E-02

0.08

-0.3

1.5E-01

0.16

-0.04

1.3E-01

-0.1

-0.24

4.2E-10
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0
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3.6E-01
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-0.23
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-0.82
-0.44

6.4E-06
6.6E-06

0.18
0.14

-0.12
-0.19

5.7E-01
7.1E-01

0.03
0.12

-0.17
-0.1

7.4E-02
7.9E-01

0.01

-0.31

1.9E-02

0.47

0.05

1.8E-03

0.05

-0.17

1.7E-01

-0.11

-0.25

1.6E-11

-0.09
0.29

-0.49
-0.12

2.0E-04
2.9E-01

-0.06
-0.05

-0.32
-0.3

1.6E-04
4.6E-04

0.15
0.54

-0.43
0.09

2.1E-01
4.0E-04

0.27
0.14

-0.33
-0.19

8.0E-01
7.1E-01

4.4 Discussion
In this study, we used gluCEST, a unique form of MRI in which the image contrast is weighted for
the presence of glutamate, to image the brains of healthy volunteers who have undergone
continuous theta-burst stimulation (cTBS). A number of studies have performed magnetic
resonance spectroscopy (MRS) upon TMS; a recent review gives a comprehensive summary of
their contexts and findings23. However, it appears that this is the first time that gluCEST has
been used for this purpose. Excitingly, gluCEST presents a tool that directly ameliorates some of
the shortcomings of MRS for measuring glutamate: namely, sensitivity and spatial resolution.
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Figure 4.5: Barplot of gluCEST changes by segment: 99% confidence intervals (CI) of mean
change, as report by unpaired T-test. A cluster of two bars, representing the upper and lower
bound of the confidence interval, is shown for each segment, beginning with the Precentral
Gyrus for each side. The 'true' change likely lies between the two confidence intervals,
generally giving a value near zero for sham subjects and most right hemisphere segments,
but a small negative value for stimulated subjects. The double asterisks indicate where pvalues reflected a high statistical significance of the change.
We find that on average, small but very statistically significant changes appear in the gluCEST
values from the brains of stimulated subjects; specifically, that gluCEST decreases in the left
hemisphere in stimulated subjects, but not generally in the right hemisphere and not in subjects
who received a ‘sham’ stimulation in between imaging sessions. The gluCEST decrease, which
was on the order of 0-5% of the baseline value (varying between subject and area of the brain)
and was not strongly localized, but appeared in several segments that are topologically
contiguous with the left motor cortex (M1), which was the site of stimulation. There are perhaps
two separate and interesting observations here which merit discussion and interpretation in the
context of existing literature:
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a) the spatial distribution of the measured change
b) the sign of this change –i.e. decrease of gluCEST upon administration of cTBS
The observation of the spatial distribution of a TMS-effected metabolic change other than BOLD
is unique to this study. GluCEST is perhaps the only way to detect glutamate in vivo with spatial
resolution comparable to other forms of magnetic resonance imaging (MRI). For MR-based
detection of specific metabolites, the standard approach is to use single-voxel MR spectroscopy
(MRS or SVS) , as employed in existing studies of TMS. Spectroscopy is an optimal and robust
way to measure a number of chemicals in the brain; and indeed, the only way to measure some
of them. Spatially resolved versions of spectroscopy are known as Magnetic Resonance
Spectroscopic Imaging (MSRI) or Chemical Shift Imaging (CSI). The ability of these techniques to
detect any particular molecule with high spatial resolution is limited by the SNR of that
molecule’s contribution to the NMR spectrum. Even for the highest-concentration
neurometabolites like N-acetyl aspartate, creatine and choline, the spatial resolution of
spectroscopic imaging has not been demonstrated to exceed a few millimeters in each
dimension, as in recent work39. Glutamate is in fact difficult to quantify accurately even with
SVS, due to its high degree of spectral overlap with glutamine40. Robust measurement and
quantification of glutamate by a spectroscopy-based technique requires a large voxel with a high
number of averages.
While our results measuring the spatial distribution of the TMS-induced changes are
preliminary, they serve to highlight that the TMS pulse effects more than just its nominal target,
which is often a motor target whose stimulation results in an observable muscle motion. The
fact that the two segments of the ipsilateral hemisphere which apparently remain unperturbed
by cTBS to M1 – the caudal and rostral middle frontal lobes—are proximal to, but not
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topologically contiguous with, M1 suggests that the distribution of effects may have to do more
with neural connectivity rather than off-target action of the pulsed field itself. Interestingly, the
only contralateral effect were observed was in the superior frontal gyrus. We anticipate
additional informative findings about the spatial profile of TMS-induced metabolic effects as we
replace the single-slice gluCEST image with a larger, volumetric acquisition in future studies.
As for observations (b) and (c), it would appear from reviewing the literature that little
conclusive understanding of the relationship between administration of particular TMS
protocols and concentrations of glutamate has been gained by MRS23. According to the review
by Cuypers and Marsman, a number of apparently contradictory results have been reported
regarding the existence and sign of a correlation between TMS-based measures of
electrophysiology and MRS-based measurements of glutamate and other metabolites. The same
is true regarding measurements of the effect of TMS itself. With regard to glutamate, this is not
terribly surprising, given the limitations of spectroscopy for detecting it -- particularly at 3T, at
which the overwhelming number of studies were performed. Moreover, variability in the TMS
protocols under investigation adds degrees of freedom that make such meta-analysis difficult.
However, one particularly comprehensive study of metabolic changes upon TMS was that of
Dyke et al 2017, one of the few studies to perform spectroscopy at 7T and compare to it several
different electrophysiology based measures that are used in the field41. They find statistically
significant correlations between spectroscopic measurements of glutamate and two different
TMS-based measures: what they designate as “Intracortical Facilitation” and the “Input/Output
plateau”. Interestingly, they find that these two correlations are of opposite sign, suggesting
that the relationships between metabolite concentrations and various electrophysiologic
parameters may be more complex and sensitive than many of the existing analyses allow for.
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Our measurement indicates that the concentration of glutamate decreases in the brains of
stimulated subjects at ~30 minutes post-cTBS. It is difficult to say definitively whether, on the
whole, this imaging result corroborates existing work about cTBS physiology, as no directly
comparable experiment has been done before.

4.5 Conclusions
We believe that the increased sensitivity of gluCEST relative to spectroscopy has allowed us to
detect subtle changes in glutamate concentration that so far have been inaccessible to the TMS
research community. Furthermore, our results provide information about the spatial
distribution of the TMS effect which is unprecedented in existing measurements.
Given the preliminary nature of our study, we refrain at this time from putting forth any specific
mechanistic conclusions about cTBS based on our observations. Indeed, the goal of this
preliminary study was simply to explore the utility of gluCEST as a method to study TMS. The
presence of coherent, statistically significant findings despite the small number of participants in
the study is very encouraging, and illustrates that indeed the spatially resolved molecular
imaging capabilities of gluCEST have a role to play in elucidating the chemical mechanisms of
therapy by non-invasive stimulation. The obvious areas for expansion in our further work
include implementation of a newly developed volumetric gluCEST protocol, acquisition of
additional types of MEP-related measures, and experiments which interleave in-magnet
administration of TMS with real-time MR measurements.
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Chapter :
Volumetric ( D) gluCEST enables in vivo detection of
metabolic differences bet een human hippocampal
subfields
5.1 Introduction
The medial temporal lobe (MTL) has been identified by modern neuroscience to be the locus of
learning and memory formation, and many neurodegenerative conditions gradually impair
cognitive ability because of their damage to these structures. The MTL is generally considered to
include the hippocampus proper, the dentate gyrus (DG), entorhinal cortex (EC), and subiculum1
(see Figure 5.113). Together with the
perirhinal and parahippocampal
cortices, these structures play vital
roles in cognitive function which
rely on glutamate-mediated
signaling2–6. Within this role,
different subfields are known to
Figure 5.1. The Human Hippocampus. Top: Schematic
of hypothesized connections and information flow
during “pattern separation” activities of the
hippocampus and neighboring regions [ref. 11].
Bottom: Illustration of the ever-evolving field of image
analysis specialized for the MTL, including a 3D
reconstruction (right).

13

have distinct functions; for
example, the DG has been assigned
as the locus of ‘pattern separation’
7–9

and spatial memory formation,

Ref for bottom portion of Figure 5.1: Lund DR, Gade MT, Jensen T, et al. Multi-Contrast Hippocampal Subfield
Segmentation for Ultra-High Field 7T MRI Data Using Deep Learning. In: Proc. of Ann. Meeting of the Intl. Soc. Mag.
Res. Med..2020.
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while CA314, of ‘pattern completion’ 1,7,8,10–12. The distinct role of CA1, particularly as separate
from the DG, remains under investigation and discussion9,10,13–18. The DG is known to be the
locus of neurogenesis in both physiological and pathological contexts19,20, but it is unclear
whether it shares that capacity with other nearby subfields10. Interestingly, it has been shown
that certain glutamate receptors, particularly the N-methyl-D-aspartate (NMDA) receptor, are
expressed in higher density in dentate gyrus cells than in those of CA1 and other subfields18,21.
One could hypothesize that amongst other molecular differences, variability in and sensitivity to
glutamate metabolism and signaling may underlie the very specific functionality of the MTL
subfields.
As previously discussed, gluCEST22 is nearly unique in its ability to provide non-invasive, spatially
resolved measurements of glutamate in vivo. In both preclinical and clinical studies, gluCEST
measurements have been shown to correlate with the presence or progression of disease in the
brain23–32. One previous work from our group demonstrated that a decrease in gluCEST was
correlated with synapse loss – as verified by histopathology - -in animal models of
neurodegeneration23. A detail from the findings of this work was that in all animals – genetic
variant and WT, and across all ages – the gluCEST measured in the dentate gyrus was higher
than in other regions. However, it is both technically challenging to identify anatomy accurately
in images of the mouse brain and conceptually unclear in some cases how to map findings to
human neurological function, as the subfield anatomy is not identical and the functions are of
obviously disparate complexity. In human beings, perhaps the leading example of gluCEST

14

The initials ‘CA’ stand for the Latin name cornu ammonis, an earlier name for these regions now
classified as the hippocampus. This full term is rarely found in the current scientific literature, while
certain subfields retain the vestigial labels CA1, CA2, CA3 and CA4. Apparently, general opinion has
favored the comparison with sea horse (hippocampus) rather than ram’s horn (cornu ammonis) to
describe the morphology of this important anatomy.
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regional analysis to date is Cai 2013, who used a single-slice sagittal acquisition to capture and
analyze gluCEST signal in a number of subcortical regions33. However, with this limited-volume
acquisition, analysis of very small structures like hippocampal subfields was not possible.
We recently developed an improved correction for B1 inhomogeneity of gluCEST images of the
human brain 34 which enabled high resolution, truly volumetric (3D k-space) imaging, even in
inferior regions where B1 inhomogeneity is problematic. In this work, we extend single slice
gluCEST MRI to partial 3D gluCEST imaging at 7T to image the MTL of healthy subjects.

5.2 Methods
5.2.1 MRI acquisition procedure
This protocol was approved by the Institutional Review Board at the University of Pennsylvania,
with written informed consent obtained prior to participation. Ten healthy adult subjects (3
female/7 male) ages 19-45 were scanned on a 7T scanner (MAGNETOM Terra, Siemens
Healthcare, Erlangen, Germany) equipped with a 1Tx/32Rx head coil (Nova Medical,
Wilmington, MA, USA). Our 3D CEST sequence is a spoiled gradient-echo acquisition, modified to
include two saturation modules consisting of eight 100ms Hamming-windowed pulses at 3.1µT
RMS B1, with a duty cycle of 99%. The acquisition has 1 x 1 mm2 in-plane resolution over a field
of view of 240 x 180 mm2, with the third dimension comprising of 12 slices of 2mm thickness
each. The sequence implements GRAPPA with an acceleration factor of 2, and elliptical k-space
acquisition with centric ordering in the slice and phase-encoding directions. Additional
acquisitions over the same field of view included a water saturation acquisition (WASSR)35 for B0
mapping, a flip/crush sequence for B1 mapping36 , and the Siemens product sequence MP2RAGE
for generation of T1 maps. A 3D reference image without saturation over the same FOV is also
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collected for each slice. The total acquisition time of the 3D CEST experiment with these
parameters, including manual optimization of the B0 field shim, is approximately 30 min.
5.2.3 Data processing and analysis
Post-processing was performed using in-house code written in MATLAB and MEX (Mathworks,

Figure 5.2 Schematic of 3D CEST sequence. Saturation module is depicted as
the initial 5 broad-band pulses on the ‘RF” line. Nshots = 2; Nshots = 12 or 16 for
gluCEST, correspond to number of slices. (This pulse sequence as shown is
not necessarily specific to gluCEST.) Courtesy of N.E. Wilson.
Natick, MA, USA), as described in33,37,38 and in Chapters 1 and 2. CEST-weighted images were
corrected for the B0 field distribution using WASSR. CEST images were corrected for B1
inhomogeneity using a procedure based on B1 and T1 mapping. A flowchart of the full CEST
acquisition and post-processing procedure, including a summary of the B1 correction, is given as
Figure 1b.4 in this thesis.
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Segmentation of the medial temporal lobe (MTL) was performed using the Magdeburg 7T Atlas
available in the Distributed Segmentation Service of ITK-SNAP39–41, with T1 and T2-weighted
structural images as input. Regional averages and distributions were calculated and visualized
using in-house code written in Matlab; statistical analysis was done using Matlab’s ‘T-test’
function.

5.3 Results
Figure 5.3 (next page): Individual slices of 3D gluCEST volume, shown with segmentation
and B1 maps. First column: gluCEST image (‘jet’ color map, 0-15% negative-normalized
asymmetry), filtered and overlaid with partial transparency on the T2-weighted structural
image with color-coded segmentation. This view allows for observation of the fine
differences in anatomy captured in each consecutive slice. Second column: only the
unfiltered gluCEST map for the corresponding slice. Third column: relative B1 maps for each
slice ‘(hot’ colormap) also overlaid with the segmented structural image. The dynamic
contrast range shown in these maps is 0.4-1.0, such that the B1 map is black and transparent
in areas with relative B1 < 0.4 . This is the relative B1 value below which it has been
determined that measurement of gluCEST is not valid (see Chapter 2). We can observe that
this B1 drop-off occurs predominantly in the distal edges of the brain, and fortuitously does
not strongly affect measurements of medial temporal lobe structures in most subjects, with
the possible exception of area A36 of the perirhinal cortex.
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Overlay: Structural,
segmentation, filtered
and partially transparent
CEST map

Unfiltered CEST map
only (same color scale
as in first column). Last
column: relative B1 map
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Figure 5.3

Figure 5.3 shows six consecutive slices of our 12-slice 3D gluCEST acquisition, focusing on the
medial temporal lobe (MTL) region. The slices are ordered in the direction inferior-superior, with
the most inferior slice being Slice 1 and the most superior being Slice 6. (The total acquisition
includes six additional slices in the superior direction, to make 12 total, but these are omitted
from the figure so as to focus on the region containing the segments of interest.) The left
column of this figure features an overlay of the CEST map (‘jet’ colormap, filtered) on the
structural image on which a segmentation for hippocampal subfields is shown in opaque colors.
This view demonstrates the value of acquiring higher resolution images along the superiorinferior axis, as the anatomy represented changes significantly from one 2mm slice to the next.
In the 2D 5mm slice acquisition used previously, our field of view would have included only two
of these six slices, and they would be superimposed on each other in a single image. Clearly, this
is suboptimal for imaging of such fine structures such as those in the medial temporal lobe.
The middle column of Figure 5.3 shows the gluCEST map, unfiltered and without the structural
underlay. It is clear that there are still large portions of signal drop-out bilaterally in this inferior
region of the brain, where the gluCEST signal is artificially very low (blue patches). This is a direct
reflection of the B1 amplitude in these regions; the corresponding B1 maps for each slice are
shown in the right column. These B1 maps (‘hot’ colormap) are scaled such that areas with
relative B1 < 0.4 are without color; this is the value of relative B1 known to us to be insufficient
for measurement of gluCEST. . Fortuitously for our present analysis, in most subjects this area of
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low B1 does not strongly affect the MTL structures of interest, as they are located in the center
of the head.

Figure 5.4. Box plots of gluCEST values by segment. Center: An example MTL segmentation
is shown, with coloring of segments corresponding to the boxplots containing their gluCEST
values. These include the CA1, CA2, CA3 and dentate gyrus subfields of the hippocampus, as
well as the more inferior segments: the entorhinal and parahippocampal cortices and A35
and A36 of the perirhinal cortex. Left, Right: The gluCEST values over all pixels in the ROI and
all subjects (n = 10) are plotted as box and whisker plots, where the 25% and 75% percentiles
form the boundaries of the box. The hippocampal tail, shown in yellow in the top portion of
the segmented image (sagittal view), was not included in this analysis, as it was captured to
an unequal degree between different subjects.
5.3.1 Identification of subfield-level metabolic differences: Elevated gluCEST in the dentate
gyrus
Figure 5.4 shows box and whisker plots of bilateral gluCEST values (right and left sides of the
brain tallied together) by MTL structures. The color of the boxes in the plot corresponds to the
segmentation shown in the center, with the left plot featuring the subfields of the hippocampus,
and the right plot featuring the perirhinal, entorhinal, and parahippocampal cortices. The
colored portion of the box shows the middle two quartiles (25th percentile-75th percentile) of
data, with the red line indicating the median. The number of pixels included in each of these
vectors is tabulated in Table 1. The distribution of gluCEST values in the dentate gyrus is
noticeably shifted relative to the remaining segments, with the 25th percentile, median, and 75th
percentile all higher than the corresponding values in the other vectors. One will also notice that
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region A36 of the perirhinal cortex has the lowest such values. However, upon inspection of the
B1 maps in the rightmost column of Figure 5.3, one can appreciate that in many subjects, the
region of B1 drop-off begins to overlap with the volume occupied by segment A36 (in purple).
and, we have not been able to demonstrate that the gluCEST measurements of segment A36 are
independent of B1 value (see Figures 5.7 and 5.8).
Figure 5.5 examines the laterality of these results. In this analysis, the five subfields of the
hippocampus are treated separately between right and left hemispheres of the brain. A high
degree of lateral symmetry is observed in the gluCEST values of the larger subfields – CA1,
dentate gyrus (DG), and subiculum – with the measurement being less stable in the smaller
subfields CA2 and CA3. We observe that the elevated gluCEST of the dentate gyrus is apparently
a bilateral effect. The bottom portion of Figure 5.3 shows the distributions of the CA1 and DG
Figure 5.5: Comparison of gluCEST
values in left and right
hippocampal subfields. Top: This
boxplot is analogous to those in 5.3,
although rather than combining the
corresponding measurements on
the left and right sides of the brain,
we inspect each separately. It can
be seen from this plot that the
gluCEST distribution in the dentate
gyrus is higher than in the other
subfields to a corresponding degree
on both sides of the brain. Bottom:
Histograms corresponding to the
distribution of gluCEST values in
CA1 and dentate gyrus of each
laterality.
measurements – the same data shown in the box and
whisker plot-- as histograms. Table 5.1 lists the means, standard deviations, and number of
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difference between all of the MTL subfields.
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2730

962
3928
2738
160
307
1823
2108
1507

No. of Pixels

3195

1498
4697
2417
148
415
1718
2077
1214

0.704156
0.604828
0.744297
0.747592
0.806718
0.761022
0.752822
0.794175

8.79
8.66
10.18
10.29
9.99
10.96
9.69
9.38

9.85

9.68
9.21
10.29
10
9.78
10.88
9.82
9.66

Mean gluCEST

0.767093 0.772551 9.99

0.694146
0.616555
0.741667
0.722587
0.78346
0.749962
0.753862
0.760571

Mean B1

2.56

2.59
2.64
2.41
2.38
2.08
2.34
2.94
2.49

2.4

2.49
2.56
2.26
1.65
2.1
2.02
2.87
2.21

St. Dev, gluCEST

Table 5.1. GluCEST means and standard deviations by segment. The first column lists the number of pixels
included in the analysis vector (corresponding to the box and whisker plots in Figure 5.4; in Figure 5.5, right and
left sides are combined). The next columns show the mean relative B1 amplitude and gluCEST of the segment,
with the standard deviation of the gluCEST measurement listed in the last column. Differences in the number of
pixels included in a particular ROI largely arise from differences in slab placement relative to subject anatomy
and head position.

A35 (Perirhinal Cortex)
A36 (Perirhinal Cortex)
CA1 (Hippocampus)
CA2 (Hippocampus)
CA3 (Hippocampus)
Dentate Gyrus
Entorhinal Cortex
Parahippocampal
Cortex
Subiculum

Left/Right
Segment Name

Table 5.1: GluCEST values measured in Medial Temporal Lobe subfields of healthy subjects (n = 10)

pixels included

in the vector

of all

segments as

well as the

corresponding

average

relative B1

value over the

segment.

Having

observed

higher gluCEST

in the dentate

gyrus by

examination

of the mean

values and

distributions

in all the

subfields measured, we sought to perform a statistical test that would confirm the observation

more quantitatively. To this end, an unpaired T-test was performed evaluating the mean

Figure 5.6 represents the results of this T-test in the form of colormaps showing the 99%

Figure 5.6. T-test for statistically significant difference in gluCEST between segments:
confidence interval colormaps. The upper or lower 99% confidence intervals of the mean
difference between two segments is shown as the corresponding matrix element. For
example, the cursor is placed on the matrix element corresponding to the mean
difference in gluCEST between the Dentate Gyrus (DG) and the Parahippocampal Cortex
(PC). The results of this T-test indicate with 99% “confidence” that the DG has average
gluCEST between 1.27 and 1.57 contrast units (% asymmetry) higher than the PC.
confidence intervals for the difference between mean values. The colormaps shown here
represent these upper and lower values, C1 and C2, which estimate the difference between
segment A and segment B, in a form analogous to a matrix or look-up table. The diagonal
elements of each colormap are zero, as these elements represent the difference in mean
between one segment and itself; corresponding elements reflected across the diagonal are
additive inverses: (segment A – segment B) or (segment B- segment A). While most elements of
the colormaps are filled with values close to zero (and colors close to green), the row and
column representing gluCEST of the dentate gyrus exhibit a robust trend of higher mean value
relative to all other segments shown. For example, the cursor in Figure 5.6 is placed on the
matrix elements representing the 99% confidence interval for the quantity (mean gluCEST,
dentate gyrus – mean gluCEST, parahip. cortex), giving the values 1.27 and 1.57. The estimate of
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a 1.27-1.57 % contrast difference between these two segments agrees well with the differences
in mean value calculated for each side (see Table 5.1): 10.96 - 9.38 = 1.58; 10.88 - 9.66 = 1.22,
respectively.
5.3.2 GluCEST findings are independent of B1 amplitude
Figure 5.7 shows average values of gluCEST (top) and B1 amplitude (bottom) for all subjects,
projected onto the anatomy of a single subject for visualization. The color of each segment

Figure 5.7: Segmentwise maps of average B1 strength and gluCEST. The color of each
segment represents the average value over all pixels from this segment in all ten subjects.
Top: Average gluCEST (%) by segment. The dentate gyrus, which has the highest average
gluCEST is displayed in red, corresponding to its value. Some asymmetry is observed
between the right and left sides in the perirhinal cortex (most inferior segments); this is
likely due to the asymmetry of the B1 distribution in this part of the headcoil. Bottom:
Average relative B1 amplitude by segment. It can be observed that while there is some
inhomogeneity in the B1 amplitude over the MTL region, the gluCEST differences seen
within the hippocampal subfields – such as the elevated gluCEST in the dentate gyrus – to
not appear to reflect or originate from corresponding B1 amplitudes.
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represents the average value over all pixels from this segment in all ten subjects. This
visualization allows for an appreciation of the gluCEST ‘hot spot’ of the dentate gyrus, and also
to illustrate the independence of the gluCEST measurement in the hippocampal subfields from
the B1 distribution – which is quite uniform—in this region. In contrast, this representation does
suggest, as posited above, that the lower gluCEST measured in A36 likely reflects the lower
average B1 in this segment.

Figure 5.8 : Relationship between average gluCEST and B1 amplitude.
While the ‘gluCEST as a function of B1’ plot appears to be flat in the
range of average relative B1 > 0.7, the data points representing segments
A35 (pink rectangle) and A36 (purple rectangle) of the perirhinal cortex –
the most inferior of measured subfields-- on either side are separate
from the cluster of remaining segments.

Figure 5.8
examines this
relationship

between relative B1 and gluCEST. The two quantities (as listed in t Table 5.1) are plotted against
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each other for each segment in the scatterplot. This plot appears to have no slope-- at least for
the segments (all except A36) for which the average B1 is > 0.65.

5.4 Discussion
Elevated gluCEST in the dentate gyrus: literature precedents and interpretation
Using a newly developed volumetric (3D) gluCEST protocol, we detected a statistically
significantly higher glutamate signal in the dentate gyrus relative to other MTL subfields.
This is a novel finding enabled by the unique spatial resolution of gluCEST, but appears to be
consistent with current knowledge of the neurochemistry in the MTL. It is generally understood
that glutamate signaling is especially important in the medial temporal lobe, and that this high
degree of excitatory signaling is correlated with synaptic and neural growth, plasticity, and
memory formation. Moreover, the dentate gyrus is known to have roles distinct from other
nearby subfields, amongst which it has been hypothesized that the DG may be the sole location
of neurogenesis within the hippocampus. Our finding of slightly increased glutamate in the DG
relative to other MTL subfields corroborates the paradigm that neurogenesis occurs
preferentially in the dentate gyrus and is strongly dependent on glutamate signaling.
The closest precedent for this work was that of Crescenzi et al, who performed gluCEST imaging
in murine models23. In this work, the authors detected an apparent k-means clustering of
gluCEST signals from the hippocampus, corresponding to known functional subregions which
have analogs in the more complex human structures. While the focus of this paper was
differences between wild type mice and those with a genetic variant making them prone to
neurodegeneration, the relatively elevated gluCEST signal in the dentate gyrus compared to the
other regions held throughout mice of varying ages and in both populations. Along with
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corroborating mechanistic understanding of the neurogenic role of the DG, the consistency of
these results suggested a robust phenomenon likely conserved in the brains of other mammals.
It is worth noting explicitly the difference in regional analysis which produced the results of each
of these studies: In Crescenzi et al, pixel values were clustered by k-means algorithm blind to
their location in the image, and then these ‘cluster masks’ were visualized and found to
correspond with anatomical regions. In this paper, recently developed high-resolution
hippocampal subfield segmentations were registered to the CEST maps in order to classify pixels
directly into their anatomical structures. The degree to which ‘reslicing’ the anatomical image
into the grid of the CEST acquisition caused a decrease in resolution can be visualized in Figure
5.6, where some coarseness of the pixels is still apparent, particularly in the vertical (non-axial
dimensions), in which the resolution of our gluCEST acquisition is only 2mm.
With continued collection of MTL gluCEST data using the present protocol or an updated
iteration, we hope to document the MTL subfield gluCEST distributions on a full range of healthy
subjects throughout the lifespan. Expansion of the current results will provide powerful insight
into basic neurophysiology, and form a baseline reference to which results on aging,
neurodegeneration, and other sources of variability can be compared.
3D gluCEST as a method to map neurochemistry: strengths, shortcomings and ongoing
improvements
At the moment, we believe that 3D gluCEST is the leading option for spatially resolved in vivo
measurements of glutamate. The other 1HNMR based option is spectroscopic imaging, whereby
a spectrum is acquired in each voxel and fit for the components representing each metabolite.
At 7T it has been argued that spectroscopic imaging is able to produce spectra in which
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glutamate and glutamine can be resolved42. Hingerl et al, for example, report maps of glutamate
and glutamine fit separately in an MRSI map with 3.8 x 3.8 x 3.8 mm3 voxel size, although there
are some features of these results which are difficult to interpret. Moreover, this does not
match the spatial resolution of the gluCEST protocol attained here (1 x 1 x 2 mm3). Likely, their
approach could meet this resolution, but with extended scan time that would exceed the limits
of human subject scanning. Their work does not attempt substructure analysis of the resulting
measurements, but it would be of interest to compare results from gluCEST and such state of
the art spectroscopic imaging methods, should comparable resolution be achieved.
On a practical level, for a few reasons there is a very high value of using a volumetric 3D slab as
in this report –rather than a ‘single slice’ acquisition – in clinical CEST studies. Firstly, one simply
captures more pixels per subject, lending greater statistical power for detecting what generally
are quite subtle effects. Indeed, it is only severe pathology that could lead to a change in
glutamate concentration on the order of multiple mM. For example, we would not have been
able to confidently distinguish the elevated gluCEST signal from the dentate gyrus, as reported
here, using a 2D imaging slice. Secondly, brain anatomy differs from person to person, and
‘single slice’ imaging studies invariably capture uneven and sometimes incomparable cross
sections between subjects, despite the best practice of the experimenter. Lastly, CEST is
extremely sensitive to subject motion, given that the final image is derived from multiple
acquisitions fed as input into a multi-step post-processing pipeline in which there must be voxelto-voxel correspondence. In the event of motion, unlike 2D slices, 3D volumes can be registered
to each other to some degree, making the 3D experiment more motion-robust.
A weakness of gluCEST is its high sensitivity to B1 inhomogeneity37. The physics of the headcoil at
7T are such that standing waves generate large B1 variations over the brain, with a particularly
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problematic drop-off of the B1 amplitude in the inferior portions. The larger the field of view of
the gluCEST image, the wider range of B1 inhomogeneity present, and imaging inferior portions
of the medial temporal lobe adequately previously posed a challenge. A recent update to our
post-processing correction for B1 inhomogeneity improved the quality of the images we were
able to generate using this 3D acquisition and increased our confidence in their accuracy.
Nonetheless, in the current analysis we took several steps to ensure that the findings did not
reflect residual influence of B1 inhomogeneity. While we believe the relative signals of the
hippocampal subfields to be a true finding, we remain suspicious of the apparently lower signal
in the A36 region of the perirhinal cortex, as this location is clearly plagued by lower B1
amplitude than the remaining anatomy. Fortunately, preliminary results (not presented here)
indicate that application of high-dielectric padding may mitigate the remaining problem in this
region.
Until recently, we considered this B1 inhomogeneity to be a major factor limiting our ability to
expand gluCEST to a whole brain acquisition. However, in light of the demonstrated progress in
B1 post-processing correction (See Chapter 2), as well as the improvement afforded by use of
high-dielectric padding (see Chapter 5A), B1 inhomogeneity no longer represents the major
challenge to expanding the coverage of gluCEST. Rather, meeting reasonable limitations on scan
time is the major impediment to whole-brain imaging in a single session.
As with any imaging protocol, optimizations can be performed regarding the k-space sampling
during the readout of the CEST sequence to allow for faster acquisition. However, a CEST
acquisition presents a particular challenge on this front, as it relies on a saturation module
which precedes the readout. The effect of the saturation pulse - -that is, the resulting CEST
contrast – begins to decay when the saturation module is over. Thus, k-space points collected
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later in the readout module contain less of the desired contrast than those collected earlier, in
addition to any such considerations regarding the inherent contrast (PWD or T1-weighted) of the
readout module itself. At some point, this signal decay becomes limiting, and we must perform
the imaging in multiple ‘shots’; that is, more than one iteration of (saturation + readout) in order
to cover all desired k-space volume. For our current 12 slice acquisition, we use two such shots.
Obviously, the need for repeating the saturation pulse exacerbates the existing need for
accelerating the acquisition. Computational mitigation of this decay is possible to some degree:
one can correct for the decay of the saturation during the pulse train, provided one has
estimated the kinetics of this process. However, like post-processing B1 correction, this is limited
by the fact that, at a certain point, the signal is simply absent.
In principle, one could elect to expand our existing protocol to provide full-brain coverage with
sacrifice of in-plane resolution. (The isotopic resolution of recently published full-brain APT CEST
in the literature, for example, is lower than that of our gluCEST acquisition.43,44) However, we
generally consider that in most cases, the scientific benefit afforded by increasing resolution
more quickly exceeds that of expanding volume coverage -- although this, of course, this
depends on the application. One can imagine that for a localization-type problem (e.g. finding an
epileptic focus), very high resolution may be less important than covering more volume, if
location is uncertain. On the other hand, an analysis of very small substructures like the one
presented here could yet benefit from finer resolution.
Lastly, for gluCEST, it is imperative to have B0 and B1 maps accompanying the CEST acquisition.
Thus the additional time needed for acquiring more volume is multiplied by the need for also
expanding the coverage of these mapping techniques. For B0 mapping, a WASSR scan is
approximately equivalent to a CEST scan in terms of temporal duration per volume. It would be
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optimal to use faster phase-based field mapping techniques, provided we can ensure that the
resulting B0 map is of equivalent accuracy. Replacing the field mapping step is amongst the
protocol updates currently being tested.
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5.5 Supplementary Information and Appendices to Chapter 5
5.5.1 Specifications of the 3D gluCEST sequence: comparison with 2D
Table 5.S1 Pulse sequence
2D gluCEST:
3D gluCEST
parameters
-B1 calibration data
-TMS
-MCI
Base sequence
‘prep MOCO’
‘prep TFL’
(gradient-recalled echo)
(turbo-FLASH)
Additional sequence notes
--spoiled gradient-echo
acquisition, modified to
include two saturation
modules
--elliptical k-space acquisition
with combined slice and
phase-encode spiraling
--GRAPPA acceleration factor:
2
TR, shot TR
4.7ms, (N/A, single shot)
3.5ms, 6s
TE
2.3ms
1.79ms
Flip angle
10°
6°
Field of view
In-plane resolution
In-plane grid size
Saturation offset frequencies
(Z-spectrum points) acquired,
ppm relative to water
Saturation B1 strength
(nominal), RMS
B1 pulse shape
Saturation pulse duration
Saturation pulse duty cycle
Saturation ‘shots’ per
acquisition
Slices per acquisition
Slice thickness
Total thickness acquired

156 x 192 x 5 mm
0.75 x 0.75 mm
256 x 208
± {1.8, 2.1, 2.4, 2.7, 3.0, 3.3,
3.6, 3.9, 4.2}

240 x 180 x 24 (or 32) mm
1 x 1 mm
240 x 180
± {1.8, 2.1, 2.4, 2.7, 3.0, 3.3,
3.6, 3.9, 4.2}

210Hz (3.1µT)

210Hz (3.1µT)

Hamming window
800ms
95%
1

Hamming window
800ms
99%
2

1
5mm
5mm

12 or 16
2mm
24 or 32 mm

Author’s note: These pulse sequences were developed by Drs. Keija Cai, Mohammad Haris, Anup
Singh, Hari Hariharan, Neil Wilson and others at the Center for Magnetic Resonance and Optical
Imaging, U. Penn., 2012-2020. The work presented in this thesis centers on understanding the
physical and chemical origin of the gluCEST signal, its dependence on saturation power, postprocessing and analysis strategies for the acquired images, and resulting findings. Credit for the
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programming of the sequences per se is due to the aforementioned individuals, whose
contributions are gratefully acknowledged.
5.5.2 Volumetric (3D) gluCEST facilitated by mitigation of B1 inhomogeneity using dielectric
padding
5.5.2.1 Introduction
As previously discussed, B1 inhomogeneity is an inherent problem in brain imaging at ultra-high
field because of the comparable dimensions of the RF wavelength and the human head. CEST
methods rely on the B1 field to create endogenous but transient contrast by applying a
metabolite-selective saturation pulse. CEST is therefore significantly more vulnerable to
B1 inconsistencies than most imaging sequences. Glutamate-weighted gluCEST is particularly
challenging in this regard because, due to the fast exchange of its proton with water, it both
requires ultra-high field (7T) and high (~3uT) B1 strength to generate adequate contrast. In
moving from single-slice (2D) imaging to volumetric slabs (3D), the absolute spread of
B1 amplitude over the field of view increases and, because one now needs to collect more points
in k-space per saturation pulse, the minimum B1 amplitude required to maintain glutamatederived contrast at an acceptable level increases.
So far, we have discussed post-processing correction for B1 inhomogeneity in gluCEST. However,
the fruitfulness of post-processing is of course limited by the content of the acquired signal
itself. Investigators using gluCEST – and even those performing structural and functional imaging
at 7T -- have struggled with the severe B1 drop-off in the inferior and anterior parts of the brain.
Apart from ‘in silico’ post-processing solutions, there are two main categories ‘physical’
solutions to this problem: doing something differently with the RF hardware (as in parallel
transmit), or doing something to change the physics of the RF propagation itself once it leaves
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the coil. The latter concept gave rise to the approach of using high-dielectric paddings to
manipulate the effective geometry of the “sample”, i.e. the human head, inside the coil. This
approach is gaining popularity in the MR research community but remains investigational for
reasons of safety and reproducibility.
Here we present 3D gluCEST data that has been improved by the use of dielectric pads to
augment the B1 amplitude during acquisition. While dielectric pads have already been adopted
in several 7T imaging studies, including NOE and APT CEST measurements7,20,21, their utility for
glutamate imaging specifically has not yet been explored, despite the fact that this an
application where they could make a particularly key improvement.
5.5.2.2 Methods
All images were obtained on a 7.0T scanner (MAGNETOM Terra, Siemens Healthcare, Erlangen,
Germany) outfitted with a single volume transmit/32 channel receive phased array head coil
(Nova Medical, Wilmington, MA, USA). Five volunteers ages 24-39 were scanned with informed
consent under local regulatory supervision. Dielectric pads used were composed of CaTiO3 in
D2O (7TNS, Multiwave Imaging, Geneva, Switzerland). By positioning the three dielectric pads
around the subject’s head --including, in deviation from manufacturer's instructions, some
mask-like coverage of the face -- we were able to expand the portion of the image which has
relative B1 > 0.4, which we use as a threshold for useability in gluCEST measurements. (Images
are still subjected to post processing correction for B1 inhomogeneity.) All gluCEST postprocessing, including B1 correction, was done as previously described.

178

5.5.2.3 Results and Discussion
Figure 5.S2 Left and middle: Dielectric (DE) pads shown by themselves and positioned
relative to a subject (head coil not shown). When used with the 32-channel headcoil, the
pads are held snugly curved around the subject's head, with the lateral pads partially
covering the jaw, cheekbones and eyes beneath the coil visor. Right: B1 map measured in
deep axial slice including the hippocampus and surrounding structures. Upon use of DE pads,
the B1 map is significantly improved in the anterior portion of the head, which is poorly
covered by the coil.

Figure 5.S2 illustrates the pads themselves, and a deep axial slice acquired with and without
their use. The maps are scaled such that areas which receive B1 amplitude insufficient to
generate valid gluCEST signal are colorless. It is clear from this comparison that application of
the pads decreased this ‘lost’ portion of the image, although the asymmetry of headcoil
performance between the right and left sides remains obvious. Presumably, the protocol could
be optimized such that asymmetric placement of the pads themselves is able to compensate for
this inherent standing wave pattern in the headcoil. Such experimentation, aided by modeling
for the RF distribution, is amongst future work.
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Figure 5.S3 shows single slices of 3D gluCEST acquisitions, now in the coronal view, with and
without use of the pads. The coronal images reflect that the improvement of the B1 profile
afforded by the pads is not uniform over the field of view: in fact, although the inferior portion is
improved as in the axial slice in Figure 5.S2, the B1 in the upper part of the head has actually
decreased, arguably to a problematic degree. The images in Figures 5.S2 and 5.S3 were
acquired with the same positioning of the high-DE pads relative to the subject, despite the fact
that the orientation of the target slab was different. Until we reach a stage where full-brain
acquisitions are standard for gluCEST, it likely makes sense to attempt optimization of pad
positioning for each orientation.
Our results to date indicate that the effects of the high-DE padding is quite sensitive to their
positioning, meaning that while they may be an indispensable tool for improving image quality,
a great deal of optimization and protocol standardization will be required in order to achieve
reproducible results. Moreover, we are optimistic that collaboration with the manufacturer will
lead to designs that are more comfortable for subjects, as this has been a challenge with the
Figure 5.S3 Dielectric pads improve B1
maps (top) and therefore gluCEST images
(bottom) in problematic regions. Left: B1
map and corresponding CEST image
acquired without the use of dielectric
pads. Color scale in the B1 maps is from
0.5 – 1.0 relative B1 strength and
transparent from 0 – 0.5, to highlight
areas where nominal B1 is less than 50%
and gluCEST signal is very low or
absent. Despite post-processing
correction, CEST remains low where B1
falls below the indicated range. Right: B1
map and corresponding CEST image
acquired on the same subject, using
dielectric pads positioned roughly as
shown in Figure 5.S2.

current design and further aggravates
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reproducibility issues. Stipulating these improvements, the primary advantage of high-DE pad
use is to bring areas of the field of view which otherwise have almost no gluCEST contrast into a
regime where signal emerges and can be adjusted by post-processing correction. In typical
circumstances, areas affected by the presence of the pads exhibit up to a 50% increase in
B1 amplitude and ~500% increase in gluCEST signal. In our view, parallel transmit (not
implemented here), dielectric padding and post-processing correction are likely all necessary to
produce volumetric gluCEST images of the highest possible quality, particularly in full-brain or
near-full-brain acquisitions.
5.5.3 Example 3D CEST images
The following pages provide example images acquired using the 3D gluCEST pulse sequence
described in 5A.1 and post-processed according to the procedure introduced in Chapter 2. In
both example images, 12 slices out of a 16 slice acquisition are presented. They represent the
highest quality images currently attainable with this gluCEST acquisition and post-processing
protocol, with and without the use of high-dielectric padding. Snapshots from the two
orthogonal views are provided below. The colormap corresponds to the snapshot shown in (A)
from the ITK-SNAP contrast inspector, which also indicates the histogram of the CEST values in
the image corresponding to the colorbar.
A) Oblique/axial slice, no high-DE pads. 23 year old female. Overlaid with T1-weighted (MPRAGE)
full-brain structural scan. Filtered: Gaussian filter, kernel size = 2. B) Coronal slice, high-DE pads
used (complete acquisition including image featured in Figure 5A.3, bottom right) . 35 year old
male. Overlaid with localizer image (low-resolution structural), as MPRAGE or other structural
image was not acquired here. Unfiltered.
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Figure 5.S4. Orthogonal views corresponding to 3D CEST acquisitions
featured on the following pages. Left: Sagittal and coronal views of image
series A. Right: Axial and sagittal views of image series B.
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Figure 5.S5A
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Figure 5.S5, B
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Chapter : Integrating 1H RS and deuterium labeled
glucose for mapping the dynamics of neural metabolism
in humans
Preface
So far, this thesis has focused on gluCEST, a proton-density weighted imaging technique with
underpinnings in chemical exchange. Despite offering many interesting new possibilities for
molecular imaging, gluCEST and other exchange-based modalities still fail to address a major
challenge in medical imaging: how to capture dynamic information. As will be explained in the
Introduction to Chapter 6, proton-based in vivo magnetic resonance spectroscopy, the other
major option for MR-detection of specific chemicals, also failed to address this challenge for
many years. The work presented in this chapter deviates from the realm of CEST imaging to
expand our quest for imaging glutamate and related metabolism into the dynamic, temporal
dimension. While the presented technique, qCSI, is currently quite incomparable to gluCEST in
terms of spatial resolution, it has several advantages over non-proton MRSI methods for
measuring dynamics of metabolism. The ability of qCSI to detect and visualize the dynamic
metabolism of glucose to glutamate provides a deeply complimentary source of information to
gluCEST. In the future, qCSI and gluCEST could be used in tandem to provide next-generation
precision diagnostics for patients suffering from neurological maladies with metabolic etiology.

6.1 Introduction
For the past century, the study of cellular metabolism has revolutionized our understanding of
biological energy production, phenotypic variation, and disease etiology. With the advent of
non-invasive medical imaging technologies, continued efforts have focused on expanding the
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capabilities of such technology to provide information beyond structural and mechanistic
aspects and into the realm of molecular biochemical and physiological insights1.
Despite the obvious appeal of such goals, the only metabolic imaging technique used routinely
in the clinic is positron emission tomography (PET), which provides information reflecting tissue
glucose uptake after infusion of the radioactive glucose analog 2-18F-fluoro-2-deoxy-D-glucose
(18FDG)1,2. PET is most commonly applied in clinical oncology, where elevated glycolytic
metabolism in cancer cells enables visualization of both primary and metastatic lesions in
patients3. However, while PET provides insight into tissue glucose uptake, it does not provide
any further information about downstream glucose metabolism. An alternate metabolic imaging
method both capable of monitoring downstream metabolism and not reliant on ionizing
radiation would be preferable in many instances.
While conventional MRI is non-ionizing and provides exceptional anatomical information, it
offers only limited insight with regard to metabolism. As introduced in previous chapters, CEST
is an emerging suite of MRI methods capable of detecting endogenous metabolite levels in both
normal and diseased tissues4. However, CEST is also limited in its ability to measure the
dynamics of metabolite turnover4–6.
Spectroscopy, which is built on the same fundamental physics as magnetic resonance imaging,
allows for chemically specific detection of small molecule metabolites7–9. While standard clinical
MRI measures the signal generated from protons (1H) on water and fat to generate bulk
structural images of the body, MRS generally suppresses these signals in order to measure much
weaker signals generated from protons on less abundant molecules, including key metabolites
such as N-acetyl-aspartate (NAA), choline, creatine, glutamate (Glu), glutamine (Gln), 190

aminobutyric acid (GABA), and lactate (Lac). Still, a major limitation of current 1H MRS based
approaches is that they only provide static measurements of metabolite concentration and as a
result are unable to assess changes in tissue metabolic rates that are not reflected in a change in
steady state concentration.
To date, the primary strategy to generate dynamic information using MRS has been to use
exogenous (non-radioactive) isotope-labeled substrates that are administered to the patient or
subject.

13

C MRS using costly 13C labeled substrates like glucose and acetate has been used

extensively to measure metabolic flux both in isolated cells and in vivo 10–12. Despite this, the
clinical application of 13C MRS has been limited owing to the requirement for additional scanner
hardware. Moreover, while hyperpolarization techniques can be employed to achieve improved
sensitivity of 13C 13,14, these approaches require further specialized equipment and technical
expertise. Recently, there has been growing interest in the use of deuterium (2H) as an
alternative to 13C for metabolite labelling studies 15–17. In deuterium MRS (DMRS), the protons
on glucose or acetate are replaced by deuterium, and as these substrates are metabolized the
deuterium label is transferred to the downstream metabolites which can then be detected by
deuterium MRS (DMRS).
Although 13C MRS and DMRS offer unique solutions to measure metabolite turnover, the
capability to detect any nucleus other than 1H is generally not available on clinical MRI
systems18. Detection of these nuclei requires specialized coils for transmission and reception
that must be designed with additional expertise or otherwise are purchased at an additional
cost. Hardware availability aside, there are also inherent physical advantages of proton
spectroscopy over DMRS: 1H has a gyromagnetic ratio (γ) almost seven times higher than 2H.
Because both the spin energy gap itself and the Larmor frequency are functions of γ, both the
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sensitivity and the spectral resolution of the 1H spectrum are higher than for 2H. Thus, while
DMRS has the advantage of very high specificity for the introduced substrate and lack of
nuisance signals, it is difficult to resolve the plurality of metabolites which are generated further
downstream upon absorption of glucose or acetate.
Given these limitations, we sought to develop a 1H MRS method that increases the sensitivity
and versatility of MRS for measuring metabolic dynamics without the need for specialized
hardware or radioactive tracers. To this end, we recently introduced quantitative exchangedlabel turnover (QELT) MRS or qMRS, a method that detects deuterium labelling of metabolites
by measuring the reduction in 1H MRS signal after administration of deuterium labelled
substrates19. Building on our preclinical qMRS studies, here we demonstrate the potential of the
analogous spectroscopic imaging technique, qCSI, for monitoring the dynamics of neural
metabolism in healthy human subjects after oral ingestion of deuterated glucose. Since
deuterium labelled glucose is non-toxic16,20 and can be easily administered orally, this approach
is safe and straightforward for use in human subjects. Given the universal availability of 1H MRS
on clinical scanners and its ability to detect several biologically relevant metabolites, we
envision an expansive translational potential for this technique.

6.2 Materials and Methods
6.2.1 Human subjects information
This protocol was approved by the Institutional Review Board at the University of Pennsylvania,
with informed consent obtained prior to the initial scan. Eight subjects participated in this study:
four male and four female, ranging in age from 23-52 years, with a mean age of 32 years. Full
chemical shift imaging timecourses were collected on four subjects, two of each sex. Remaining
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subjects participated in SVS, single-timepoint CSI acquisitions, or non-deuterated glucose
experiments.
Volunteers were scanned during two sessions on separate days: one ‘baseline’ measurement,
and one measurement after oral deuterated glucose ingestion. For both sessions, the volunteers
fasted overnight before undergoing studies in the morning. Baseline scanning sessions lasted
approximately 45 minutes. In the second session, subjects were scanned for approximately two
hours, beginning directly after oral ingestion 0.8g/kg of body weight of [6,6′-2H2]-glucose
dissolved in water. This oral preparation was provided by the pharmacy service of the Hospital
of the University of Pennsylvania, based on the self-reported body weight of each participant.
To ensure normoglycemia, blood glucose testing was performed on all subjects before the
baseline session, and both before and after the glucose-ingestion session. To evaluate the
choice of glucose dosage, in four subjects a full time-course of blood glucose measurements was
also performed upon ingestion of an equivalent amount of non-deuterated glucose (Glucon-D,
Dabur, Inc.). Testing was performed using standard home blood glucose monitoring equipment
(Accu-check, Roche Diabetes). Results shown in Supplementary Figure 6.S4 show some intersubject variability in blood glucose levels, but with all subjects returning to baseline glucose
levels within 2 hours.
6.2.2.MRI acquisition methods
MR experiments were performed on a 7T scanner (MAGNETOM Terra, Siemens Healthcare,
Erlangen, Germany) equipped with a 1Tx/32Rx head coil (Nova Medical, Wilmington, MA, USA).
Axial T1-weighted FLASH images were obtained to enable localization of the cortex. Following
localization, spectroscopy data were acquired using custom sequences for CSI with sLASER
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localization (MRSI) 21,22and SVS with PRESS localization23. Localized shimming was performed to
obtain water line widths of 0.08 ppm or less. Water suppression was achieved using variable
pulse power and optimization relaxation (VAPOR) pulse cluster24 pre-encoded to the PRESS
sequence.
Specifically, SVS in two voxels and two MRSI measurements of the encompassing slab were
performed in the baseline session. In the second (post-glucose) session, SVS measurements in
two voxels were performed directly upon positioning the subject in the scanner (t = 20-30 mins
post-ingestion), with six subsequent MRSI acquisitions (t = 50, 60, 70, 80, 90, 100 mins) and one
additional pair of SVS acquisitions (t = 120 mins) at the end of the experiment. Voxel sizes of
MRSI and SVS were 10 x 10 x 10mm (before interpolation) and 40 x 10 x 10 mm, respectively.
Intrasubject registration between session was accomplished using an in-house co-registration
program, ImScribe (available at https://www.med.upenn.edu/cmroi/imscribe.html), as
described in previous work27.
Sequence parameters were as follows:
SVS: TR/TE = 3000/23 ms, spectral width = 4 kHz, averages = 64, scan time = 5 min. In each
instance, an additional spectrum with 8 averages was acquired without water suppression to
obtain a water reference signal for quantification and eddy current correction.
CSI: TR/TE = 2050/40 ms, spectral width = 4kHz with 2048 points, averages = 4, FOV = 160 x
160mm x 10 mm slice thickness on a 16 x 16 grid, interpolated to 32 x 32. The sequence
incorporated elliptical weighting with Hamming-windowed spatial filtering. This resulted in a
true voxel size ~2.7x larger than the acquired volume, but removed Gibbs ringing associated
with the lower resolution scanning.
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6.2.3 Quantification and data analysis
Metabolite concentrations measured by in vivo 1H MRS were quantified using LCModel software
(v.6.3) 28. Custom basis sets were simulated using specific timings and pulse shapes of the
refocusing pulses in the custom sequences29,30 . For the PRESS sequence, a spatial distribution of
20 x 20 locations covering the voxel were simulated and summed to take into account the
effects of chemical shift artifacts caused by relatively low bandwidth refocusing pulses. In order
to account for the difference in spectral patterns that occur when glutamate becomes
deuterated, two additional metabolites representing single proton replacement and double
proton replacement were also included. For the former, it has been noted16 that replacement
can occur on either the H4 or the H4’ glutamate proton with equal probability. Here we have
chosen to include the H4 proton replacement simulation as the spectral patterns of both are
very similar for typical in vivo linewidths (shown in Figure 6.S1). For the double proton
replacement case, both the H4 and H4’ glutamate protons were replaced with deuterium. Exact
coupling constants involving deuterium nuclei were not known, though D-H couplings are
typically 1-2 Hz. In Figure 6.S1, we show that the spectral differences at in vivo linewidths are
minimally dependent on D-H coupling over this range and chose 1.5 Hz for the basis set. All fits
were performed over the spectral range from 0.5 to 4.2 ppm. While our previous paper
presenting experimental data from rats showed changes in GABA and Gln, preliminary analysis
in humans did not observe those same effects. Therefore, no deuterated versions of these
metabolites were included in the basis set.
Metabolite ratios to NAA were reported as NAA does not show signal changes after deuterated
glucose ingestion (see Figure 6.3). For CSI, ROIs representing primarily grey matter and primarily
white matter were manually drawn on the Glu to NAA ratio map, and individual fits over the
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ROIs were averaged. Representative ROIs are shown in Figure 6.2 overlaid on the baseline
image. .

6.3 Results
The very first experiments in which we observed the qMRS effect upon subject ingestion of
deuterated glucose were single voxel spectroscopy experiments at 3T and 7T31. Comparing only
one pre-ingestion and one post-ingestion acquisition, we observed visually apparent decrease of
the main glucose resonance at 2.3ppm in mostly gray matter voxels. An example pair of such
spectra is shown in Figure 6.1C. We sought to extend this measurement to a form which
proffers some degree of spatial and temporal resolution, and continued experiments using a
semi-LASER based CSI sequence at 7T, collecting sequential post-ingestion timepoints to create
CSI map timecourses which can be viewed with respect to any of the fitted resonances in the
basis set. Figure 6.1 shows spectra from selected voxels intended to be mostly gray (A) or most
white (B) matter and illustrates the presence of the same decrease observed in the SVS data.
Figure 1D illustrates the simulated proton resonances of deuterated glutamate species which
were included in the basis set used to fit the qCSI data.
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Figure 6.1. Spectroscopic underpinnings of qCSI. A,B) Example spectra from two CSI voxels
(A,B, as shown in white boxes overlaid on image) showing decrease in main Glu resonance.
C) Corresponding decrease observed in experiments with a larger SVS voxel. D) Simulations
of glutamate elements in the basis set for fitting of semi-LASER data, including unlabeled
Glu (top), singly-labeled [2D,1H]-glutamate-4 (middle), and doubly-labeled [2D2]-glutamate4 (bottom).

The resulting timecourses from qCSI can be visualized as in Figure 6.2, in which the colormap
corresponds to the ratio [Glu]/[NAA] as fit in each voxel. This subject exhibits a strong decrease
in the unlabeled Glu signal in the central gray matter region as well as rather dramatic decreases
in certain regions of white matter. This reflects that neural glutamate present at baseline has
been replaced by newly synthesized, labeled glutamate upon metabolism of the ingested
glucose. Timecourses of the [Glu]/[NAA] map for the remaining subjects are available in Figure
6.S2.
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Figure 6.2. Example
timecourse, CSI
maps of [Glu]/[NAA]
from a single subject.
Approximate gray
and white matter
ROIs as analyzed
further are indicated
on the baseline
image.

Figure 6.3 shows data from a different subject in the form of
barplots. NAA is plotted normalized to its initial value, while
glutamate and derivatives are plotted as a ratio of their LC-model

reported concentration to that of NAA. Even in individual subjects, the trend of decreasing
unlabeled glutamate is robustly apparent in both gray and white matter ROIs. The appearance
of the labeled derivatives was less consistent, but the appearance of singly-labeled [2D,1H]glutamate-4 was detectable with statistical significance in both gray and white matter when all
subjects’ data were taken together. Barplots analogous to those in Figure 6.3 are available for all
subjects in Figure 6.S3.
Figure 6.4 shows the group averages (n = 4 subjects) over time of the Glu, [2D,1H]-glutamate-4
and doubly labeled [2D2]-glutamate-4. In taking data from all subjects, nearly all timepoints
show statistically significant difference from baseline with respect to measurements of
unlabeled (decrease) and singly unlabeled (appearance/increase) glutamate. In gray matter, a
generally monotonic trend is apparent over time, suggesting that even at this relatively long
time scale, we are still capturing the dynamics of a pathway that has not reached steady state.
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The doubly-labeled form of glutamate, as expected, appeared at a lower rate than the singlylabeled version. This quite low concentration made it difficult to detect robustly, but its
appearance provides further validation that we are indeed observing changes due to
downstream steps of glucose metabolism.
Tables 6.1 and 6.2 list the results (as a ratio of concentration relative to [NAA]) from all
metabolites by timepoint, as well as their standard deviation and the p-value of the paired Ttest which compared data from each timepoint to the baseline measurement.

Figure 6.3. [NAA] and ratios of glutamate varieties derived from CSI
data in a single subject. In all plots, data from gray matter ROI is
shown in the background, white matter ROI in foreground. Clockwise
from top left: [NAA], [Glu]/[NAA],
[(2D,1H)-glutamate-4]/[NAA], [(2D2)-glutamate-4]/[NAA].
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Figure 6.4. Ratios of glutamate/NAA derived from CSI data in all subjects. Stars
indicate a statistically significant difference from the baseline measurement.
Top: Data from gray matter ROIs. Bottom: Data from white matter ROIs.
Columns, left to right, are [Glu]/[NAA], [(2D,1H)-glutamate-4]/[NAA], [(2D2)glutamate-4]/[NAA].
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0
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GABA

Table 6.1
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0
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1.15E-05

Baseline

[2D2]-glutamate-4

[2D,1H]-glutamate4
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5.77E-37

0.314815 0.303783 0.289559 0.300469 0.300401 0.292885 0.303049
0.082496 0.08866 0.095685 0.095947 0.078866 0.091577 0.095838
0
0.407793 0.070393 0.30317 0.251569 0.106942 0.39782
0.129936 0.128
0.10285 0.124278 0.141418 0.114505 0.106092
0.076542 0.06451 0.05644 0.053602 0.055007 0.050979 0.054466
0
0.860332 0.010324 0.581948 0.268715 0.12829 0.022003

Gln

GABA

Table 6.2
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0
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matter
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6.4 Discussion
Building on our previously proposed method for indirectly measuring 2H metabolism using 1H
MRS in rats, the present work extends the method into human beings and uses CSI for greater
spatial coverage. While we are primarily interested in showing comparisons of gray and white
matter, CSI has the advantages of larger coverage with smaller voxel sizes compared to SVS and
could potentially provide more specifically localized information. However, due to nuisance
signals from skull lipids, we restricted our excited volume to a limited portion covering less than
half the brain. Also, we restricted our acquisition to a single slice to keep adequate temporal
resolution and to ensure more homogenous B0 and B1 fields over the VOI. This is particularly
important at UHF where whole brain spectroscopic imaging is more challenging. We believe that
some of the variability manifesting in the analysis presented here arises from the shortcomings
in our ability to accurately draw pure gray and white matter ROIs on a map of this resolution.
However, because of the coarse-grained visible differences in the map corresponding to these
tissue types, we nonetheless decided to perform regional analysis in this manner.
At 7T, sequences optimized for UHF should be used that have higher bandwidths to
accommodate the increased spectral dispersion and manifest greater robustness to B1 errors.
(Our initial implementation of human qMRS used an unoptimized, PRESS-based SVS sequence.
Because of this, quantifying small changes in overlapping metabolites was difficult even when
basis set simulations took into account specific RF pulse shapes and spatial localizations.) In
future improvements to the qCSI methodology, fast spectroscopic imaging techniques optimized
for UHF could be used to acquire higher resolution metabolic images that allow for larger
coverage and better separation of gray and white matter 32,33.
As expected, average qCSI-quantified glutamate values are consistently higher in gray matter
than in white matter. Our results indicate that the turnover from glucose to glutamate is also
slightly higher in gray matter than in white matter, although the standard deviation is higher in
our white matter measurements, making it difficult to quantify this relationship with our
present results. Roughly, the labeling detected in gray matter at 100 minutes is ~20%, while in
white matter it is 15-20%. While there appears to be inter-subject variability on this front, this is
more likely due to different degrees of partial voluming in the ROIs than to physiologic
differences between healthy subjects.
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As for temporal resolution, it could be argued that at such a timescale, all measurements are
already of a steady state. However, the time-dependent trends visible in our gray matter data
suggest that this is not the case. We would like to observe that much of the metabolic dynamics
work in the literature has been done on humans or animals who are receiving an IV or similarly
invasive infusion of the labeled substrate. Indeed, if this were the case, no changes would be
likely to occur > 1 hour after administration. However, absorption of glucose through the
digestive system presents a considerable rate-limiting step and is far from instantaneous. This is
illustrated clearly in the blood glucose measurements we performed on four healthy volunteers
(see SI). Thus, we don’t find it inconsistent that we may be still be seeing rise of the
downstream deuterated glutamate species even at this time scale.
In the present work, we were not yet able to robustly measure changes in GABA or glutamine in
human subjects. This could be due to the reliance on oral ingestion of deuterated glucose, as
opposed to the continuous infusion used in animal experiments, or to reduced spectral
sensitivity to GABA and glutamine as compared to glutamate. The use of a GABA-edited MEGAPRESS sequence34 or other specialized acquisition may improve quantification of these less
salient components. Future work would also consider incorporating deuterated versions of
these metabolites into the basis set.
Another spectroscopic approach for detecting metabolic dynamics using the 1H signal would be
to introduce glucose labeled not with deuterium, but instead with 13C 35–37. Once metabolized,
13

C would end up on the fourth carbon of glutamate. This carbon has two coupled protons

whose J-coupling would then split by ~80Hz on either side of the original resonance resulting in
a spectrum that exhibits only 85-90% of the original signal at 2.35 ppm (arising from protons
that are coupled 12C4) and about 10-15% of the signal (those coupled to 13C4) would be
transferred to split peaks around the center frequency. Since protons attached to 13C4 labeled
glutamate would be split and moved away from the glutamate proton resonance on unlabeled
12

C4, the main glutamate resonance intensity would be reduced in proportion to deuterium

labeling, not unlike in qMRS. However, it is important to note that leveraging splitting due to Jcoupling would also interfere with other resonances, making spectral quantification more
difficult. 13C-labeled glucose is also 4-5x more expensive than that labeled with 2H. Accordingly,
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from the perspective of cost and robustness, qMRS based on 2H metabolites would therefore
appear to have a greater potential for clinical translation.
qMRS not only probes the kinetics of metabolic flux, but also provides information about all
steady state metabolites normally accessed in an MRS acquisition, whereas in an experiment
detecting 2H or 13C, this information would be unavailable unless a dual-tuned coil were used.
Specifically, in principle qMRS presents the potential to measure labeling not only of glutamate,
but of glutamine and GABA, opening the doors to quantifying rates of neuronal metabolic
cycling38,39.
Investigators in the area of oncology may be particularly interested in monitoring lactate
changes after ingestion of [6,6'-2H2]-glucose as a measure of the Warburg effect40. Based on
successful preclinical work using the qMRS lactate signal to monitor glycolytic metabolism in
glioblastoma41, we are currently pursuing human studies correlating anaerobic metabolism
quantified by qMRS with pathological tumor grade and prognosis.
While the feasibility studies presented in this work are performed at 7T, there is potential to
extend the scope of these measurements to the much more available 3T MRI scanners. At 3T,
field inhomogeneity is less of an issue, thus facilitating full brain coverage. However, in addition
to a reduction in SNR, spectral resolution is compromised, making unambiguous detection of
Glu more difficult, especially for an extended basis set that includes deuterated versions of
metabolites. We have initiated these studies to a limited degree, and preliminary results suggest
that SVS-based qMRS to detect at minimum the decrease of the main glutamate resonance is
feasible at 3T31. In the realm of qCSI, sequence development is still underway to find an optimal
compromise between spatial and temporal resolution at this field strength.
In summary, we demonstrated the feasibility of qCSI upon oral ingestion of deuterated glucose
in human brain studies with modest –but novel for any 1H-based technique--temporal and
spatial resolution. We were able to detect both the decrease in the unlabeled glutamate and the
increase in the labeled derivatives by taking advantage of their specific splitting patterns in the
proton spectrum. Given the centrality of glucose-to-glutamate turnover to neural metabolism,
this simple experiment opens many new doors for probing neural metabolism in basic research
on healthy volunteers as well as in investigations of numerous pathological conditions.
205

6.5 Supplementary Figures and Information

Supplementary Figure 6.S1. Simulation of basis set glutamate metabolites. (A)
Single replacement of H with D can occur at H4 (top) or H4’ (bottom). (B) Same as (A)
with 27 Hz additional line broadening to simulate realistic in vivo conditions. (C)
Single replacement at H4 with H-D coupling constants of 1 Hz (top) and 2 Hz
(bottom). (D) Same as (C) with 27 Hz additional line broadening. (E) Glutamate
elements in the basis set included normal, undeuterated (top), single proton
replacement (middle), and double proton replacement (bottom). Note that figure
S1E is also included as Figure 1D in the main text.
Courtesy of N. Wilson
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Supplementary Figure 6.S2. Additional qCSI data sets (3 subjects) analogous to
that shown in Figure 2.
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Supplementary Figure 6.S3. Additional barplots of qCSI-quantified metabolites
(3 subjects) analogous to that shown in Figure 3.

209

Supplementary Figure 6.S4. Blood glucose data in four subjects after ingestion of
0.8g/kg of (non-deuterated) dextrose in aqueous solution. The variation present in this
data would appear to reflect age, sex and body composition. All subjects were
normoglycemic by 110 minutes following this “bolus” drink. Supplementary Figure 6.S5 .
SVS-quantified metabolites upon ingestion of 0.8g/kg of non-deuterated dextrose in
aqueous solution (control experiment to qMRS). Data from two subjects is plotted, as
indicated in the legend (S2: Subject 2). A sample linear fit is shown to the NAA and Glu data
for this subject. In contrast to qMRS with labeled glucose, this line has no slope over this
time course. A white matter voxel was selected for this measurement.
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Appendices
Note regarding authorship of Appendix contents:
All of the code that appears in Appendix A: Bloch-McConnell Simulations of the CEST
experiment was written by me, A. Cember, with the exception as indicated of the ‘matrix
exponential’ function, which is adapted from the r8 library, and the general structure of the
Matlab ‘Main’ function, which is adapted from the corresponding function written by Dr. Hari
Hariharan. As explained in the Introductory Note to Appendix A, the remaining calculations, to
whatever degree they were performed explicity in the original Matlab version, are based off of
Dr. Hariharan’s Matlab function CEST4sim.m, which in turn is likely inspired by the reference
provided in the Appendix. The Mex-based architechture and implementation is by my own
design.
In Appendix B, I am the author of all functions relating to B1 correction, and all ‘wrapper’
functions that are explicitly documented here. As indicated, many internally called functions
which relate to CEST post-processing outside of B1 correction are previously existing, as is the
GUI from which screenshots are taken to explain the steps of 3D CEST post-processing. My
contribution there, outside of B1 correction, is only as the narrator. To the best of my
knowledge, Dr. Hari Hariharan, Dr. Anup Singh and Dr. Mark Elliott are the CMROI-based
contributors to this code. Of course, libraries like spm8 and NIfTI were developed by the wider
imaging community. Specifically, as per the documentation included in these packages, SPM is
developed by members and collaborators of the Wellcome Trust Centre for Neuroimaging; the
author of NifTI identifies himself only as the proprietor of the email address
jimmytoolbox@gmail.com.
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Appendix A: Bloch-McConnell simulations of the CEST experiment
Abby, CMROI
January 2021
Introductory Note
The Bloch equations are a set of coupled differential equations which phenomenologically
describe the dynamics, or motion, of a magnetization vector under the physical conditions of an
NMR experiment. McConnell, who was interested in how the MR signal is affected by chemical
exchange, realized that he could simply add terms to the Bloch equations which allowed the
same mathematics to be used for his purposes. These equations which include terms
representing chemical exchange are thus known as the Bloch-McConnell equations. For more
about chemical exchange as a phenomenon and the classical physics treatment of NMR and
MRI, please see Chapter 1 of this thesis. Like all differential equations, the Bloch-McConnell
equations can be expressed in matrix form and solved numerically using the mathematics of
matrices. The purpose of this Appendix is to document and explain the Matlab and C (Mex) code
behind simulations of the gluCEST experiment, with explicit mention of the mathematics or
physics only to the extent that it is necessary to follow along with the calculation.
This version of the simulation is based off of Hari’s ‘CEST4sim.m’, and I believe that he based his
simulations off of the theoretical treatment outlined in Woessner’s 2005 paper15 . The math is
identical to any in that original code; my modifications were to ‘translate’ most of this math into
the C language rather than Matlab, as this speeds up the calculation, and I wanted to do many,
many of these simulations in order to study the B1 dependence of the signal. Also, the default
parameter values in CEST4sim have Pool 4 representing myoinositol (MI), whereas I have
modified them in an attempt to instead model the slow, ‘NOE’ like exchange that probably
originates from cross-relaxation of the bulk water with lipids and other non-polar moieties in
macromolecules.
The structure of this documentation is sort of in layers: I start with the outermost “layer” of
code – the main Matlab function—and then move in to the functions and further subfunctions
written in C that do the actual calculating. Eventually, we arrive at matrix operations that are
general, and for which I was able to use existing code provided in Numerical Recipes (the
world’s most important scientific computing book) or in the widely available r8 library. If you are
a CMROI user, you may not need to read beyond the explanation of the main Matlab function
for your purposes. If you are someone on the internet who knows nothing about chemical
exchange or MRI and just wants an instructive example of how to use MEX to integrate C code
into Matlab for any kind of scientific computing purposes, then you definitely do want to keep
reading. Have fun!

15

1. Woessner DE, Zhang S, Merritt ME, Sherry AD. Numerical solution of the Bloch equations provides
insights into the optimum design of PARACEST agents for MRI. Magn Reson Med. 2005;53(4):790-799.
doi:10.1002/mrm.20408
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Main function (Matlab)
The simulation is called by running the script mainCalcMz_December2018edits_1.m.
In other words, this is the function that needs to be open in Matlab so that you can press “play”
- -you probably don’t want to run this blindly by command line unless you know what you’re
doing, as the parameter values are set ‘manually’ in this script. It looks like this, with my
comments from this document added in bright pink, in this font. Comments that are actually in
the code are in green, as in the Matlab interface.
%Ha. Since we're using MATLAB, we can just pass CalcMz() these whole
%arrays. Only then once we're in C, we'll have to pass pointers to
the
%inner functions.

If you don’t understand what this comment means, that’s OK – if you do, and you want to mess
with the underlying C code, just heed the warning to be *very* careful when passing arguments
back and forth!!!
pathnam = '.';
f1 = 'hanning.pta';
f1a = [pathnam filesep f1];

The above code is the first step to starting the simulation: it takes a file which describes the
shape of the pulse. In all honesty, I have no idea what a .pta file actually contains or how to
make a new one – but presumably somebody does. This is, needless to say, beyond the scope of
the present document. I have never simulated any other pulse shape, but if you would like to,
simply replace this file.
switch exist(f1a)

This section of code is checking whether we have used that .pta file to specify the pulse shape; if
we don’t have one, it throws an error. It also contains code that specifies a rectangular pulse.
case 2
krect = strfind(f1a,'rect');
if (isempty(krect))
fid = fopen(f1a,'r');
jj = 0;
while 1
tline = fgetl(fid);
if ~ischar(tline),
break,
end
jj = jj+1;
if (jj > 8)
str1 = strtok(tline,';');
a = sscanf(str1,'%f%f');
amp1(jj-8) = a(1);
phi(jj-8) = a(2);
end
end
count1 = jj-8;
fclose(fid);
else
amp1 = (1:100)*0.0+1.0;
phi = amp1-1;

216

count1 = 100;
end
otherwise
amp1 = [];
phi = [];
error(' No file selected. No data returned.\n\n');
end
% amp1 = [0.1,0.25,0.5,0.25,0.1,0.25,0.5];
% phi = [0,30,60,90,60,30,0,30,60,90];
%{0,25,50,75,100,125,150,175,200,225,250}

Now that we have our pulse shape defined as a vector over 100 points in “time”, we need to set
the rest of the parameters. We are going to store them in a customized ‘struct’, as pairs of ‘field’
and ‘value’. The first two, amplitude and phase, are set by the .pta file read in above. The
commented out lines that I was using for debugging give you an idea of their structure.
General parameters:
%General
field1 =
field2 =
field3 =
field4 =

parameters
'amplitude_array';
'phase_array';
'count1';
'pw1';

value1
value2
value3
value4

=
=
=
=

amp1;
phi;
count1;
800; Saturation pulse duration, in

ms
field5 = 'b1';
value5 =
{0,10,20,30,40,50,60,70,80,90,98,126,154,182,210,238,266,294,322,350};
field6 = 'puloffsetppm';
value6 = 3.0; %%%% Saturation pulse offset,

in ppm – here, you can change the ‘type’ of CEST experiment… 3.0 is for gluCEST, of course
field7 = 'pw1dc';
value7 = 99.8; Saturation pulse duty cycle
field8 = 'cf';
value8 = 300; Saturation pulse carrier
frequency
Note that saturation B1 amplitude here is expressed as a vector of values, in Hz.
IMPORTANT NOTE: If you want to run the simulation iteratively with respect to some other
parameter instead of B1, you can! You will see later on how to do this. In that case, this other
parameter would be entered as a vector, and B1 would take only a single value. If you want to
loop over two parameters, you will have to write this capability in yourself, but that would be
straightforward.
After this, we enter in MR-revelant properties of the components we’re interested in simulating.
Each component has the following properties specified: concentration (M), T1, T2, resonant
frequency relative to water (‘offset ppm’), and exchange rate with bulk water. Concentration is
expressed as ‘M0’, since what we’re basically saying is that this is the relative contribution of this
set of spins to the magnetization of the sample as a whole.
Some important notes about concentrations:
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--The concentration of water itself differs between gray and white matter of the brain
--The fraction of this water that is ‘bound’ differs between gray and white matter of the brain.
(--The parameter called ‘bwfraction’ here is not doing anything. It is vestigial, but one can enter
a value there basically as a note, in order to not have to do the math when you look at these
again later.)
--Both of these parameters may be very different for other tissues, but as long as you look them
up and have a reasonable estimate there is no reason this simulation is not valid for non-brain
application.
--Metabolites that have multiple protons have to be treated as [concentration normally found
in vivo] x [number of protons per molecule]. This is why, for example, M0 of glutamate is
entered here as .036, or 36mM: that’s for 12mM glutamate multiplied by the three protons on
each which contribute to that 1H resonance.
%Bulk water
field9 = 'M0w';
field10 = 'T1a';
field11 = 'T2a';
at 7T: 80-90ms
field12 = 'offsetappm';
field13 = 'bwfraction';
field14 = 'M0a';
%%%%%%%%

value9 = 77;%G:77, W:88 %%%%%%%%
value10 = 1.7;
value11 = .085; %T2 of bulk water
value12 = 0;
value13 = 0;%%%%%%%%%
value14 = 77;%G: 66.99; W: 67.76; %

%Bound water: proton exchange term
field15 = 'M0bw';
value15
%% 0;%%%%%%%
field16 = 'T1bw';
value16
field17 = 'T2bw';
value17
.02 ms (also set to match exp. data)
field18 = 'offsetbwppm';
value18
field19 = 'exratebw';
value19
BW exchange rate is 20Hz
%Protein amides
field20 = 'M0b';
protein amides
field21 = 'T1b';
field22 = 'T2b';
field23 = 'offsetbppm';
field24 = 'exrateb';
%Lipids: cross-relaxation term
field25 = 'M0c';
from lipid
field26 = 'T1c';
field27 = 'T2c';
field28 = 'offsetcppm';
field29 = 'exratec';

= 11;%G: 10.01; W: 20.24;
= 1;
= 1e-5; %T2 of bound water:
= -2.4;
= 20; %Literature value of

value20 = .08; %0.072; %%%%%%%%
value21
value22
value23
value24

=
=
=
=

1;
0.001;
3.5;
10;

value25 = 1;
value26
value27
value28
value29

%Creatine
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=
=
=
=

%%%%%%%% New: NOE

1; %
.001; %1ms
-3.5; %
5; %cross-relaxation rate

field30 = 'M0d';
%%%%%%%%creatine
field31 = 'T1d';
field32 = 'T2d';
field33 = 'offsetdppm';
field34 = 'exrated';
%Glutamate
field35 = 'M0e';
glutamate
field36 = 'T1e';
field37 = 'T2e';
field38 = 'offseteppm';
field39 = 'exratee';

value30 = 0.032;% 0.032;
value31
value32
value33
value34

=
=
=
=

1;
0.01;
1.8;
800;

value35 = 0.036;%.036; % %%%%%%%%
value36
value37
value38
value39

=
=
=
=

1.0;
0.01;
3.0000;
1000; %2400

Before running the script, you should set these values to whatever you want. When the script
runs, these are now all packaged into this struct called ‘parameters’. Because this is now going
to be passed to a function in C, it has to be assigned something called a pointer (ptr).
parameters = struct(field1, value1, field2, value2, field3,
value3,field4, value4, field5, value5, field6, value6, field7, value7,
field8, value8,field9, value9, field10, value10, field11, value11,
field12, value12, field13,value13, field14, value14, field15, value15,
field16, value16, field17, value17,field18, value18, field19, value19,
field20, value20, field21, value21, field22,value22, field23, value23,
field24, value24, field25, value25, field26, value26,field27, value27,
field28, value28, field29, value29, field30, value30, field31,value31,
field32, value32, field33, value33, field34, value34, field35,
value35,field36, value36, field37, value37, field38, value38,field39,
value39);
ptr2pars = StructureHandle(parameters);

This is just checking to make sure that you haven’t accidentally told the simulation to go for
longer ‘time’ than the definition of the pulse shape. If you haven’t messed with anything, this
shouldn’t come up. You will just see the message that you are ‘good to go’.
if (parameters(1).count1 > length(amp1) || parameters(1).count1>
length(phi))
fprintf("Error: count1 will overstep the allocated phi and ampl
arrays! Exiting without calling calculate().\n");
return;
else
fprintf("Check to make sure that count1 is not greater than
array lengths-- good to go!\n");
end

%
for i =1:11
%
CalculatedContrast = CalculateMz2(ptr2pars.structure(i));
%
fprintf("Returned from CalculateMz back to main.Calculated
Contrast = %f\n", CalculatedContrast);
%
end
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The actual calculation is going to be done in CalculateMz3 and subsidiary functions. It will return
back to you a variable called ‘Calculated Contrast’, which is a list of two values: ±3.0ppm of the
Z-spectrum for each of the values of the vector-variable used as input (in my case, B1). The idea
is that these can then easily be plotted against that independent variable vector or otherwise
used conveniently.
CalculatedContrast = CalculateMz3(parameters);
%7/21/2019
Mz_pos = CalculatedContrast(1,:); Mz_neg = CalculatedContrast(2,:);

Calculate Mz (C ++)
CalculateMz3.cpp is a C++ file. C and C++ files are quite different from Matlab files. One
important difference is that unlike in Matlab, multiple functions can be defined in a single file.
They have to be declared as ‘prototypes’ somewhere before their actual code. The prototype
gives the following information: the name of the function, the output variable of the function,
and the input variable(s) of the function. I will point these out when they show up.
They also need to be ‘compiled’. I am unqualified to explain what precisely this means in
computer science terms, but the practical point here is that they won’t ‘just work when you
press play’ like Matlab functions – if you’re using a C-based function, you have to call Matlab’s
function ‘mex’ (short for ‘Matlab executable’) which does some kind of special compilation
which allows Matlab to interface with C. I recommend checking the Matlab documentation for
the latest version of the mex compilation command, as these sometimes change between
Matlab versions. *Important*: if you are using a Windows machine, always compile mex with
the flag: -compatibleDimArrays
/*CalculateMz2.cpp
*THIS VERSION is different from CalculateMz in that no calls are made
via mexCallMatlab.
*Instead, it uses functions from r8lib.c, which requires that it be
included in the call to mex:
*'mex CalculateMz3.cpp r8lib.c'

So, before you use this program, you need to type the above line into Matlab. It compiles
CalculateMz3.cpp, and also includes the C library ‘r8lib’.
*IT WORKS, as of 9/14/2017
*
*This function calculates the magnetization (and contrast in
magnetization
*arising from "+" and "-" pulses) for a given voxel. It accepts as an
argument
*a structure that contains:
*Input arguments:
field1 = 'glutamate_concentration'; value1 = {2.0, 4.0};
field2 = 'B1_strength';
value2 = 200;
field3 = 'T1_freeWater';
value3 = 1000;
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...and so on
*and outputs the magnetization for that voxel given a "+" pulse, a "-"
pulse
*(away from resonance frequency, that is) and the contrast between the
two.
*

Below: this is true, but ignore it. The current version of the Bloch simulations are not fully
integrated with the ‘virtual phantoms’ code, but if you are imaginative, you can see how this
would be done.
*It is designed to be called as a "mex" from another function that
contains "maps"/
*"masks"/"phantoms", or whatever you want to call them -- objects that
have
*properties as a function of space that will generate MRI contrast.
These will
*be in the form of structs like the one below. For simplicity, we'll
start with
*just six ROIs, in which only one parameter is changing between them-meaning that
*all fields in the struct will be just single numbers, except for one
which will
*be a vector with six elements (a la field1, currently). */
/*
parameters = struct(field1, value1, field2, value2, field3,
value3};*/
/*In a loop over r, Mz(r) = CalculateMz(parameters(r));*/
/*In this way, parameters(1) will contain parameters for the ROI in
which
*[glutamate] = 2, while parameters(2) will contain those for the
ROI in which
*[glutamate] = 4. For now, parameters other than [glutamate] remain
the same between
*ROIs. To access [glutamate], we ask for parameters(1).f1; to
access B1,
*parameters(1).f2, and so on.*/
/* Read in file to create amplitude and phase arrays*/
/* This is done in the Matlab calling function*/

#include and #define statements: Needed for C functions. They tell the compiler to go look for
these header (.h) files, which you need to have in the directory. The headers <named like this>
are some kind of existing or standard thing. Ones <like this> were introduced by me.
“Calculate2” … “LU” stands for “lower-upper decomposition”, a matrix operation that we’ll
need. ‘Pi’ is self explanatory.
#include <stdio.h>
#include <string.h>
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#include <math.h>
#include <mex.h>
#include "LU.h"
#include "Calculate2.h" //for new version of CalculateY()
#define pi 3.14159;

Next, we’re going to define some structs. Unlike in Matlab, where you can just tack things on, in
C you need to define ahead of time everything that a struct is going to contain.
/*C structs*/

Input parameters: Basically, we’ll take the corresponding struct passed from Matlab, and reassign all the contents to this local one.
struct InputParameters{
/*Things determined from reading the pulse shape file*/
double *ampl; //I think these vectors are 0-100; if they're 0-1,
change this pointer to double.
double *phi;
int count1;
/*Other pulse-related ones. Some of these may be OK as ints, not
sure at present*/
double pw1;
double b1;
double puloffsetppm;
double pw1dc;
double cf;
/*Chemical species-specific*/
double M0w,T1a,T2a,offsetappm,bwfraction,M0a;
double M0bw, T1bw, T2bw, offsetbwppm, exratebw;
double M0b, T1b, T2b, offsetbppm, exrateb;
double M0c, T1c, T2c, offsetcppm, exratec;
double M0d, T1d, T2d, offsetdppm, exrated;
double M0e, T1e, T2e, offseteppm, exratee;
};

‘Z contrast’: This will hold our output: positive offset MZ,water, negative offset MZ,water, and
then the negative normalized contrast between them. (Note that if you are doing the loop of
simulations over offset frequency to generate a Z-spectrum, you only need to do the positive
half, because the other side is done automatically.)
struct Zcontrast {
double SimMza;
double SimMzb;
double contrastz;
};

Here are the prototypes, as promised. Important note: Not all of these prototypes are actually in
this file, CalculateMz3.cpp – that would have just made the code too long. The first two,
calculate () and MatrInv() are in CalculateMz3.ccp; CalculateY is in the header file “Calculate2.h”
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which we included above. Multiple and Divide were later replaced by functions from the r8
library, and are vestigial.
/*Prototypes*/
void calculate (struct InputParameters *voxelPars1, struct Zcontrast
*contrast, double **pntrA,double *pntrAinvB, double **CopyOfMatrix,
double *vector, double *col,int *indx, double *Aat, double *Aate,
double *sum, double *product, double *pntrA1, double *pntrB, double
*pntrY, double *pntrY0);
void MatrInv (double **matrix, int n, double **CopyOfMatrix, double
*vector, int *indx, double *col);
void Multiply (double *pntrAinvB, double **pntrAinv, double *pntrB);
void Divide (double *pntrMz, double *pntrY0, double M0a);
void CalculateY(double *pntrY, double timeScalar, double **pntrA,
double *pntrY0, double *pntrAinvB, double *Aat, double *Aate, double
*sum, double *product);

Now we have to do some tricky stuff having to do with going back and forth between C and
Matlab. When you call ‘CalculateMz3.cpp’ from Matlab, what you’re actually calling is this thing
called ‘mexFunction’. ‘Void’ in C means that the function does not return anything. However, in
the case of mex, this is supremely misleading, because what actually happens is that the mex
Function returns the pointer to the array called “plhs”. (If you don’t know what a pointer is,
don’t worry. It’s basically what it sounds like.) In the mex function, no matter what in the world
it does, there are only four arguments: the contents of the input (which Matlab calls ‘right hand
side, as if it were an equation), an integer proclamining how many items are in this array, and
the same two things for the output.
The designation ‘void’ for all of the above functions may also be confusing to someone
unfamiliar with C style: how can we get any output or answers if none of the functions return
any arguments? In effect, the function returns the argument in the form of modifying the
pointers themselves. For example, we may send MatrInv the pointer **matrix full of zeros,
but it gets returned to us filled with the answer to the matrix inversion problem that we gave it.
Mex Function – still part of CalculateMz3.cpp
/* MEX business*/
void mexFunction(int nlhs, mxArray *plhs[], int nrhs, const mxArray
*prhs[]){
/* mexPrintf("Inside the mex function of CalcMz2.\n");
mexEvalString("drawnow;");*/
/*declare local variables*/
struct InputParameters voxelPars;
struct InputParameters *point2pars;
struct Zcontrast contrast;
struct Zcontrast* ptr2contrast;
ptr2contrast = &contrast;
mxArray *in, *out;
mxArray *temp;
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double *output;
int nFields;
int i,j,k;

A note about the syntax of these declarations: the first line can be translated as “we’re declaring
a struct of the type ‘Input Parameters’ which we are going to call ‘voxelPars’.” The second line
means, “we’re declaring a pointer to point to a struct of the tyoe ‘Input Parameters’; the name
of this pointer is ‘point2pars’”. And so on.
The next step is to “associate the inputs”; i.e., receive this ‘rhs argument’ that was sent to the
mex function into a local variable. All I do right now is simply make a copy of it, and check that
the number of input fields (that big parameters struct ) is what I intend.
in = mxDuplicateArray(prhs[0]); /*'in' now is a copy of the input
struct*/
nFields = mxGetNumberOfFields(prhs[0]);
if (nFields != 39) mexPrintf("Error: the number of fields in the
input struct is incorrect.\n");
// if (nFields == 39) mexPrintf("The number of fields in the input
struct is correct: 39.\n");
/* mexPrintf("Should have examined the input struct by now...\n");
mexEvalString("drawnow;");*/
/*These calls are going to return pointers...
which means I need pointers to receive their values...(temp)
Then, I can assign the values of the struct by dereferencing the
pointer.*/

After that, we “associate the outputs”. We now have to do something which is required in C but
not in Matlab: declare memory for the variables we need. As far as I can tell, since the mex
function was already sent the input argument(s), memory sort of automatically exists for this
variable. However, we need to declare memory for the output. Imagine you order something
from Amazon: it already came in a box. But if you are sending something to someone else, you
are responsible for procuring a box yourself. Same idea.
*Important* If you are familiar with C, you will notice that we do not use the familiar malloc
function. MEX has its own memory allocation functions, called “mxCreate***”, “mxCalloc” and
so on. See Matlab’s documentation for all the flavors of these functions. Regular C memory
allocation calls do not work in Mex!!!
//associate outputs
// out = plhs[0] =
mxCreateDoubleMatrix(1,(mxGetDimensions(prhs[0])[1]), mxREAL); /*this
has no memory allocated for it yet*/
/*TEST 7/21/10*/ out = plhs[0] =
mxCreateDoubleMatrix(3,(mxGetDimensions(prhs[0]) [1]), mxREAL);
// out = plhs[0] = mxCreateDoubleScalar(0.0);
/*TEST, used to be output = mxGetPr(out); - figured perhaps I need a
double pointer */
output = mxGetPr(out);
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/*mexPrintf("Number of dimensions has been determined as: %d.\n",
mxGetNumberOfDimensions(prhs[0]));
mexPrintf("Size of x-axis array has been determined as: %d.\n",
mxGetDimensions(prhs[0])[1]);
mexEvalString("drawnow;");*/

Now we’re going to do a whole bunch more memory allocation for the variables we need for the
calculation. There is nothing going on here outside of regular C programming. If you’re not
familiar with C, you can think of this as “buying the boxes” that we need to ship stuff around in,
and assigning them labels.
/*Passed variables memory allocation*/
double **pntrA;
/*CAUTION! At different times in this function, pntrA is used to
point to matrices Aa, Ab, Ad AND their inverses*/
pntrA = (double **)mxCalloc(18, sizeof(double*));
for (i=0; i <18; i++){
pntrA[i] = (double *) mxCalloc(18, sizeof(double));
}
double *pntrAinvB;
pntrAinvB = (double *) mxCalloc(18, sizeof(double));
/*Single dimension version of pntrA*/
double *pntrA1;
pntrA1 = (double*)mxCalloc(18*18, sizeof(double));

/*used by MatrInv()*/
double **CopyOfMatrix;
CopyOfMatrix = (double**)mxCalloc(18, sizeof(double*));
for (i=0; i<18; i++){
CopyOfMatrix[i] = (double*)mxCalloc(18, sizeof(double));
}
double *vector;
double *col;
int *indx;
vector = (double *)mxCalloc(18, sizeof(double));
indx = (int *)mxCalloc(18, sizeof(int));
col = (double *)mxCalloc(18, sizeof(double));
/*used by CalculateY()*/
double *Aat;
Aat = (double*)mxCalloc(18*18, sizeof(double));
double *Aate;
Aate = (double*)mxCalloc(18*18, sizeof(double));
double *sum;
sum = (double*)mxCalloc(18, sizeof(double));
double *product;
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product = (double*)mxCalloc(18, sizeof(double));
double *pntrB;
pntrB = (double *) mxCalloc(18, sizeof(double));
double *pntrY;
pntrY = (double *) mxCalloc(18, sizeof(double));
double *pntrY0;
pntrY0 = (double *) mxCalloc(18, sizeof(double));

Next, we perform the somewhat tedious operation of retrieving all of the simulation parameters
from our friend ‘prhs’ that was holding them. The names of the first few are highlighted for
visibility. Note that we keep using this function mxGetScalar( ) – this is because everything
in our parameters struct is some kind of number. In the event that you have something else in
there, you need to use the appropriate “get” function for that variable type.
for (k = 0; k< (mxGetDimensions(prhs[0])[1]); k++){
/* mexPrintf("Looping over input values. k = %d\n",k);
mexEvalString("drawnow;");*/

temp = mxGetFieldByNumber(prhs[0],0,0);
voxelPars.ampl = mxGetPr(temp);
temp = mxGetFieldByNumber(prhs[0],0,1);
voxelPars.phi = mxGetPr(temp);
/* for (i=0; i<4; i++){
mexPrintf("%f\t%f\t\n", voxelPars.ampl[i],voxelPars.phi[i]);
}*/
temp = mxGetFieldByNumber(prhs[0],0,2);
voxelPars.count1 = mxGetScalar(temp);
temp = mxGetFieldByNumber(prhs[0],0,3);
voxelPars.pw1 = mxGetScalar(temp);
temp = mxGetFieldByNumber(prhs[0],k,4); /*This argument must be 'k'
for B1*/
voxelPars.b1 = mxGetScalar(temp);
temp = mxGetFieldByNumber(prhs[0],0,5);/*This argument must be 'k'
for offset*/

*Important* We now interrupt this code to explain how to change what simulation parameter
the series of simulations will vary. Note that this whole thing is in a loop over the indexing
variable ‘k’. ‘k’ only appears once: in whatever field you want to loop over. The two that I’ve
ever used are B1 amplitude (as the code is set up for here) and frequency offset, to create a Zspectrum. If you want to do the latter, you would replace the ‘k’ in the B1 line with ‘0’ (to set it
at a single value), and replace that middle 0 in the ‘puloffsetppm’ line here with ‘k’. Of course, if
you wanted to, you could simulate a surface of any number of dimensions with one press of the
button by adding more layers to this loop.
voxelPars.puloffsetppm = mxGetScalar(temp);
temp = mxGetFieldByNumber(prhs[0],0,6);
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voxelPars.pw1dc = mxGetScalar(temp);
temp = mxGetFieldByNumber(prhs[0],0,7);
voxelPars.cf = mxGetScalar(temp);
temp = mxGetFieldByNumber(prhs[0],0,8);
voxelPars.M0w = mxGetScalar(temp);
temp = mxGetFieldByNumber(prhs[0],0,9);
voxelPars.T1a = mxGetScalar(temp);
temp = mxGetFieldByNumber(prhs[0],0,10);
voxelPars.T2a = mxGetScalar(temp);
temp = mxGetFieldByNumber(prhs[0],0,11);
voxelPars.offsetappm = mxGetScalar(temp);
temp = mxGetFieldByNumber(prhs[0],0,12);
voxelPars.bwfraction = mxGetScalar(temp);
temp = mxGetFieldByNumber(prhs[0],0,13);
voxelPars.M0a = mxGetScalar(temp);
temp = mxGetFieldByNumber(prhs[0],0,14);
voxelPars.M0bw = mxGetScalar(temp);
temp = mxGetFieldByNumber(prhs[0],0,15);
voxelPars.T1bw = mxGetScalar(temp);
temp = mxGetFieldByNumber(prhs[0],0,16);
voxelPars.T2bw = mxGetScalar(temp);
temp = mxGetFieldByNumber(prhs[0],0,17);
voxelPars.offsetbwppm = mxGetScalar(temp);
temp = mxGetFieldByNumber(prhs[0],0,18);
voxelPars.exratebw = mxGetScalar(temp);
temp = mxGetFieldByNumber(prhs[0],0,19);
voxelPars.M0b = mxGetScalar(temp);
temp = mxGetFieldByNumber(prhs[0],0,20);
voxelPars.T1b = mxGetScalar(temp);
temp = mxGetFieldByNumber(prhs[0],0,21);
voxelPars.T2b = mxGetScalar(temp);
temp = mxGetFieldByNumber(prhs[0],0,22);
voxelPars.offsetbppm = mxGetScalar(temp);
temp = mxGetFieldByNumber(prhs[0],0,23);
voxelPars.exrateb = mxGetScalar(temp);
temp = mxGetFieldByNumber(prhs[0],0,24);
voxelPars.M0c = mxGetScalar(temp);
temp = mxGetFieldByNumber(prhs[0],0,25);
voxelPars.T1c = mxGetScalar(temp);
temp = mxGetFieldByNumber(prhs[0],0,26);
voxelPars.T2c = mxGetScalar(temp);
temp = mxGetFieldByNumber(prhs[0],0,27);
voxelPars.offsetcppm = mxGetScalar(temp);
temp = mxGetFieldByNumber(prhs[0],0,28);
voxelPars.exratec = mxGetScalar(temp);
temp = mxGetFieldByNumber(prhs[0],0,29);
voxelPars.M0d = mxGetScalar(temp);
temp = mxGetFieldByNumber(prhs[0],0,30);
voxelPars.T1d = mxGetScalar(temp);
temp = mxGetFieldByNumber(prhs[0],0,31);
voxelPars.T2d = mxGetScalar(temp);
temp = mxGetFieldByNumber(prhs[0],0,32);
voxelPars.offsetdppm = mxGetScalar(temp);
temp = mxGetFieldByNumber(prhs[0],0,33);
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voxelPars.exrated = mxGetScalar(temp);
temp = mxGetFieldByNumber(prhs[0],k,34);
voxelPars.M0e = mxGetScalar(temp);
temp = mxGetFieldByNumber(prhs[0],0,35);
voxelPars.T1e = mxGetScalar(temp);
temp = mxGetFieldByNumber(prhs[0],0,36);
voxelPars.T2e = mxGetScalar(temp);
temp = mxGetFieldByNumber(prhs[0],0,37);
voxelPars.offseteppm = mxGetScalar(temp);
temp = mxGetFieldByNumber(prhs[0],0,38);
voxelPars.exratee = mxGetScalar(temp);
/*Perfect!*/

Now that all of these parameters are stored in the struct called voxelPars, we have to create a
pointer to that struct so that we can pass it to other functions. That’s what the ‘&’ operator is
doing below.
point2pars = &voxelPars;
/*This is to test my matrix inversion function*/
double Test[2][2] = {{2,1},{2,2}};
double **ptr2Test;
ptr2Test = (double**)mxCalloc(2,sizeof(double*));
for (i=0; i<2; i++){
ptr2Test[i] = (double *)mxCalloc(1, sizeof(double));
for (j=0; j<2; j++){
ptr2Test[i][j] = Test[i][j];
}
}
/* mexPrintf("Test's original values are: %f, %f, %f, %f.\n",
ptr2Test[0][0], ptr2Test[0][1], ptr2Test[1][0],ptr2Test[1][1]);
MatrInv(ptr2Test,2);
mexPrintf("Test has been inverted to: %f, %f, %f, %f.\n",
ptr2Test[0][0], ptr2Test[0][1], ptr2Test[1][0],ptr2Test[1][1]);
mxFree(ptr2Test);*/

Above, we declared another local variable called ‘contrast’. This holds the answer to our
simulation. What I wrote in the comment is that we’re initializing it to zero, but that’s confusing,
because what’s actually happening right here is that we’re initializing the Z magnetization of the
positive and negative sides of the Z-spectrum to 1. (Since ‘contrast’ is the difference between
them, it is indeed being initialized to zero.) This is representing the physical situation before any
saturation is applied.
/*Initialize contrast's values to zero*/
ptr2contrast->SimMza = ptr2contrast->SimMzb = ptr2contrast>contrastz = 1.0;

The real math is then done by the C function calculate() – this current function was just a
wrapper function in order to go between C and Matlab. What we want back from calculate() is
the value of the Z magnetization at the positive and negative offsets, for every value of
228

whatever simulation parameter we’re looping over. This is exactly what we’re taking when we
assign output[ ] = ptr2contrast… after running calculate().
//Then I'll have to call calculate()
calculate(point2pars, ptr2contrast, pntrA, pntrAinvB,
CopyOfMatrix,vector, col, indx, Aat, Aate, sum, product, pntrA1, pntrB,
pntrY, pntrY0);
//*output = ptr2contrast->contrastz;
//mexPrintf("The contrast has been calculated as :%f.\n", ptr2contrast>contrastz);
/*TEST 7/21/2019*/
/*I think I have to do it this way, because I don't know how to get a
double pointer to output*/
output[3*k] = ptr2contrast->SimMza;
output[3*k+1] = ptr2contrast->SimMzb;
output[3*k+2] = ptr2contrast->contrastz;
}/// end loop over different values of the input struct

That is, end loop over ‘k’.
Then, before leaving the mex function, we ‘free’ the memory that we used. I don’t know exactly
what happens in Matlab/mex if you fail to do this, but in principle you risk crashing your
machine.
/*mexPrintf("About to free memory.\n");
mexEvalString("drawnow;");*/
/*Free memory
mxFree(pntrA); mxFree(pntrAinvB);*/
mxFree(CopyOfMatrix); mxFree(Aat); mxFree(Aate);
mxFree(vector);mxFree(indx);mxFree(col);
mxFree(sum); mxFree(product);
}//end mex function

At the end of the mex function, it will return ‘output’ back to Matlab for us.
Now let’s see what actually happens in Calculate().
calculate() – still part of CalculateMz3.cpp
/* Calculation: then, do the same calculation, calling LU functions to
do the matrix
* inversions and Matlab functions to do the other operations. The
calculation has two loops over time:
* one over the number of pulses, and one over time increments within
the pulse.
* It actually does two such calculations -- one for 'positive' offset
and one
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* for negative, and then calculates the difference ("contrast").*/
void calculate (struct InputParameters *voxelPars1, struct Zcontrast
*contrast, double **pntrA,double *pntrAinvB, double **CopyOfMatrix,
double *vector, double *col,int *indx, double *Aat, double *Aate,
double *sum, double *product, double *pntrA1, double*pntrB, double
*pntrY, double *pntrY0){
/*Starting here, everything we need is included in the struct
InputParameters*/
/*mexPrintf("Using CalculateMz2\n");
mexEvalString("drawnow;");*/

This stuff should be self explanatory by now… You’ll also see that in addition to assigning local
versions of these parameters, we have to do some unit conversions before actually calculating.
See the comments in green.
/*Local variables*/
int i, j, k, l, n1, m;
double pwms, pw1delay;
int npul;
double timeStepSize;
double W;
double Wa, Wbw, Wb, Wc, Wd,
double Cbw, Cb, Cc, Cd, Ce;
double M0a, M0bw, M0b, M0c,
just to make life easier
double pa, pbw, pb, pc, pd,
double Cabw, Cab, Cac, Cad,
double k1a, k1bw, k1b, k1c,
double k2a, k2bw, k2b, k2c,

We;
M0d, M0e; //declaring these as locals
pe;
Cae;
k1d, k1e;
k2d, k2e;

//
double **pntrA;
//
/*CAUTION! At different times in this function, pntrA is used to
point to matrices Aa, Ab, Ad AND their inverses*/
//
pntrA = (double **)mxCalloc(18, sizeof(double*));
//
for (i=0; i <18; i++){
//
pntrA[i] = (double *) mxCalloc(18, sizeof(double));
//
}
//
double AdinvB[18];
double AinvB[18];
for(i=0; i<18; i++){
AdinvB[i] = 0.0;
AinvB[i] = 0.0;
}
//
// /*Passed variables memory allocation*/
//
double **CopyOfMatrix; /*used by MatriInv()*/
//
CopyOfMatrix = (double**)mxCalloc(18, sizeof(double*));
//
for (i=0; i<18; i++){
//
CopyOfMatrix[i] = (double*)mxCalloc(18, sizeof(double));
//
}
//
//
double *vector;
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//
//
//
//
//
//
//
//
//
//
//
//
//
//
//
//
//
//
//
//
//
//
//

double *col;
int *indx;
vector = (double *)mxCalloc(18, sizeof(double));
indx = (int *)mxCalloc(18, sizeof(int));
col = (double *)mxCalloc(18, sizeof(double));
/*used by CalculateY()*/
double *Aat;
Aat = (double*)mxCalloc(18*18, sizeof(double));
/* for (i=0; i<18; i++){
Aat[i] = (double*)mxCalloc(18, sizeof(double));
}*/
double *Aate;
Aate = (double*)mxCalloc(18*18, sizeof(double));
/* for (i=0; i<18; i++){
Aate[i] = (double*)mxCalloc(18, sizeof(double));
}
*/
double *sum;
sum = (double*)mxCalloc(18, sizeof(double));
double *product;
product = (double*)mxCalloc(18, sizeof(double));

double W1[voxelPars1->count1]; //Now THIS might require a pointer,
since count1 is only passed in the argument struct. We'll see.
double W1x[voxelPars1->count1];
double W1y[voxelPars1->count1];
/* mexPrintf("Declared all local variables in calculate().\n");
mexEvalString("drawnow;");*/
/*Fill local variables with values from input struct voxelPars*/
pwms = voxelPars1->pw1dc;
pw1delay = 100-voxelPars1->pw1dc;
npul = (int)voxelPars1->pw1/100;
timeStepSize=0.001*(pwms/voxelPars1->count1);
/* mexPrintf("Count1 has been set equal to: %d; npul has been set
equal to:%d.\n", voxelPars1->count1, npul);
mexEvalString("drawnow;");*/
/*Determine offset frequency of the metabolites in Hz (?)*/
Wa = voxelPars1->offsetappm * voxelPars1->cf * 2 * pi;
// mexPrintf("Wa has been set to: %f.\n", Wa);
Wbw = voxelPars1->offsetbwppm * voxelPars1->cf * 2 * pi;
// mexPrintf("Wbw has been set to: %f.\n", Wbw);
Wb = voxelPars1->offsetbppm
* voxelPars1->cf * 2 * pi;
// mexPrintf("Wb has been set to: %f.\n", Wb);
Wc = voxelPars1->offsetcppm
* voxelPars1->cf * 2 * pi;
// mexPrintf("Wc has been set to: %f.\n", Wc);
Wd = voxelPars1->offsetdppm
* voxelPars1->cf * 2 * pi;
// mexPrintf("Wd has been set to: %f.\n", Wd);
We = voxelPars1->offseteppm
* voxelPars1->cf * 2 * pi;
// mexPrintf("We has been set to: %f.\n", We);
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/* Set "absolute" rates of proton exchange from each metabolite -"bw" is bound water*/
Cbw = voxelPars1->exratebw;
// taub is in Hz units
Cb = voxelPars1->exrateb;
// taub is in Hz units
Cc = voxelPars1->exratec;
// taub is in Hz units
Cd = voxelPars1->exrated;
// taub is in Hz units
Ce = voxelPars1->exratee;
// taub is in Hz units
/*Move M0 values from voxelPars into local bins*/
/*M0a = M0w * (1-bwfraction);
M0bw = M0w * bwfraction;*/
/* M0a = voxelPars.M0a;
M0bw = voxelPars.M0bw;*/
M0a = voxelPars1->M0a;
M0bw = voxelPars1->M0bw;
M0b = voxelPars1->M0b;
M0c = voxelPars1->M0c;
M0d = voxelPars1->M0d;
M0e = voxelPars1->M0e;
/*Determine fraction of the total proton signal coming from each
metabolite*/
pa = M0a /(M0a+M0bw+M0b+M0c+M0d+M0e);
pbw = M0bw /(M0a+M0bw+M0b+M0c+M0d+M0e);
pb = M0b /(M0a+M0bw+M0b+M0c+M0d+M0e);
pc = M0c /(M0a+M0bw+M0b+M0c+M0d+M0e);
pd = M0d /(M0a+M0bw+M0b+M0c+M0d+M0e);
pe = M0e /(M0a+M0bw+M0b+M0c+M0d+M0e);
/*Calculate exchange rate between "a" (bulk water) and each
metabolite*/
Cabw=voxelPars1->exratebw*pbw;
Cab=voxelPars1->exrateb*pb;
Cac=voxelPars1->exratec*pc;
Cad=voxelPars1->exrated*pd;
Cae=voxelPars1->exratee*pe;
/*Determine total decay rate constants from T1 and T2 decay and
chemical exchange*/
k1a=1/voxelPars1->T1a+Cabw+Cab+Cac+Cad+Cae; k2a=1/voxelPars1>T2a+Cabw+Cab+Cac+Cad+Cae;
k1bw=1/voxelPars1->T1bw+Cbw; k2bw=1/voxelPars1->T2bw+Cbw;
k1b=1/voxelPars1->T1b+Cb; k2b=1/voxelPars1->T2b+Cb;
k1c=1/voxelPars1->T1c+Cc; k2c=1/voxelPars1->T2c+Cc;
k1d=1/voxelPars1->T1d+Cd; k2d=1/voxelPars1->T2d+Cd;
k1e=1/voxelPars1->T1e+Ce; k2e=1/voxelPars1->T2e+Ce;
/*Define bulk (ALL spins) magnetization vector B, which starts out
composed only of z components*/
/*And Y, which will hold our calculated signal vectors*/
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double B[] = {(M0a/voxelPars1->T1a),0,0,(M0bw/voxelPars1>T1bw),0,0,(M0b/voxelPars1->T1b),0,0,(M0c/voxelPars1>T1c),0,0,(M0d/voxelPars1->T1d),0,0,(M0e/voxelPars1->T1e),0,0};
double Y0[] = {M0a,0,0,M0bw,0,0,M0b,0,0,M0c,0,0,M0d,0,0,M0e,0,0};
double Y[18] = {0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0}; ;
/*double *pntrB;
pntrB = (double *) mxCalloc(18, sizeof(double));
double *pntrY;
pntrY = (double *) mxCalloc(18, sizeof(double));
double *pntrY0;
pntrY0 = (double *) mxCalloc(18, sizeof(double));*/
double *pntrMz;
/* mexPrintf("Did all of the arithmetic using values from
voxelPars.\n");
mexEvalString("drawnow;");*/

Now we define the matrices describing the Bloch-McConnell equations themselves. This is
obviously a little too small to read, but see Chapter 1b of this thesis for closer examination of
these matrices and the equations that they represent. First, the ‘pulse off’ matrix, Ad. This matrix
is static once we have defined all of the input parameters to the simulation.
/*Define matrix Ad, which describes evolution of the magnetization
during periods with no pulse (decay)*/
double Ad [18][18] = {
{ -1.0*k1a,
0,
0,
Cbw,
0,
0,
Cb,
0,
// Mza
{0,
-1.0*k2a,
Wa,
0,
Cbw,
0,
0,
Cb,
// Mya
{0,
-1.0*Wa,
-1.0*k2a,
0,
0,
Cbw,
0,
0,
// Mxa
{Cabw,
0,
0,
-1.0*k1bw, 0,
0,
0,
0,
// Mzb
{0,
Cabw,
0,
0,
-1.0*k2bw,
Wbw,
0,
0,
Myb
{0,
0,
Cabw,
0,
-1.0*Wbw,
-1.0*k2bw, 0,
0,
// Mxb
{Cab,
0,
0,
0,
0,
0,
-1.0*k1b,
0,
Mzb
{0,
Cab,
0,
0,
0,
0,
0,
-1.0*k2b,
// Myb
{0,
0,
Cab,
0,
0,
0,
0,
-1.0*Wb,
// Mxb
{Cac,
0,
0,
0,
0,
0,
0,
0,
0,
Mzc
{0,
Cac,
0,
0,
0,
0,
0,
0,
0,
Myc
{0,
0,
Cac,
0,
0,
0,
0,
0,
0,
// Mxc
{Cad,
0,
0,
0,
0,
0,
0,
0,
0,
// Mzd
{0,
Cad,
0,
0,
0,
0,
0,
0,
0,
// Myd
{0,
0,
Cad,
0,
0,
0,
0,
0,
0,
// Mxd
{Cae,
0,
0,
0,
0,
0,
0,
0,
0,
// Mze
{0,
Cae,
0,
0,
0,
0,
0,
0,
0,
// Mye
{0,
0,
Cae,
0,
0,
0,
0,
0,
0,
// Mxe
};

0,

Cc,

0,

0,

Cd,

0,

0,

Ce,

0,

0},

0,

0,

Cc,

0,

0,

Cd,

0,

0,

Ce,

0} ,

Cb,
0,

0,
0,

0,

0,

Cc,

0,

0,

0,

0,

0,

0,

0,

0,

0,
0,

0,
0,

0,

0,

0,

Cd,
0,
0,

0,

0,

0,

0,
0,
0,

0,
0,
0,

0,

Ce},
0},
0},

0,

0,

0,

0,

0,

0,

0,

0,

0,

0,

0},

Wb,

0,

0,

0,

0,

0,

0,

0,

0,

0},

-1.0*k2b,

0,

-1.0*k1c,

0,
0,

0,

-1.0*k2c,

0,

-1.0*Wc,

0,

0,

0,

0,

0,

0,

0,

0,

0,

0,

0,

0},

Wc,

0,

0,

0,

0,

0,

0},

0,

-1.0*k1d,

0,

0,

0,

0,

0,

0,

0,

0,

-1.0*k2d,

0,

0,

0,

0,

-1.0*Wd,

0,

0,

0,

0,

0,

0,

0,

0,

0,

0,

0,

0,

0,

Wd,

0,

0,

-1.0*k2d,

0,

-1.0*k1e,

//
//
0},

0},
0},
0,

0,

//

0},

0,

-1.0*k2c,

//
0},

0},
0},

0,

0,

0,

0,

0,

0,

0,

-1.0*k2e,

We},

0,

0,

0,

0,

0,

0,

0,

-1.0*We,

-1.0*k2e}

/*Define matrix Aa, which describes the evolution of the
magnetization during the pulse for the "positive offset" calculation.
*The relevant elements with W get updated within the loop*/
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As I wrote above, the other matrix is ‘pulse on’, so its elements change as a function of whatever
the pulse is doing at that instant in time (i.e., that index of the vector representing time, which
the loop is over). There are actually two copies of this matrix, labeled Aa and Ab, to represent the
saturation pulse being at the positive offset or negative offset. They are actually “the same” if
you look at this code closely, but note that the value of ‘W’ which they are filled with changes,
gaining a negative sign before filling the second matrix Ab.
/*First we're going to do the "experiment" with the positive offset
frequency*/
W = voxelPars1->puloffsetppm * voxelPars1->cf *2.0*pi;
// mexPrintf("W of the positive offset experiment has been set to:
%f.\n", W);
// mexPrintf("W-Wa equals: %f. Wa-W equals:%f\n", W-Wa, Wa-W);
double

Aa[18][18] = {
{-1.0*k1a,
W1x[0],
W1y[0],
Cbw,
0,
0,
Cb,
0,
0,
Cc,
0,
0,
Cd,
0,
0,
Ce,
0,
0 },
// Mza
{ -1.0*W1x[0],
-1.0*k2a,
Wa-W,
0,
Cbw,
0,
0,
Cb,
0,
0,
Cc,
0,
0,
Cd,
0,
0,
Ce,
0 },
// Mya
{
W1y[0],
W-Wa,
-1.0*k2a,
0,
0,
Cbw,
0,
0,
Cb,
0,
0,
Cc,
0,
0,
Cd,
0,
0,
Ce },
// Mxa
{ Cabw,
0,
0,
-1.0*k1bw, W1x[0],
W1y[0],
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0 }, // Mzb
{
0,
Cabw,
0,
-1.0*W1x[0],
-1.0*k2bw, Wbw-W, 0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0 },
// Myb
{
0,
0,
Cabw, W1y[0],
W-Wbw, -1.0*k2bw, 0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0 }, // Mxb
{
Cab,
0,
0,
0,
0,
0,
-1.0*k1b,
W1x[0],
W1y[0],
0,
0,
0,
0,
0,
0,
0,
0,
0 }, // Mzb
{
0,
Cab,
0,
0,
0,
0,
-1.0*W1x[0],
-1.0*k2b, Wb-W,
0,
0,
0,
0,
0,
0,
0,
0,
0 }, // Myb
{
0,
0,
Cab,
0,
0,
0,
W1y[0],
W-Wb,
-1.0*k2b, 0,
0,
0,
0,
0,
0,
0,
0,
0 }, // Mxb
{
Cac,
0,
0,
0,
0,
0,
0,
0,
0, -1.0*k1c,
W1x[0],
W1y[0],
0,
0,
0,
0,
0,
0 }, // Mzc
{
0,
Cac,
0,
0,
0,
0,
0,
0,
0, -1.0*W1x[0], -1.0*k2c, Wc-W,
0,
0,
0,
0,
0,
0 }, // Myc
{
0,
0,
Cac,
0,
0,
0,
0,
0,
0,
W1y[0], W-Wc,
-1.0*k2c, 0,
0,
0,
0,
0,
0 }, // Mxc
{
Cad,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
-1.0*k1d,
W1x[0],
W1y[0],
0,
0,
0 }, // Mzd
{
0,
Cad,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
-1.0*W1x[0], -1.0*k2d, Wd-W,
0,
0,
0 }, // Myd
{
0,
0,
Cad,
0,
0,
0,
0,
0,
0,
0,
0,
0,
W1y[0], W-Wd, -1.0*k2d,
0,
0,
0 },
//Mxd
{
Cae,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
-1.0*k1e, W1x[0],
W1y[0] },
// Mze
{
0,
Cae,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
-1.0*W1x[0], -1.0*k2e, We-W }, // Mye
{
0,
0,
Cae,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
W1y[0], W-We, -1.0*k2e }
// Mxe

};
//
mexPrintf("Element [2][1] of [Aa] has been set equal to:
%f.\n", Aa[2][1]);
/*Then we're going to the the "negative offset" experiment.*/
W = -(voxelPars1->puloffsetppm) * voxelPars1->cf *2.0*pi;
// mexPrintf("W of the negative offset experiment has been set
to: %f.\n", W);
// mexPrintf("W-Wa equals: %f. Wa-W equals: %f\n", W-Wa, Wa-W);
/*Define matrix Ab (same as Aa), which describes the
evolution of the magnetization during the pulse for the "negative
offset" calculation.
*The relevant elements get updated within the loop*/
double Ab[18][18] = {
{ -1.0*k1a,
W1x[0],
W1y[0],
Cbw,
0,
0,
Cb,
0,
0,
Cc,
0,
0,
Cd,
0,
0,
Ce,
0,
0 },
// Mza
{ -1.0*W1x[0],
-1.0*k2a,
Wa-W,
0,
Cbw,
0,
0,
Cb,
0,
0,
Cc,
0,
0,
Cd,
0,
0,
Ce,
0 },
// Mya
{ W1y[0],
W-Wa,
-1.0*k2a,
0,
0,
Cbw,
0,
0,
Cb,
0,
0,
Cc,
0,
0,
Cd,
0,
0,
Ce },
// Mxa
{ Cabw,
0,
0,
-1.0*k1bw, W1x[0],
W1y[0],
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0 },
// Mzb
{
0,
Cabw,
0,
-1.0*W1x[0],
-1.0*k2bw, Wbw-W,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0 },
// Myb
{
0,
0,
Cabw, W1y[0],
W-Wbw, -1.0*k2bw, 0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0 },
// Mxb
{
Cab,
0,
0,
0,
0,
0,
-1.0*k1b,
W1x[0],
W1y[0],
0,
0,
0,
0,
0,
0,
0,
0,
0 },
// Mzb
{
0,
Cab,
0,
0,
0,
0,
-1.0*W1x[0],
-1.0*k2b, Wb-W,
0,
0,
0,
0,
0,
0,
0,
0,
0 },
// Myb
{
0,
0,
Cab,
0,
0,
0,
W1y[0],
W-Wb,
-1.0*k2b, 0,
0,
0,
0,
0,
0,
0,
0,
0 },
// Mxb
{
Cac,
0,
0,
0,
0,
0,
0,
0,
0, -1.0*k1c,
W1x[0],
W1y[0],
0,
0,
0,
0,
0,
0 },
// Mzc
{
0,
Cac,
0,
0,
0,
0,
0,
0,
0, -1.0*W1x[0], -1.0*k2c, Wc-W,
0,
0,
0,
0,
0,
0 },
// Myc
{
0,
0,
Cac,
0,
0,
0,
0,
0,
0,
W1y[0], W-Wc,
-1.0*k2c, 0,
0,
0,
0,
0,
0 },
// Mxc
{
Cad,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
-1.0*k1d,
W1x[0],
W1y[0],
0,
0,
0 },
// Mzd
{
0,
Cad,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
-1.0*W1x[0], -1.0*k2d, Wd-W,
0,
0,
0 },
// Myd
{
0,
0,
Cad,
0,
0,
0,
0,
0,
0,
0,
0,
0,
W1y[0], W-Wd,
-1.0*k2d, 0,
0,
0 },
// Mxd
{
Cae,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
-1.0*k1e, W1x[0],
W1y[0]},
// Mze
{
0,
Cae,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
-1.0*W1x[0], -1.0*k2e, We-W},
// Mye
{
0,
0,
Cae, 0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
W1y[0], W-We, -1.0*k2e}
// Mxe

};
/* mexPrintf("Initialized our three big matrices!\n");
mexEvalString("drawnow;");*/

In order to solve the system of differential equations, we’ll need to use the inverse of matrix Ad,
so we’re calculating it ahead of time. This is done by a separate function, MatrInv, which will be
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defined below. Note that the function r8mat_mm is a matrix multiplication function from the r8
library.
/*Calculate inverse of Ad, for use in solution to Bloch equation;
determine its action on B, store in vector AdinvB. */
for (i=0; i<18; i++){
for(j=0; j<18; j++){
pntrA[i][j] = Ad[i][j];
CopyOfMatrix[i][j] = pntrA[i][j]; /* 9/5/17*/
}
}
MatrInv(pntrA, 18, CopyOfMatrix, vector, indx, col);

for (i=0; i<18; i++){
pntrB[i] = B[i];
}
/*pntrA is already pointing to Adinv, but needs to be 1d for
MM()*/
for (i=0; i<18; i++){
for(l=0; l<18; l++){
pntrA1[i*18+l] = pntrA[i][l];
}
}
r8mat_mm(18,18,1, pntrA1, pntrB, pntrAinvB);
/*Dereference pointer to store result*/
for (i=0; i<18; i++){
AdinvB[i] = pntrAinvB[i];
}
/*Set the RF pulse vector W1.*/
for (i=0; i<voxelPars1->count1; i++){
W1[i] = voxelPars1->ampl[i]*voxelPars1->b1*2*pi;
}
/*First we're going to do the "experiment" with the positive
offset frequency*/
for (n1=0; n1< npul; n1++){ //loop over number of pulses
for (j=0; j< voxelPars1->count1; j++){ //loop over time
increments within each pulse
/*Define x and y components of the (circularly polarized)
RF pulse*/
/*

W1x = W1(j-1)*cos(phi(j-1)); W1y = W1(j-1)*sin(phi(j-1));

*/
W1x[j] = W1[j-1]*cos(voxelPars1->phi[j-1]);
W1y[j] = W1[j-1]*sin(voxelPars1->phi[j-1]);
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These lines below update the values of Aa in accordance with the pulse vector. The line with the
asterisks is what makes this the positive offset run and not the negative one (by setting pntrA to
point to matrix Aa as opposed to matrix Ab). Otherwise, the two blocks of code are identical.
/*Update relevant elements of Aa with new values of W1x and
W1y*/
for (i=0; i<6;
k = i*3;
Aa[k][k+1]
Aa[k][k+2]
Aa[k+1][k]
Aa[k+2][k]
}

i++){
=
=
=
=

W1x[j];
W1y[j];
-W1x[j];
W1y[j];

/*Invert A and determine its action on B*/
for (i=0; i<18; i++){
for(m=0; m<18; m++){
pntrA[i][m] = Aa[i][m]; *****
CopyOfMatrix[i][m] = pntrA[i][m]; /* 9/11/17*/
}
}
MatrInv(pntrA,18, CopyOfMatrix, vector, indx, col);
/*pntrA is now pointing to Ainv*/
for (i=0; i<18; i++){
pntrB[i] = B[i];
}
/*pntrA is already pointing to Aainv, but needs to be 1d
for MM()*/
for (i=0; i<18; i++){
for(l=0; l<18; l++){
pntrA1[i*18+l] = pntrA[i][l];
}
}
r8mat_mm(18,18,1, pntrA1, pntrB, pntrAinvB);
for (i=0; i<18; i++){ /*Dereference pointer to store
result*/
AinvB[i] = pntrAinvB[i];
}

/*Use AinvB in the solution for the Bloch equation, for
Y(t) after this very small dt*/
/* [Y=expm(timeStepSize*Aa)*(Y0+AinvB)-AinvB] using:
void CalculateY(double *pntrY, double timeScalar, double
**pntrA, double *pntrY0, double *pntrAinvB);*/
/*
mexPrintf("AinvB = %f ,%f ,%f ,%f ...\n", AinvB[0],
AinvB[3], AinvB[6], AinvB[9]);
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mexPrintf("Y0 = %f ,%f, %f, %f ... \n", Y0[0], Y0[3],
Y0[6], Y0[9]);
mexPrintf("Y = %f ,%f, %f, %f ... \n", Y[0], Y[3], Y[6],
Y[9]);*/
/*Assign pointers--pntrA is already pointing to matrix Aa*/
for (i=0; i<18; i++){
pntrY[i] = Y[i];
pntrY0[i] = Y0[i];
pntrAinvB[i] = AinvB[i];
for(m=0; m<18; m++){
pntrA[i][m] = Aa[i][m];
}
}

CalculateY is yet another subfunction which does the rest of the math once we have already
done the step of calculating the matrix inverse and its action on the magnetization vector B.
First, it is called with ‘AinvB’ set for one of the positive offset “pulse on” matrix. It will be
documented next.
/*Call function, pass pointer arguments*/
CalculateY(pntrY,timeStepSize,pntrA,pntrY0,pntrAinvB, Aat,
Aate, sum, product);
/*Dereference pointer to store result*/
for (i=0; i<18; i++){
Y[i] = pntrY[i];
}
// mexPrintf("Y = %f ,%f, %f, %f ... \n", Y[0], Y[3], Y[6],
Y[9]);
/*Set this solution Y as Y0, the ansatz for the next
iteration*/
for (i=0; i< 18; i++){
Y0[i] = Y[i];
}
//
mexPrintf("Finished this interation of CalculateY.j = %d.
Y[0] = %f, M0a = %f.\n", j, Y[0], M0a);
}//end loop over time increments within one pulse

The duty cycle (i.e. the time that the pulse is actually on) of our experiments is not 100%. So,
next we call CalculateY again with AinvB set to describe the action of that ‘decay’ matrix instead.
/*Use AdinvB to calculate the evolution of the magnetization
during the time between pulses*/
/* [Y=expm(pw1delay*0.001*Ad)*(Y0+AdinvB)-AdinvB] using:
void CalculateY(double *pntrY, double timeScalar, double
**pntrA, double *pntrY0, double *pntrAinvB);*/
/*Assign pointers*/
for (i=0; i<18; i++){
pntrY[i] = Y[i];
pntrY0[i] = Y0[i];
pntrAinvB[i] = AdinvB[i];
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for(j=0; j<18; j++){
pntrA[i][j] = Ad[i][j];
}
}
/*Call function, pass pointers*/
// mexPrintf("Upcoming call to CalculateY is for
relaxation.\n");
CalculateY(pntrY, pw1delay*0.001, pntrA, pntrY0,pntrAinvB, Aat,
Aate, sum, product);
/*Dereference pointer to store result*/
for (i=0; i<18; i++){
Y[i] = pntrY[i];
// if(n1 == (npul-1)) mexPrintf("Y[i] = %f.\n", Y[i]);
}
/*Zero Mx and MY for all six species before next pulse-- EDITED
9/13/17*/
for (i=0; i<6;i++){
Y[(i)*3 + 1] = 0.0;
Y[(i)*3 + 2] = 0.0;
}
for (i=0; i< 18; i++){
Y0[i] = Y[i];
// if(n1 == (npul-1)) mexPrintf("Y[i] = %f.\n", Y[i]);
}
// mexPrintf("Y[0] after pulse %d = %f\n", n1,Y[0]);
}//end loop over pulses

This is the end of the ‘positive offset’ experiments. The answer (that is, the values of Mz after
the saturation pulse for pulses of all B1 values - -or whatever the variable parameter is) is
assigned to the variable contrast.SimMza. After the ‘negative offset’ experiments, we will store
the vector of answers in contrast. SimMzb.
/*Store the resuls of the "+" simultion in SimMza.*/
contrast->SimMza = Y[0]/M0a;
/* mexPrintf("After SimA. Y[0] = %f, M0a = %f.\n", Y[0], M0a);*/
////////////////////////////////////////////////Repeat everything for
negative offset experiment
/*Now we're going to the the "negative offset" experiment.*/
/* W = -(voxelPars.puloffsetppm) * voxelPars.cf *2.0*pi;*/
/*double Y0[] =
{M0a,0,0,M0bw,0,0,M0b,0,0,M0c,0,0,M0d,0,0,M0e,0,0};*/
for (i=0; i<18; i++){
if (i ==0) Y0[i] = M0a;
else if (i ==3) Y0[i] = M0bw;
else if (i ==6) Y0[i] = M0b;
else if (i ==9) Y0[i] = M0c;
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else if (i ==12) Y0[i] = M0d;
else if (i ==15) Y0[i] = M0e;
else Y[i] = 0;
}
for (n1=0; n1< npul; n1++){ //loop over number of pulses
for (j=0; j< voxelPars1->count1; j++){ //loop over time
increments within each pulse
/*Define x and y components of the (circularly polarized)
RF pulse*/
/*

W1x = W1(j-1)*cos(phi(j-1)); W1y = W1(j-1)*sin(phi(j-1));

*/
W1x[j] = W1[j-1]*cos(voxelPars1->phi[j-1]);
W1y[j] = W1[j-1]*sin(voxelPars1->phi[j-1]);
// mexPrintf("W1x = %f, W1y = %f, j = %d.\n", W1x[j],
W1y[j], j);
/*Update relevant elements of Ab with new values of W1x and
W1y*/
for (i=0; i<6; i++){
k = i*3;
Ab[k][k+1] = W1x[j];
Ab[k][k+2] = W1y[j];
Ab[k+1][k] = -W1x[j];
Ab[k+2][k] = W1y[j];
//mexPrintf("Inside loop to reassign W1[k]. W1x[k] =
%f.\n", W1x[k]);
}
/*Invert A and determine its action on B*/
/* AinvB = LUAug4(Ab)*B;*/
for (i=0; i<18; i++){
for(m=0; m<18; m++){
pntrA[i][m] = Ab[i][m]; *****
CopyOfMatrix[i][m] = pntrA[i][m]; /* 9/11/17*/
}
}
MatrInv(pntrA, 18, CopyOfMatrix, vector, indx, col);
// mexPrintf("Calculated inverse of [Ab].\n");
/*pntrA is already pointing to Ainv*/
for (i=0; i<18; i++){
for(l=0; l<18; l++){
pntrA1[i*18+l] = pntrA[i][l];
}
}
for (i=0; i<18; i++) pntrB[i] = B[i];
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r8mat_mm(18,18,1, pntrA1, pntrB, pntrAinvB);
/*Dereference pointer to store result*/
for (i=0; i<18; i++){
AinvB[i] = pntrAinvB[i];
}

/*Use AinvB in the solution for the Bloch equation, for
Y(t) after this very small dt*/
/*[Y=expm(timeStepSize*Ab)*(Y0+AinvB)-AinvB] using:
void CalculateY(double *pntrY, double timeScalar, double
**pntrA, double *pntrY0, double *pntrAinvB);*/
/*Assign pointers*/
for (i=0; i<18; i++){
pntrY[i] = Y[i];
pntrY0[i] = Y0[i];
pntrAinvB[i] = AinvB[i];
for(m=0; m<18; m++){
pntrA[i][m] = Ab[i][m];
}
}
/*Call function, pass pointer arguments*/
CalculateY(pntrY,timeStepSize,pntrA,pntrY0,pntrAinvB, Aat,
Aate, sum, product);
/*Dereference pointer to store result*/
for (i=0; i<18; i++){
Y[i] = pntrY[i];
}
/*Set this solution Y as Y0, the ansatz for the next
iteration*/
for (i=0; i< 18; i++){
Y0[i] = Y[i];
}
}//end loop over time increments within one pulse
/*Y=expm(pw1delay*0.001*Ad)*(Y0+AdinvB)-AdinvB;
void CalculateY(double *pntrY, double timeScalar, double
**pntrA, double *pntrY0, double *pntrAinvB);*/
/*Assign pointers*/
for (i=0; i<18; i++){
pntrY[i] = Y[i];
pntrY0[i] = Y0[i];
pntrAinvB[i] = AdinvB[i];
for(j=0; j<18; j++){
pntrA[i][j] = Ad[i][j];
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}
}
// mexPrintf("Upcoming call to CalculateY is for
relaxation.\n");
CalculateY(pntrY, pw1delay*0.001, pntrA, pntrY0,pntrAinvB, Aat,
Aate, sum, product);
for (i=0; i<18; i++){ /*Dereference pointer to store result*/
Y[i] = pntrY[i];
//if(n1 == (npul-1)) mexPrintf("Y[i] = %f.\n", Y[i]);
}
/*Zero Mx and MY for all six species before next pulse-- EDITED
9/13/17*/
for (i=0; i<6;i++){
Y[(i)*3 + 1] = 0.0;
Y[(i)*3 + 2] = 0.0;
}
for (i=0; i< 18; i++){
Y0[i] = Y[i];
//if(n1 == (npul-1)) mexPrintf("Y[i] = %f.\n", Y[i]);
}
//mexPrintf("Y[0] after pulse %d = %f\n", n1,Y[0]);
}//end loop over pulses

/*Store the resuls of the "+" simulation in SimMza.*/
contrast->SimMzb = Y[0]/M0a;
/* mexPrintf("After SimB. Y[0] = %f, M0a = %f.\n", Y[0], M0a);*/

Now that we’ve done both offsets, before we return our answer to the main mex function,
we’re going to calculate one more thing: the negative-normalized asymettry as a percent, giving
us what we usually report as the gluCEST value.
/*Calculate contrast between "+" and "-" experiments*/
contrast->contrastz = 100 * (contrast->SimMzb - contrast>SimMza)/contrast->SimMzb;
// mexPrintf("pw1 was set equal to: %f.\n", voxelPars.pw1);
// mexPrintf(" %f\t %f\n", contrast->SimMza, contrast->SimMzb);
/* Output arguments: ....
*...I guess they should just be SimMza1, SimMzb, and contrastz.
--remember that if the pointers are assigned properly, you won't need
to explicitly
return anything! */
/* mxFree(CopyOfMatrix); mxFree(Aat); mxFree(Aate);
mxFree(vector);mxFree(indx);mxFree(col);
mxFree(sum); mxFree(product);*/
//mexPrintf("Reached end of calculate(). Contrastz has been calculated
as: %f .Going back to mex function.\n", contrast->contrastz);
return;
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}

Ok, at long last, this is the end of calculate().
Matrix inversion – still part of CalculateMz3.cpp
Here’s the matrix inverstion function. This is basically taken from Numerical Recipes.
/*Adapted from wrapper function of LUAug4.cpp*/
void MatrInv(double **matrix, int n, double **CopyOfMatrix, double
*vector, int *indx, double *col){
/* mexPrintf("Inside MatrInv().\n");
mexPrintf("The first square of matrix is: %f, %f, %f, %f.\n",
matrix[0][0],matrix[0][1],matrix[1][0],matrix[1][1]);
mexEvalString("drawnow;");*/
//for our friends *indx and *vector
/* double *vector;
int *indx;
double *col;*/
int i,j;
/*Create copy of matrix to send to internal functions
double **CopyOfMatrix;
CopyOfMatrix = (double**)mxCalloc(n, sizeof(double*));
for (i=0; i<n; i++){
CopyOfMatrix[i] = (double*)mxCalloc(n, sizeof(double));
for (j=0; j<n; j++){
CopyOfMatrix[i][j] = matrix[i][j];
}
}*/
/* for (j=0; j<n; j++){
CopyOfMatrix[i][j] = matrix[i][j];
}*/
/* vector = (double *)mxCalloc(n, sizeof(double));
indx = (int *)mxCalloc(n, sizeof(int));
col = (double *)mxCalloc(n, sizeof(double));*/
double holder;
int d = 0;
// mexPrintf("Inside MatrInv(). Declared local variables. \n");
// mexEvalString("drawnow;");
//then we send everything to ludcmp, which returns c as its
decomposition
ludcmp(CopyOfMatrix, n, indx, vector, d);
// mexPrintf("Inside MatrInv(). Returned from ludcmp.\n");
// mexEvalString("drawnow;");
for (j=0; j<n;j++){
for (i=0; i<n; i++){
col[i] = 0.0;
}
col[j]=1.0;
//This constructs the necessary column of the identity matrix to
send to lubksb()
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lubksb(CopyOfMatrix, n ,indx, col);
// mexPrintf("Inside MatrInv(). Returned from one call of
bksb.\n");
// mexEvalString("drawnow;");
//the key output we care about from here is actually "col"
for (i=0; i<n; i++){
//
mexPrintf("Col[i] = %f.\n", col[i]);
holder =(double)col[i];
matrix[j][i] = holder; //Now "matrix" will hold the inverse
of the "matrix" that was sent...
}
/* mexPrintf("Filled 'matrix'. Returning now for safety.\n");
mexEvalString("drawnow;");
return;*/
}
/* mexPrintf("Done with loops in MatrInv().\n");
mexEvalString("drawnow;");*/
/* mxFree(vector);mxFree(indx);mxFree(col);*/
/* mxFree(CopyOfMatrix);*/
return;
}

Calculate2.h
This header file contains the function that actually does the numerical solving, which I’ve
divided into five steps, or ‘functions’. It uses one more function defined in a separate header,
matrix_exponential, which will follow. As mentioned before, I ended up not using my own
Multiply and Divide, so they are actually not defined here.
#include <stdio.h>
#include <string.h>
#include "matrix_exponential.h"
void CalculateY(double *pntrY, double timeScalar, double **pntrA,
double *pntrY0, double *pntrAinvB, double *Aat, double *Aate, double
*sum, double *product);
void MatrInv (double **matrix, int n, double **CopyOfMatrix, double
*vector, int *indx, double *col);
void Multiply (double *pntrAinvB, double **pntrAinv, double *pntrB);
void Divide (double *pntrMz, double *pntrY0, double M0a);

CalculateY() --in Calculate2.h, called by Calculate()
void CalculateY(double *pntrY, double timeScalar, double **pntrA,
double *pntrY0, double *pntrAinvB, double *Aat, double *Aate, double
*sum, double *product){
int i,j;
char *title;
/*declare pointers to mxArrays*/
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mxArray *input1, *input2, *output;
mxArray *ppRHS[2];

/*First function: Add Y0 to AinvB*/
for (i=0; i<18; i++){
sum[i] = pntrY0[i]+pntrAinvB[i];
}
/*Second function: Multiply timeScalar by A*/
for (i=0; i<18; i++){
for (j=0; j<18; j++){
Aat[i*18+j] = pntrA[j][i]*timeScalar;
}
}
/*
mexPrintf("About to display output (2): Aat. \n");
title = "Aat";
r8mat_print(18,18,Aat,title);
*/
/*Third function: Find matrix exponential of Aat*/
Aate = r8mat_expm1(18, Aat);
/* mexPrintf("About to display output (3): Aate. \n");
title = "Aaate";
r8mat_print(18,18,Aate,title); */
/*Fourth function: multiply Aate and sum*/
r8mat_mm(18,18,1, Aate, sum, product);
/* mexPrintf("About to display output (4): product. \n");
title = "Product";
r8mat_print(18,1,product,title); */
/*Fifth function: Subtract AinvB from product*/
for (i=0; i<18; i++){
pntrY[i]= product[i]-pntrAinvB[i];
}
/*

mexPrintf("About to display output (5): Y. \n");
title = "Y (result)";
r8mat_print(18,1,pntrY,title); */

}

matrix_exponential.h
This is copied and pasted from a multi-function C file from the r8 library.
#include <stdlib.h>
#include <stdio.h>
#include "r8lib.h"
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/*
Complex functions.
double complex *c8mat_expm1 ( int n, double complex a[] );
/*
Real functions. A.C: I'm only going to use r8mat_expm1, matrix
exponentiation by Pade approximation.
*/
double *r8mat_expm1 ( int n, double *a );
double *r8mat_expm2 ( int n, double a[] );
double *r8mat_expm3 ( int n, double a[] );
double *r8mat_expm1 ( int n, double *a )
{
/*mexPrintf("Are we there yet??");
char *title = "matrixSent2Exp";
r8mat_print(18,18,a,title);*/
double *a2;
double a_norm;
double c;
double *d;
double *e;
int ee;
int k;
const double one = 1.0;
int p;
const int q = 6;
int s;
double t;
double *x;
a2 = r8mat_copy_new ( n, n, a );
/* mexPrintf("n is %d. First element of a2 is: %f\n",n, a2[0]);*/
a_norm = r8mat_norm_li ( n, n, a2 );
ee = ( int ) ( r8_log_2 ( a_norm ) ) + 1;
s = i4_max ( 0, ee + 1 );
t = 1.0 / pow ( 2.0, s );
r8mat_scale ( n, n, t, a2 );
x = r8mat_copy_new ( n, n, a2 );
c = 0.5;
e = r8mat_identity_new ( n );
r8mat_add ( n, n, one, e, c, a2, e );
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d = r8mat_identity_new ( n );
r8mat_add ( n, n, one, d, -c, a2, d );
p = 1;
for ( k = 2; k <= q; k++ )
{
c = c * ( double ) ( q - k + 1 ) / ( double ) ( k * ( 2 * q - k + 1
) );
r8mat_mm ( n, n, n, a2, x, x );
r8mat_add ( n, n, c, x, one, e, e );
if ( p )
{
r8mat_add ( n, n, c, x, one, d, d );
}
else
{
r8mat_add ( n, n, -c, x, one, d, d );
}
p = !p;
}
/*
E -> inverse(D) * E
*/
r8mat_minvm ( n, n, d, e, e );
/*
E -> E^(2*S)
*/
for ( k = 1; k <= s; k++ )
{
r8mat_mm ( n, n, n, e, e, e );
}
free ( a2 );
free ( d );
free ( x );
/* mexPrintf("At the end of exmp. e[0] = %f; e[1] = %f\n", e[0],
e[1]);*/
return e;
}
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Appendix B: GluCEST post-processing in Matlab
Abby, CMROI
January 2021
Introductory Note
The purpose of this documentation is to explain in an accessible, informal, hands-on way how to
do the post-processing and analysis of human brain gluCEST data, including some things that I
developed while working in our lab. This includes:
--How to collect and fit B1 calibration data as in Cember et al 2021 [done]
--How to use the resulting ‘surfaces’ in post-processing of 2D [done] and 3D gluCEST data
--How the rest of the post-processing works (i.e., what is this code doing, anway?)
--How to create DICOMs and NIFTIs from the resulting CEST maps [done]
--How to do automatic segmentation of brain anatomy using Freesurfer and the Segmentation
Service in ITK-SNAP
--How to do ROI-based analysis of your CEST data based on the results of these segmentations
Currently, I do post-processing of 2D CEST data in a command-line based function that I wrote
myself, but use Hari’s GUI-based post-processing for 3D data. Most of the underlying code –and
everything that happens after we get the CEST map-- is the same.
Important note: ALL AUTOMATIC SEGMENTATIONS REQUIRE A FULL-BRAIN T1 IMAGE. If you do
not acquire this on your subjects, you can generate CEST maps of your slice or slab, but cannot
do any of the other analysis that I describe here. ALWAYS COLLECT A FULL-BRAIN T1
STRUCTURAL IMAGE.
All of the code described here already exists. However, this document is designed so that, if
desired, you can copy and paste Matlab code from this word document into Matlab to create
your own version of these scripts and functions.
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Let’s start with walking through using my code to process 2D CEST data, as this will serve as an
overview and provide context before we dive into everything else.
Important note on compiling mex files: Some of the steps in CEST post-processing (e.g. B0
correction) and also in ‘B1 fitting’ as described here make use of mex files. Unlike regular
Matlab .m files, mex files need to be compiled before they can run. If someone gave you a
bunch of code, it’s likely that the compiled version of the mex file already exists, and you
don’t need to worry about this. However, if someone with a Windows machine gave you
code, and you have a Mac – or vice versa—you might need to. For every file that ends with
“.c” or “.cpp”, you need to have a corresponding one that ends with “.mexw64” for Windows
or something else (I’m not sure what the extension is) on Mac. Compiling is as simple as
typing: mex filename.cpp
However, if you’re on Windows, I highly recommending including this flag:
mex filename.cpp -compatibleDimArrays

I’m not 100% how to tell when this will and won’t be needed, but if you don’t use it, you can
cause a memory leak during the conversion between Matlab dim variable types and C int.
Matlab will crash and you will have no idea why.
Post-processing of 2D CEST data: Getting from scanner data to a CEST map DICOM or NIFTI
If you have gotten your data off of the scanner, it will already be sorted into folders based on
the sequence. If you got your data off of the Linux machine known affectionately as Pedro (and
the RTEXPORT folder), the dicoms will be unsorted. You will need to begin by running the
function cdsort3d.m.
Almost all of our in-house code requires a library of functions contained in a folder labeled
“COMMON”. It has to be on the path in order for all downstream functions to work. (‘cdsort’ is
in this folder.)
To do post-processing of GluCEST data, use the folder called “Code for using Abby’s B1
correction”.
Begin by running the main function – right now, it’s called
MAINFunction_CorrectUsingFittingGear319A. I will call it ‘Main’ for short from
here on. It does not require any input arguments.
function processed = MAINFunction_CorrectUsingFittingGear319A()
%Changed Fitting Gear to 319A, 10/11/2020
load('FittingGear_319A');
DataStruct = ReadNewData();
DataStruct = NewDataToDataStruct(DataStruct);
DataStruct = CreateMasks(DataStruct, FittingGear_319A);
DataStruct = CorrectB1_F(DataStruct, FittingGear_319A);
processed = DataStruct;
end
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The first thing that this function will do is prompt you to read in all of the data from their
original dicom folders. If you look at the code, you will see that this is being accomplished by the
function ReadNewData(), which in turn calls several functions which begin with the word ‘Read’.
B0 correction and other things are accomplished here.
The next function that Main will call is called NewDatatoDataStuct(). This is a wrapper function
for internal use, and does not require you to do anything.
Next, CreateMasks() will sort the pixels into T1 bins. This sorting is done based on bin bounds
defined in the file called “FittingGear”. It will show you a color-coded T1 map as output so that
you can visualize the sorting.
Lastly, the B1 correction will be performed – also in accordance with “FittingGear”, which
specifies the correction surfaces. This function will prompt you to enter the nominal B1 value in
Hz: for our CEST sequences, this is 210 Hz.
NOTE: If you generate new and improved correction surfaces (collecting and fitting more data,
for example, or using a different sequence), only the “FittingGear” .mat file needs to be replaced;
it is modular. However, if the functional form itself changes (and not just the parameter values or
T1 bins), then the function called “evaluate…m” also needs to be replaced.
When you’re done, the struct which internally is called ‘processed’ will be returned as ‘ans’,
unless you gave it a name when you called the function. For example, you could type:
SubjectAC = MAINFunction_CorrectUsingFittingGear319A()

And then when this function is finished running, a variable called ‘SubjectAC’ will exist in the
workspace, which holds the data you just read in, and all of the outputs: T1 map, B1 map, etc. Of
course, it has the final CEST map: this will be in:
SubjectAC.B1correctedCEST_normNeg

I generally save this single-subject struct as a .mat file, and call it something like
‘SubjectAC_date_ProcessedData.m’. However, if you’re processing the data from many related
subjects at the same time, you can save all of the structs into a single .mat file. Just make sure to
save the workspace after each data set that you process! Occasionally, something may cause
Matlab to crash, and you don’t want to have to load all of this stuff over again!
At this point, you probably want to generate a DICOM and/or NIFTI from the final CEST map. To
do this, you can use the script WriteDicomNiftiCESTmap.m. (You can always do this later by
reloading the ‘ProcessedData’.m files.) When you press ‘Play/Run’ on this function, it will ask
you what struct you want the DICOM for. You should type the name of the struct exactly as it
appears in the workspace, e.g.: SubjectAC.
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It will also ask you to choose where you would like them saved, and then for a series number
(which can be totally arbitrary) and a file name/description.
DataName = input('Which DataStruct do you need a dicom for?');
str1 = sprintf('Please choose where you would like to save the
dicoms.');
pathname1 = uigetdir([DataName.refpath filesep '..'],str1); % file
chooser
outfolder = pathname1;
new_series = input(' Type in a new dicom series number between 500-999
: ');
new_description = input('Please type a description for these files
(dicom and nifti) (e.g. CEST map)', 's');
%%%
%Create Dicom from CEST map in Data Struct
%I think I need to actually create the dicoms in a folder that is on
the
%path for this function, otherwise dicom2nifit won't be able to find
%them...
[CESTdicom, outfolder1] = dicom_create_Abby(DataName.dicomhdr,
DataName.B1correctedCEST_normNeg, outfolder,new_series,
new_description,1);
addpath(outfolder1);
outfile = strcat(new_description,'.nii');
%Convert Dicom to Nifti
files=dir(CESTdicom);
names{1} = files(1).name;
dicom_spm2nifti(names,outfile); %8/14/2018
%vol = dicom_spm2nifti(infiles,outfile).'outfile' has to be a string
that
%includes a file extension.
%Edit nifti to be "three dimensional"
fixNIFTI(outfile);

The function will then also create a NIFTI from this DICOM. This whole process requires two
libraries to be in the Matlab path: spm8, and NIfTI (in addition to COMMON). You’ll see that at
the end of the script WriteDicomNiftiCESTmap.m, a function is called called fixNIFTI(). This is a
workaround to force the viewing program ITK-SNAP to treat a 2D image as if it is a 3D image,
thus orienting it properly in 3D space. The load_untouch_nii() and save_untouch_nii() functions
called here are part of the NIfTI library.
function fixNIFTI(filename)
%This will load an object of type 'nii'
current_NIFTI = load_untouch_nii(filename);
%This changes the variable
current_NIFTI.hdr.dime.dim(1) = 3;
%This saves the object 'nii' with given file name
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save_untouch_nii(current_NIFTI, filename);
end

The CEST NiFTI will be created in whatever the current Matlab directory is – which is probably
not where you want it to be stored indefinitely. I just immediately cut and paste it from there to
wherever the rest of the data is for that subject.
At this point, you can load your CEST DICOM or NIFTI to ITK-SNAP or another viewing program
and look at it as if you would any other image. Later on, I’ll talk about what to actually do with
these files in terms of analysis.
Fitting calibration data to produce the correction surfaces defined in “FittingGear***.mat”
Creating “Fitting Gear” Structs
Suppose we have collected B1 calibration data at B1 strengths ….[50,90,130,170,210,250]
Calibration data is read in by ReadCalibrationData.m:
This function reads in all of the data needed from a B1 calibration data set, but does NOT do any of the
fitting. The next step in the process is to run versions of sort*() and fit*() for the data set.

The user will see the following instruction, to which we respond with the B1 strengths
mentioned above:
Please enter the nominal B1 strengths at which data were
collected.(Use square brackets)
[50,90,130,170,210,250]

Type in the required CEST offset value in ppm :

(For gluCEST) 3.0
Note that if you’ve already loaded some of the data into a Matlab struct, you can send this
struct as an input argument to ReadCalibrationData, so that you don’t have to go through the
process of loading it again. The default situation coded here is that it assumes that a previously
loaded struct contains a B1 map and a defined ROI, but not the CEST data. You can change these
assumptions (and, consequently), the steps that are skipped, by altering the values of these
Boolean variables inside the code.
if isstruct(CurrentStruct)
%If we sent an input argument, it means that we've already loaded this
stuff
haveCEST = 0;
haveB1 = 1;
haveROI = 1;
else
haveCEST = 0;

251

haveB1 = 0;
haveROI = 0;
end

The user will then be asked to select the T1 images, to draw an ROI of none yet exists, the CEST
images for the first B1 point and WASSR images. The code will calculate the B0 map and do a B0
correction on the positive and negative offset CEST images for this B1 point. This process will be
repeated until all the data of all B1 points has been loaded and B0-corrected. Then, the user will
select the B1 map images, and the code will calculate the B1 map.
The new‘StructCalibration’ will then be returned from ReadCalibrationData.m
Setting the intervals for T1 bins: If for some reason one wants to re-determine the intervals for
T1 binning (for example, for collecting several new data sets which are on different slices – or
even, to use something entirely different as the ‘Index Image’), then this function can take up to
three different Index Images (eg. T1 maps), ask the user how many evenly-populated (e.g. T1)
bins they’d like to sort the data into, and it will figure out what the intervals should be.
function [NumMasks, Intervals] = setMaskIntervals(GoodIndexImage1,
GoodIndexImage2, GoodIndexImage3, LB, UB)
%Figure out how many useable pixels we have
if (~GoodIndexImage2)
%We only have one input T1 image
GoodIndexImage = GoodIndexImage1;
else
%We have at least two input T1 images
if(~GoodIndexImage3)
GoodIndexImage = [reshape(GoodIndexImage1,1, []),
reshape(GoodIndexImage2, 1, [])];
else
%We have three input T1 images
GoodIndexImage = [reshape(GoodIndexImage1,1, []),
reshape(GoodIndexImage2, 1, []),reshape(GoodIndexImage3, 1, [])];
end
end
AllValues = sort(GoodIndexImage(:));
AllValues = AllValues(AllValues > LB); %Set min pixel value for
binning
AllValues = AllValues(AllValues < UB); %Set max pixel value " " "
NumGoodPixels = numel(AllValues);
%Then, divide that number by whatever the user enters as the
%number of masks.variable: NumMasks
MasksPrompt = 'Please enter the number of masks to divide the data
into\n';
NumMasks = input(MasksPrompt);
MaskPopulation = int64(NumGoodPixels/NumMasks);
Intervals = zeros(2,NumMasks);
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%--Then, we want to to figure out the ranges in mask values that
correspond
%to those numbers. variable: 2xNumMasks array which holds start and
end
%values for each mask. ImageDims(2) x NumMasks array which holds
the masks
maskIndex = 1;
Intervals(1,maskIndex)= AllValues(1);%lower bound of first mask
%
Intervals(1,maskIndex) = 1000; %9/17/2018 --just kidding, see
above
Intervals(2,maskIndex)= AllValues(MaskPopulation); %upper bound
for maskIndex = 2:NumMasks-1
Intervals(1,maskIndex) = AllValues(MaskPopulation*(maskIndex1)+1);
Intervals(2,maskIndex) = AllValues(MaskPopulation*(maskIndex));
end
maskIndex = NumMasks;
Intervals(1,maskIndex) = AllValues(MaskPopulation*(maskIndex-1)+1);
Intervals(2,maskIndex) = AllValues(NumGoodPixels);
end

The next step is to sort the pixels in each data set into T1 bins, and then to fit the resulting
clumps of pixels to our functional form. Assuming the intervals have been defined (either from
an existing FittingGear struct, or as re-determined by the above function) , then we can call:
[sorted] = sortIntoBins(StructCalibration, NumMasks, Intervals)
StructCalibration.sorted = sorted

Where ‘sorted’ is basically a discretized T1 map, with each pixel holding the T1 bin number. It is
used in the function defineUseable( ) to weed out pixels
I haven’t written functions for these, just scripts which can be used as templates for any
further use. For example, in this case I was using a data set which I named ‘TFL’ (as it was the
first collected with this sequence )contained in a ‘StructCalibration’ variable which I had named
‘TestStructDelta’ :
np = ones(1,26); %this index is for the CEST values vectors
TestStructDelta = defineUseable(TestStructDelta, 0, .2, 0.1, 1.5);
for i = 1:240
for j = 1:180
if (TestStructDelta.useable(i,j))
bin = TestStructDelta.sorted(i,j);
for m = 1:6 %loop over nominal B1 values
PosValsByBin_TFL(bin,np(bin)) =
TestStructDelta.CESTposImages(i,j,m);
NegValsByBin_TFL(bin,np(bin)) =
TestStructDelta.CESTnegImages(i,j,m);
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B1valsByBin_TFL(bin,np(bin)) =
TestStructDelta.B1map(i,j) * TestStructDelta.B1vals(m);
np(bin) = np(bin) + 1;
end
end
end
end
npTFL = np;

Basically, what we’ve done here is sorted all of the CEST values and absolute (nominal * B1
map) B1 values into vectors. The length of these vectors is tabulated by the tally ‘np’, which
stands for ‘number of points’. Basically, ‘np’ in each bin index is going to correspond to the
number of ‘useable’ pixels in that bin in that dataset, as defined by this first function called by
the script:
Define useable pixels of data set:
%Define useable area of calibration images
%Requirements:
% 1)B1 map value has to have a certain value
% 2)T1 value has to fall into range of bins
% 3)Data has to be "good" (if using ‘CheckData’)
% 4)CEST signal has to be within certain bounds
%Update, 8/29/2019: Now takes B1threshold as an input argument
%Update, 9/14/2019: CEST threshold now has to be met for more points
%Update, 9/17/2019: Re-introduce "GoodYesNo".
%Note, 11/6/2020: CheckData and its internal function RightShape
return the element
%'CalibrationStruct.GoodYesNo' which is refences above) were
%originally meant for use in pixel-by-pixel fitting; they should
really be necessary now that pixels in one bin are being fit all
once. However,
%in some cases where data is excessively noisy, its use may help
exclude
%problematic pixels.
function StructCalibration = defineUseable3(StructCalibration,
CEST_LB,CEST_UB, B1_LB, B1_UB)
%

B1threshold = 0.8; %%%%%%%%%
useable = StructCalibration.roiMask;
useable(StructCalibration.B1map > B1_LB) = 1;
useable(StructCalibration.B1map < B1_LB) = 0;
useable(StructCalibration.B1map > B1_UB) = 1;
useable = useable .* StructCalibration.sorted;
%useable = useable .* StructCalibration.GoodYesNo;
%9/17/2019
useable(StructCalibration.sorted <0) = 0;
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(which
not
at
to

%useable = useable .* StructCalibration.GoodYesNo;

%
= 0;
%

useable(StructCalibration.CESTposImages(:,:,1) < CEST_LB) = 0;
useable(StructCalibration.CESTposImages(:,:,2) < CEST_LB * 0.5)
useable(StructCalibration.CESTposImages(:,:,1) > CEST_UB) = 0;
useable(StructCalibration.CESTposImages(:,:,2) > CEST_UB) = 0;
% (above) lower bound for first B1 point, Struct 1. Make this 100

for
% prepTFL dataset, 1500 for TLE dataset -- still using as on
7/9/19
StructCalibration.useable = useable;
end

Now that we have PosValsByBin_DataSet, NegValsByBin_DataSet and B1valsByBin_Data, we’re
ready to fit these things to Equation [1].

vars = {'lengthCurrent', 'yfitN', 'yfitP', 'resnormN', 'resnormP',
'residualN', 'residualP', 'exitflagN', 'exitflagP', 'An', 'Ap', 'Cn',
'Cp', 'Dn', 'Ep', 'En', 'Ep'};
clear(vars{:})
E = E_TFL_test;
for i = 1:26
%NewSimpleArray = SimpleArray(SimpleArray ~= 0)
%July 16th, 2019: new E bounds
B1valsCurrent = B1valsByBin_TFL(i,:); NegValsCurrent =
NegValsByBin_TFL(i,:); PosValsCurrent = PosValsByBin_TFL(i,:);
B1valsCurrent = B1valsCurrent(B1valsCurrent ~= 0 );NegValsCurrent =
NegValsCurrent(NegValsCurrent ~= 0 );PosValsCurrent =
PosValsCurrent(PosValsCurrent ~= 0 );
lengthCurrent(i,:) = size(B1valsCurrent);
[yfitN(i,1:lengthCurrent(i,2)),resnormN(i),residualN(i,1:lengthCurrent(
i,2)),exitflagN(i),An(i),Cn(i),Dn(i),En(i)] =
curvefit_Abby_6(B1valsCurrent,NegValsCurrent,E(i));
[yfitP(i,1:lengthCurrent(i,2)),resnormP(i),residualP(i,1:lengthCurrent(
i,2)),exitflagP(i),Ap(i),Cp(i),Dp(i),Ep(i)] =
curvefit_Abby_6(B1valsCurrent,PosValsCurrent,En(i));
end
for i = 1:26
FitPars4Average(1,i)
FitPars4Average(2,i)
FitPars4Average(3,i)
FitPars4Average(4,i)

=
=
=
=

An(i);
Cn(i);
Dn(i);
En(i);

FitPars4Average(5,i) = Ap(i);
FitPars4Average(6,i) = Cp(i);
FitPars4Average(7,i) = Dp(i);
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FitPars4Average(8,i) = Ep(i);
end
%ResultsTFL =
[yfitP(i,1:lengthCurrent(i,2)),resnormP(i),residualP(i,1:lengthCurrent(
i,2)),exitflagP(i)];
% residualP_TFL = residualP; resnormP_TFL = resnormP;
% residualN_TFL = residualN; resnormN_TFL = resnormN;
% yfitN_TFL = yfitN; yfitP_TFL = yfitP;
% lengthCurrentTFL = lengthCurrent;
% FitPars4Average_TFL = FitPars4Average;
FitTFL.residualP = residualP; FitTFL.resnormP = resnormP;
FitTFL.residualN = residualN; FitTFL.resnormN = resnormN;
FitTFL.yfitN = yfitN; FitTFL.yfitP = yfitP;
FitTFL.lengthCurrent = lengthCurrent;
FitTFL.FitPars4Average = FitPars4Average;
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
figure, imagesc(FitTFL.FitPars4Average)
colormap('hsv'), caxis([-3e-4 3e-4])

After we’ve generated these ‘Fit***’ structs for every data set, we’ll take a weighted
average of the results to form the final correction surface. An algebraic description of
this math (rather than computer code) is provided in my B1 correction paper16. The
steps we’re doing below are: 1) counting the number of points in each vector 2) dividing
the residual norm vector for each fit by the value of the scaling parameter, E
(representing M0) for each fit 3) further dividing this result by the number of points in
that vector -- since either larger E or a larger number of points will automatically result
in the residual norm being larger, which does not reflect the fit being worse. This is
being done for all three data sets (A, B, C) for both the positive and negative offset fits.
(In the following code, you might want to replace labels ‘A’ ‘B’ and ‘C’ with more
descriptive names of the data set e.g., the initials of the subject they were created
from).
%Calculate residual norms normalized by E and by number of data points
NumberOfPoints_A = length(B1valsByBin_A);
NumberOfPoints_B = length(B1valsByBin_B);
NumberOfPoints_C = length(B1valsByBin_C);
resnormP_A_NormE = FittingResultsStructA.resnormP ./
FittingResultsStructA.FitPars4Average(4,:).^2;
resnormP_B_NormE = FittingResultsStructC.resnormP ./
FittingResultsStructC.FitPars4Average(4,:).^2;

16

Cember ATJ, Hariharan H, Kumar D, Nanga RPR, Reddy R. Improved method for post-processing
correction of B1 inhomogeneity in glutamate weighted CEST images of the human brain. NMR Biomed.
2021;in press.
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resnormP_C_NormE = FittingResultsStructB.resnormP
FittingResultsStructB.FitPars4Average(4,:).^2;

./

resnormP_A_NormENP = resnormP_A_NormE ./ NumberOfPoints_A;
resnormP_B_NormENP = resnormP_B_NormE ./ NumberOfPoints_B;
resnormP_C_NormENP = resnormP_C_NormE ./ NumberOfPoints_C;
resnormN_A_NormE = FittingResultsStructA.resnormN ./
FittingResultsStructA.FitPars4Average(4,:).^2;
resnormN_B_NormE = FittingResultsStructC.resnormN ./
FittingResultsStructC.FitPars4Average(4,:).^2;
resnormN_C_NormE = FittingResultsStructB.resnormN ./
FittingResultsStructB.FitPars4Average(4,:).^2;
resnormN_A_NormENP = resnormN_A_NormE ./ NumberOfPoints_A;
resnormN_B_NormENP = resnormN_B_NormE ./ NumberOfPoints_B;
resnormN_C_NormENP = resnormN_C_NormE ./ NumberOfPoints_C;
%Then, we initialize the matrix that will be our ‘final product’:
ParameterValue = ones(8,26);
% %To use three data sets
for i = 1:26
%This is a loop over T1 bins
%First we want to examine the value of resnorm_ENP of each data
set,and
%take its reciprocal
A0 = 1/resnormP_A_NormENP(i); B0 = 1/resnormP_TLE_NormENP(i); C0 =
1/resnormP_TFL_NormENP(i);
Sum = A0+B0+C0;
Coefficient = 1/Sum;
A1 = A0*Coefficient; B1 = B0*Coefficient; C1 = C0*Coefficient;
for p = 5:7
%This is a loop over fitting parameters
ParameterValue(p,i) = A1*FitA.FitPars4Average(p,i)+
B1*FitB.FitPars4Average(p,i)+C1*FitC.FitPars4Average(p,i);
end
%Paramters 1-3 hold negative offset values
%Parameters 5-7 hold positive offset values
%Parameters 4 and 8 are E i.e. M0, the scaling parameter
A0 = 1/resnormN_A_NormENP(i); B0 = 1/resnormN_TLE_NormENP(i); C0 =
1/resnormN_TFL_NormENP(i);
Sum = A0+B0+C0;
Coefficient = 1/Sum;
A1 = A0*Coefficient; B1 = B0*Coefficient; C1 = C0*Coefficient;
for p = 1:3
ParameterValue(p,i) = A1*FitA.FitPars4Average(p,i)+
B1*FitB.FitPars4Average(p,i)+ C1*FitC.FitPars4Average(p,i);
end
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end

Now that we’ve filled this matrix called ‘ParameterValue’, we’re going to evaluate
Equation 1 to make surfaces described by these parameters, smooth that surface, and
then refit it to Equation 1 to get our final ‘Correction Surfaces’.
for i = 1:26
%ParameterValue(4,i) = 1; ParameterValue(8,i) = 1;
surfaceP(i,:) = evaluateJanuary2019(ParameterValue(:,i),1);
surfaceN(i,:) = evaluateJanuary2019(ParameterValue(:,i),-1);
end
%Now smooth the surface, with some degree of Gaussian filtering
SmoothSurfaceP = im_filtNew(surfaceP,5);
SmoothSurfaceN = im_filtNew(surfaceN,5);
%Or no filtering
% SmoothSurfaceP = surfaceP;
% SmoothSurfaceN = surfaceN;
FittedSurfaceP = zeros(26,51);
FittedSurfaceN = zeros(26,51);

x = [0:5:250];
for i = 1:26
[FittedSurfaceP(i,:),~,~,~,Ap(i),Cp(i),Dp(i),Ep(i)] =
curvefit_Abby_6(x, SmoothSurfaceP(i,:), 1);
[FittedSurfaceN(i,:),~,~,~,An(i),Cn(i),Dn(i),En(i)] =
curvefit_Abby_6(x, SmoothSurfaceN(i,:), 1);
end

for i = 1:26
FitPars4Average(1,i)
FitPars4Average(2,i)
FitPars4Average(3,i)
FitPars4Average(4,i)

=
=
=
=

An(i);
Cn(i);
Dn(i);
En(i);

FitPars4Average(5,i)
FitPars4Average(6,i)
FitPars4Average(7,i)
FitPars4Average(8,i)

=
=
=
=

Ap(i);
Cp(i);
Dp(i);
Ep(i);

end
FittedSurfaceParameters = FitPars4Average;
figure, imagesc(FittedSurfaceParameters)
caxis([-3e-4 3e-4]), colormap('hsv'), colorbar
%Use smoothed, fitted surface to create Fitting Gear
FittingGearNew.NumMasks = 26;
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FittingGearNew.intervals = IntervalsA_B_C;
FittingGearNew.FitPars4Average = transpose(FittedSurfaceParameters);
FittingGearNew.averagesPos = SmoothSurfaceP;
FittingGearNew.averagesNeg = SmoothSurfaceN;

End of ‘Creating Fitting Gear Structs’
We’ve now generated a ‘FittingGear’ struct of the kind used by the B1 correction code described
above. Note that my code (MAINFunction_CorrectUsingFittingGear319A.m) can
only handle 2D CEST data. For processing 3D CEST data, we need to use Hari’s GUI-based code,
CEST3DB1NEW.m.
Evaluate() and CurveFit()
However, before we move on, we need to take a look at the key subfunctions from above
process: evaluateJanuary2019() and curvefit_Abby_6(). These are the functions that actually
define the functional form, a.k.a Equation 1. For outdated reasons, the variables here are
designated with the letters {B,C,D} instead of their current form of Greek letters. Evaluate() does
just what it sounds like: it simply takes the values that you want to plug in for each variable and
evaluates the expression. It’s used to generate curves or sufaces (which are families of curves)
from parameter values.
function curve = evaluateJanuary2019(parameters, offset)
%Now with an extra parameter for scaling instead of sending normalized
%data.
Bn = parameters(1); Cn = parameters(2); Dn = parameters(3); En =
parameters(4);
Bp = parameters(5); Cp = parameters(6); Dp = parameters(7); Ep =
parameters(8);
x = [0:5:250];
curveN = En*(1+(Bn*x.^2 ./ (Cn*x.^2 +1)) - Dn*x.^2);
curveP = Ep*(1+(Bp*x.^2 ./ (Cp*x.^2 +1)) - Dp*x.^2);
if (offset == 1)
curve = curveP;
end
if (offset == -1)
curve = curveN;
end
end

The opposite is done by curve_fit_Abby_6() – it takes data which is assumed to fall along a
curve, and fits it to generate parameter values. What’s a little bit confusing here is that the real
fitting is done by lsqcurvefit() (LSQ stands for “least squares”), which is a built-in Matlab
function. The reason we need our own function as a “wrapper” is because we’re defining some
customized functional form. If we wanted to use one of the built-in options, like a regular linear
fit, we wouldn’t need to do this. Something very tricky happens when we actually call
lsqcurvefit() : as one of the input arguments, we actually send it a handle to another function,
called composite(). That’s where our customized functional form is defined – we specify the
259

initial guess for the parameters in curve_fit_Abby_6(), but the definition of their actualy ‘role’
doesn’t show up until composite().
function [yfit,resnorm,residual,exitflag,B,C,D,E] = curvefit_Abby_6(x,
yin, E)
%Note: while we retain the option to send E as an input argument, right
now
%this has no functionality. E will be fit separately for each pixel's
%positive and negative offset curve.
%plot(x, yin, 'or','markerFaceColor', 'r')
np = length(x); %number of points
if (length (yin) ~= np)
error('curvefit_Abby: x and y array sizes do not match')
end
if ( size(x,1) == size(yin,1) )
y = double(yin);
else
y = double(yin)';
end
pars = double(4);
lb = double(4);
ub = double(4);
%
%
%
%
%
%
%
%
%
%

%fill pars with initial guess values%%%%%%%%%%%%%%%%%%%
from simulation of CEST with MT and DS:
B
-0.1135
* 1.9837 e-4 = -2.25e-5
C
0.0932

* 1.9837 e-4 = 1.85e-5

D
-0.0040 * 1.9837 e-4 = 8e-7

pars(1) = -2.25e-5; %A (called B in this function)
pars(2) = 1.85e-5;% %C
pars(3) = 6e-7; %D -- had been 8e-7
pars(4) = 2000; %E
lb(1) = -1e-3;
lb(2) = 1e-7;
ub(1) = 1;
ub(2) = 1;%1;
lb(3) = 6e-7;%-1;
ub(3) = 6e-7;%1e-5
if (E) %The intention here is that if E is predetermined and sent to
the function, then we want to freeze it at that value.
pars(4) = E;
lb(4) = E;
ub(4) = E;
else
lb(4) = -100;%-100;
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ub(4) = 3500;%10000;
end

%Took these options from Hari:
oldoptions = optimoptions('lsqcurvefit');
%options = optimoptions(oldoptions, 'TolFun', 1e-18,'TolX', 1e18,'MaxFunEval',20000,'MaxIter', 12000 );
%Above: current code. Below: experimentation on 8/6/2018
% options = optimoptions(oldoptions, 'TolFun', 1e-5,'TolX', 1e5,'MaxFunEval',1000,'MaxIter', 1000 );
options = optimoptions(oldoptions, 'TolFun', 1e-12,'TolX', 1e12,'MaxFunEval',1000,'MaxIter', 10000 );
[ip, resnorm, residual, exitflag,~,~,~] =
lsqcurvefit(@composite,pars,x,y,lb,ub,options);
%[ip, resnorm, ~, ~,~,~,~] =
lsqcurvefit(@composite,pars,x,y,lb,ub,options);
%This 'pars' will become 'ip' used by composite; x will be sent as x.
% Fitted parameters are returned back in ip.
% ...
%Refill arrays A, B, C and D to return
%Initialize and refill yfit to return
yfit = x*0;
B
C
D
E

=
=
=
=

ip(1);
ip(2);
ip(3);
ip(4);

% yfit = yfit + ((1.0)./(A*x.^2 +1)) + (B*x.^2 ./ (C*x.^2 +1)) D*x.^2;
%yfit = yfit + E*(((1.0)./(A*x.^2 +1)) + (B*x.^2 ./ (C*x.^2 +1)) D*x.^2);
yfit = yfit + E*(1 + (B*x.^2 ./ (C*x.^2 +1)) - D*x.^2);
%disp(transpose(yfit)); -- Useful if you want to copy into an Excel
sheet
end
function yfit = composite(ip,x)
yfit = x*0; %This initializes the result by creating a vector the
same size as x, but of all zeros.
%Assign parameters from argument vector
b = ip(1);
c = ip(2);
d = ip(3);
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e = ip(4);

%define functional form
% yfit = yfit + ((1.0)./(a*x.^2 +1)) + (b*x.^2 ./ (c*x.^2 +1)) d*x.^2;
%yfit = yfit + e*(((1.0)./(a*x.^2 +1)) + (b*x.^2 ./ (c*x.^2 +1))
- d*x.^2);
yfit = yfit + e*(1+ (b*x.^2 ./ (c*x.^2 +1)) - d*x.^2);
end

Post-processing of 3D CEST data
This GUI works as do previous versions of Hari’s GUI for post-processing of CEST data (my
intention is that the individual functions will be documented in more detail elsewhere). The
feature that has been added to incorporate my B1 correction is the option ‘NEWB1’ in the menu
that appears when one clicks the button “Calculate B1 corrected CEST”. This correction relies
upon two things: that you have loaded the T1 map (MP2RAGE) instead of an MT image, and the
presence of a file in the directory called “NewgluCESTB1Cal.mat”. This .mat file holds
information analogous to that in a ‘FittingGear’ struct. Multiple versions of this file can be saved
in the directory; only the one with this exact file name will be used (unless you edit the code to
do otherwise).
The contents of this .mat file are:
--a double (regular number) called ‘NumMasks’
--a 2 x 26 double (vector) called ‘Intervals’
--a 26 x 8 double (vector) called ‘B1FitPars’
One can take a FittingGear struct and generate the variables needed in this .mat file by simply
doing the following:
Intervals = FittingGear_319A.intervals;
B1FitPars = FittingGear_319A.FitPars4Average;
NumMasks = FittingGear_318A.NumMasks;

Then, save the three variables into a .mat file and give it the file name “NewgluCESTB1Cal.mat”.
I would recommend that you save it with some designation indicating which FittingGear it came
from, and then make a copy which has the default “…Cal.mat” name when you actually want to
run it inside CEST3DB1NEW.
One useful thing to note before getting started is that, unlike the 2D post-processing pipeline in
which we had to create Dicoms and NIFTIs as a separate step, this GUI should do it for you
automatically – both for the final CEST maps and the images comprising intermediate steps. The
NIFTIs will be in the same newly created directory that the Dicoms are in.
We can walk through the whole process with some screenshots:
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When you press
“run” (green
“play” button) or
type
‘CEST3DB1NEW’
into the command
line, this GUI
should appear.
Frustratingly, on
Windows at least,
it is scrunched like
this an cannot be
expanded. The
first thing to notice
is that there are
two “menus”
where our
selection is
highlighted in
blue: We have
chose “Siemens”
data instead of
“Bruker” (which is
the animal
scanner), and
“Neg” instead of
“MTR”. This
second
designation is a
choice of how to
normalize the CEST asymettry data. I would say that negative normalization is the default. There
may, however, be intances where you want to normalize by the 0 ppm image of the MTR
acquisition, which is why this option is here.
The first thing you will want to do – provided you already have the data sorted into directories;
if not, run cdsort3d – is click the button ‘1. Load REF images’. When prompted, you should
choose the “NONE” images for the CEST acquisition. For the prep-TFL based 3D gluCEST
sequence, I think the none image is just called _sat_hippo, or something similar. A window will
appear where these are visible. If you don’t see the slice you think you are processing data for,
stop now, figure out what’s wrong, and start over. After you close this window, if you want to
see the references images at any later time, click button 1A. (This is the function of all of the
other ‘A’ buttons: they just let you display something again that you already calculated and
might have closed.)
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The next step is to choose the ROI. This GUI is
assuming that you want to do this manually. If you
have an ROI as an output from some other program
(like an automatic segmentation), then you will need
to either a) not use this GUI or b) feed the GUI your
pre-existing ROI matrix. I will try to address how to
do this later. When you click button 2, you will be
asked a) whether you want an ROI (I think the
alternative is that it does the processing on the
whole image, but you shouldn’t do this, because it
will waste computational time calculating on empty
space) b) whether you want them to be defined
separately for each slice and c) and which tool to
use. The best selection for the latter is “Poly”, which
allows you to define a polygon with as many sides
(and therefore, whatever arbitrary shape) you want
by clicking with t he mouse each time you want one line segment to end and another to begin.
In the picture here, I chose to draw an ROI that’s “Common for all slices”, so it gave me the
middle slice of the reference image to draw on: Slice 8. Every blue circle is where I clicked the
mouse to “cut out” the brain mask. To complete
ROI selection, double click somewhere inside the
polygon. I always choose the “Display ROI” to be
the same as the “Processing ROI”. Because
drawing manual ROIs is tedious, I highly
recommend that you click “Save All” after you
have drawn the ROI. If Matlab crashes or
anything else goes wrong in later steps, you don’t
want to have to do this over again.
Next we’re going to load the WASSR scan and
calculate the B0 map. Note that there are actually
options for B0 mapping: WASSR or Field Mappping, which is the option presented by button 4.
So, you will only every use one of these two buttons to process the data for a particular
experiment. (For clarification, the WASSR scan itself does not automatically generate a B0 map –
as in, that’s not what you see on the scanner or in these images. The B0 map has to be calculated
from the WASSR acquisitions, which have a structure similat to the CEST acquisition: we
collected several images with saturation at different offsets. If you want to understand the
general idea of how this works, you can read the original paper.17) Calculating the B0 map the
most computationally intensive step of the CEST post-processing. If anything is wrong, Matlab

17

Kim M, Gillen J, Landman BA, Zhou J, Van Zijl PCM. Water saturation shift referencing (WASSR) for
chemical exchange saturation transfer (CEST) experiments. Magn Reson Med. 2009;61(6):1441-1450.
doi:10.1002/mrm.21873
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may crash during this step, hence my earlier recommendation. If this keeps happening, try
recompiling the B0 correction related mex files with the compiler flag that I mentioned at the
beginning.
…
Please note that this documentation is a work in progress, as of April 2021 when this thesis was
submitted. If you have found this thesis online at a later date and are seeking the contents listed
below as “Coming soon”, please search for Abigail Cember on LinkedIn, ResearchGate, GitHub or
on the website of the Center for Advanced Metabolic Imaging in Precision Medicine, U. Penn.,
where a final version of this documentation as well as updates to the code it describes will be
provided in the future.
Coming soon:
--The rest of 3D gluCEST processing
--How to run segmentation on Freesurfer for cortical gray matter or in ITK-SNAP for the medial
temporal lobe
--How to respace the Freesurfer segmentation so that you can overlay it with your original T1
and CEST maps
--How to take these segmentations and reslice them using c3d
--How to use lstat, either in the GUI or in command line, to get regional averages of gluCEST or
any other map type
--How to use the resliced NIFTIs and CEST maps to generate histograms and other types of
visualizations that I like in Matlab (back to code written by Abby)
--How to run T-tests on your CEST data for statistical significance
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Сама наука не простоит минуты без красоты.
Ф.М. Достоевский
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